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Abstract 
Introduction: Coronary Wave Intensity Analysis (WIA) provides an invasive measure of 
energy transfer within the coronary circulation. I set out to derive a non-invasive 
measure of the backward expansion wave (BEW) responsible for coronary flow and 
assess it during exercise and in aortic stenosis (AS). 
Methods: 17 patients (mean age 60, 11 male) with normal cardiac function underwent 
invasive LAD WIA calculation using a pressure- and flow-tipped wire. Non-invasive WIA 
was calculated immediately after angiography from simultaneous PW Doppler of the 
LAD and a suprasystolic-cuff derived measure of central pressure. Non-invasive WIA 
was then assessed in 9 healthy volunteers whilst exercising on an exercise bike, 25 
patients with varying degrees of AS (AVmax range: 2.41-5.43m/s) and 29 patients 
before, after and at 6 and 12 months following aortic valve intervention for severe AS. 
Results:  Mean peak BEW was -14.7± 8.7x104 Wm-2s-2 invasively and -14.4± 8.2 Wm-2s-2 
non-invasively and increased with exercise (at peak: -20.5±6.8Wm-2s-2, p=0.02) along 
with a rise in coronary flow (28.8cm/s to 42.1cm/s, p 0.06).  
A significant correlation was noted with the BEW and AS severity, strongest when 
valvulo-arterial impedence was assessed (r=-0.66, p<0.001). In severe AS, a reduction in 
coronary flow (0.41 to 0.33m/s, p<0.01) and the BEW (-22.1 vs 10.9x104Wm-2s-2, 
p<0.01) was seen after intervention. With LVH regression BEW increased (-
21.6±12.6x104 Wm-2s-2 at 6 months) without a significant change in coronary flow. 
Conclusion: It is possible to construct a non-invasive measure of coronary WIA thus 
markedly increasing its applicability. Using this technique, the BEW is seen to increase 
during progressive levels of exercise accounting for the increase in coronary flow. The 
7 
 
BEW progressively climbs with increasing AS, falls to sub-normal levels after aortic 
valve intervention but then increases to normal levels with LVH regression. 
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1 INTRODUCTION: MYOCARDIAL ISCHAEMIA IN AORTIC STENOSIS 
AND THE APPLICATION OF WAVE INTENSITY ANALYSIS 
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1.1 AORTIC STENOSIS AND SYMPTOMS 
 Calcific aortic stenosis (AS) is the most common reason for aortic valve 
replacement (AVR) in developed countries and affects 2-3% of individuals by the age of 
65(Lindroos et al., 1993). As the disease state progresses, it is associated with left 
ventricular hypertrophy (LVH), a process characterised by the enlargement of cardiac 
myocytes, accumulation of sarcomeric proteins and reorganisation of the myofibrillar 
structures(Yang et al., 2007). This is initially a compensatory mechanism to maintain an 
appropriate ejection fraction but ultimately results in myocardial ischaemia. This is 
reflected clinically as the well-recognised symptoms of aortic stenosis: chest pain, 
shortness of breath or syncope. 
The occurrence of symptoms also leads to a rapid decline in prognosis and this is 
felt therefore to represent the onset of significant myocardial ischaemia and, 
uncorrected, leads to a decline in cardiac function(Ross and Braunwald, 1968) with a 
50% mortality over the following 1-3 years(Ross and Braunwald, 1968, Caruthers et al., 
2003, Leon et al., 2010). This marker of symptom-onset is therefore used to guide the 
need for aortic valve intervention(Bonow et al., 2008).  
However, this apparent ‘binary’ nature of ischaemia aortic stenosis is not quite 
so straight-forward as even in asymptomatic patients there is evidence of myocardial 
ischaemia through exercise testing(Rafique et al., 2009), BNP levels(Rajani et al., 2010), 
exercise ejection fraction(Marechaux et al., 2007), peak aortic velocity or valve 
area(Rosenhek et al., 2010), and strain patterns(Kitai et al., 2011). Moreover, other 
studies have demonstrated that both mild and moderate aortic stenosis impart a higher 
risk of cardiovascular events than the background population(Horstkotte and Loogen, 
1988, Kennedy et al., 1991, Otto et al., 1997, Rosenhek et al., 2004) 
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It is therefore perhaps not surprising that more recent studies have promoted 
the idea that asymptomatic aortic stenosis may not be so benign, particularly when very 
severe(Rosenhek et al., 2010, Kitai et al., 2011) and the merits of pursuing a more 
aggressive treatment strategy in these patients has been demonstrated(Kang et al., 
2010), although strong evidence for this approach is lacking at present(McCann et al., 
2011). Despite this, current guidelines would advocate the onset of symptoms as the 
most reliable marker of myocardial ischaemia and this is used to guide the need for 
aortic valve intervention as (Bonow et al., 2008, Vahanian et al., 2007). 
 
1.2 CAUSE OF CALCIFIC AORTIC STENOSIS AND LEFT VENTRICULAR HYPERTROPHY 
The concept of calcific aortic valve disease as a degenerative and unmodifiable 
process induced by long-term mechanical stress has now been revised. Recent studies 
have suggested that the calcification process in aortic valves is actively regulated(Yetkin 
and Waltenberger, 2009) with the observance of inflammatory (Akat et al., 2008) and 
neovascular (Mazzone et al., 2004) changes at a histological level. Aortic valve 
calcification is most likely initiated in a similar fashion to atherosclerosis as a 
“response-to-injury”(Rajamannan et al., 2002). For example, a correlation has been 
noted between aortic valve sclerosis (without valve leaflet restriction) and relative risk 
of death(Otto et al., 1999), a new coronary event(Aronow et al., 1999) or prognosis in 
patients who suffer with chest pain(Chandra et al., 2004). This initially promoted the 
idea that statins may be used in the treatment of aortic stenosis which was supported 
by retrospective studies (Chua and Kalb, 2006, Chan et al., 2010). Initial prospective 
work using atorvastatin failed to show a benefit on aortic valve calcification or velocity 
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(Cowell et al., 2005); however, a later study demonstrated a protective effect of 
rosuvastatin in terms of aortic valve gradient and area (Moura et al., 2007). 
The process of myocardial hypertrophy is also a dynamic one. Left ventricular 
wall thickness has a constant relationship with its systolic pressure(Gaasch, 1979) and 
hypertrophy is considered one of the most important mechanisms in adapting to the 
haemodynamic overload of aortic stenosis allowing cardiac performance to be 
maintained despite these high outflow pressures(Grossman et al., 1975). Wall-stress 
can therefore be displayed mathematically as a relationship between pressure and wall 
thickness as in Equation 1-1 so that as pressure increases, so does wall 
thickness(Gould and Carabello, 2003). 
 
Wall stress = Pressure x Radius / Thickness  
EQUATION 1-1. WALL STRESS AND ITS RELATIONSHIP TO PRESSURE AND WALL THICKNESS 
 
Myocytes make up 75% of the left ventricle by weight and their hypertrophy is 
seen in all conditions that produce either pressure or volume overload of the ventricles. 
Myocyte hypertrophy can be seen in various extreme physiological conditions where 
individuals undergo high levels of isometric exercises (such as weightlifters) without 
adverse prognostic implications. However, this hypertrophy is histologically well 
organised and there is no increase in collagen content, parenchymal cell loss or fibrosis 
in contrast to LVH secondary to AS or hypertension(Gradman and Alfayoumi, 2003). 
The myocardial hypertrophy of LVH is mediated through an increase in 
sarcomere synthesis which reflects a switch to foetal gene expression and begins almost 
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immediately after pressure loading(Yetkin and Waltenberger, 2009). There is also 
evidence of apoptosis in both experimental and clinical cardiac hypertrophy(Yetkin and 
Waltenberger, 2009) and in those with severe AS and LVH(Galiuto et al., 2006). The 
presence of LVH increases cardiac morbidity and mortality(Villa et al., 2006) and in 
aortic stenosis LV mass predicts the presence of systolic dysfunction and heart failure 
independent of the severity of valvular obstruction(Kupari et al., 2005). 
1.3 EVIDENCE FOR CORONARY MICROVASCULAR DYSFUNCTION IN AORTIC STENOSIS 
Myocardial ischaemia results when cellular oxygen demand exceeds supply. In 
patients with severe aortic stenosis and angiographically normal coronary arteries, 
angina is reported in 30-40%(Julius et al., 1997) and this is one of the crudest 
demonstrations of the presence of ischaemia in aortic stenosis. Appropriately therefore, 
it is also a marker of severity and increases the risk of sudden death(Kelly et al., 1988). 
Microvascular dysfunction is often expressed investigatively as coronary flow 
reserve (CFR), a measure of maximal flow capacity of the resistance vessels. It is defined 
as the maximal increase in myocardial blood flow above its resting level for a given 
perfusion pressure where the coronary vasculature is maximally dilated(Garcia et al., 
2009). In the absence of epicardial (angiographically-demonstrable) disease, CFR 
reflects microvascular dysfunction(Kaufmann and Camici, 2005). It has been speculated 
that the microvascular dysfunction in severe aortic stenosis may be a major component 
in the progression to heart failure and may also allow ventricular arrhythmias to 
emerge(Levy et al., 1987). 
Several investigative tools have been used since the late 1960s to demonstrate 
microvascular dysfunction in aortic stenosis as summarised below. 
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1.3.1 LACTIC ACIDOSIS PRODUCTION 
Coronary microvascular dysfunction was initially noted in invasive studies of 
humans(Fallen et al., 1967) and animals(Griggs et al., 1973) with aortic stenosis and no 
angiographic disease. It was appreciated that these subjects had a relative increase in 
myocardial lactate production in response to pharmacological stimulation compared to 
controls. 
1.3.2 THALLIUM-201 POSITRON TOMOGRAPHY AND HOLTER MONITORS 
Thallium scans of patients with significant aortic stenosis often demonstrate 
perfusion deficits. However, 43% of the patients scanned in one study had normal 
coronary arteries at angiography(Kupari et al., 1992). ST segment shift has also been 
observed on 24-hour holter monitors of patients with LVH and normal angiograms 
suggesting episodes of ischaemia occurred over this period of time(Scheler et al., 1992). 
1.3.3 THERMODILUTION AND INVASIVE DOPPLeR TECHNIQUES 
CFR, as obtained from the coronary sinus thermodilution technique, has been 
shown to be significantly reduced in patients with severe AS and anginal-symptoms 
compared to both asymptomatic patients with severe AS and controls(Julius et al., 
1997). This value improved when reassessed 12 months after valve replacement(Eberli 
et al., 1991). Invasive coronary Doppler has also demonstrated a reduced CFR in AS 
with LVH measured at the time of aortic valve replacement using a brief occlusion of the 
Left Anterior Descending Artery (LAD) to generate hyperaemia(Marcus et al., 1982).  
1.3.4 ECHOCARDIOGRAPHY 
Echocardiography (largely, so far, transoesophageal - TOE) has been used to 
measure coronary flow in aortic stenosis. Patients with severe aortic stenosis have been 
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shown to have a higher peak diastolic coronary flow velocity compared with normal 
subjects (Meimoun et al., 2012) and an inverse relationship between peak systolic 
velocity and aortic valve gradient. It was also recognised that asymptomatic patients 
with aortic stenosis had a lower coronary velocity to mass index compared to 
symptomatic patients (Isaaz et al., 1994).  
Additionally, Omran et al. demonstrated a liner relationship between aortic valve 
gradients and peak diastolic velocity with higher velocities in aortic stenosis patients 
with chest pain or syncope compared to those who were asymptomatic. This group also 
showed that peak diastolic velocity in patients with severe aortic stenosis and shortness 
of breath did not differ significantly from controls(Omran et al., 2011).  
More recently, quantitative myocardial contrast echocardiography has shown 
that myocardial blood flow in the subendocardium but not subepicardium is reduced in 
patients with aortic stenosis(Galiuto et al., 2006). As assessed by this method, 
subendocardial blood flow improved immediately after aortic valve replacement (at 2 
weeks) and was maintained in the long term (at 1 year)(Miyagawa et al., 2009).  
The effect of transcatheter aortic valve implantation (TAVI) on coronary flow 
velocity has also been assessed using TOE and has demonstrated an immediate increase 
in coronary flow velocity after TAVI(Ben Dor et al., 2009) although this may reflect 
anaesthetic or iatrogenic-inotropic effects. 
Stress echocardiography using adenosine demonstrated a reduced CFR in 
patients with severe aortic stenosis as well as highlighting an improvement in CFR and 
LVH six months after valve replacement (Hildick-Smith and Shapiro, 2000). Impairment 
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of the coronary flow reserve in these patients has been linked with aortic valve area and 
peak aortic gradient rather than the degree of LVH(Kume et al., 2004). 
1.3.5 PET SCANNING 
PET scanning is another novel way to assess the myocardial burden from AS. 
Studies have clearly demonstrated reduced myocardial perfusion and have even been 
able to confirm this is most severe in the subendocardial layer echoing the results found 
in experimental animal models of aortic stenosis(Vinten-Johansen and Weiss, 1980). 
Using PET, the severity of CFR impairment has been linked to aortic valve area, 
imposed haemodynamic load and diastolic perfusion time rather than left ventricular 
mass(Rajappan et al., 2003, Rajappan et al., 2002), similar to those results found with 
TOE (Isaaz et al., 1994, Omran et al., 2011). PET scanning can also be used to distinguish 
types of low-flow, low-gradient aortic stenosis where a reduced CFR separates those 
with severe AS but preserved myocardial reserve from those with heart failure and low-
output(Burwash et al., 2008).  
 
1.4 CAUSE OF MYOCARDIAL ISCHAEMIA IN AORTIC STENOSIS 
Several potential mechanisms have been suggested in the aetiology of 
myocardial ischaemia in aortic stenosis(Kingsbury et al., 2000). Some of these proposed 
concepts are based on studies of LVH induced by obstruction after the origin of the 
coronary vessels (e.g. though aortic banding or hypertension). Aortic stenosis obviously 
produces pressure changes before their origin so these results should be interpreted 
cautiously but the results remain interesting and may still be applicable to AS. 
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1.4.1  DECREASED DENSITY OF CORONARY RESISTANCE VESSELS IN HYPERTROPHIED 
MYOCARDIUM 
 Changes in the vascular bed do not seem to parallel myocyte growth in LVH. In 
pig(Breisch et al., 1986) and dog(Mueller et al., 1978) models of left ventricular 
hypertrophy with impaired CFR, anatomical studies showed hypertrophy causes a 
reduction in endomyocardial capillary density. Interestingly, a separate study has 
shown this phenomenon is less evident at one year suggesting there may be a lag, rather 
than absolute deficit, between LVH and new vessel growth(Bishop et al., 1996).  
A similar relative reduction in cardiac vessel growth during hypertrophy has also 
been demonstrated in rats by assessing cardiac cyclic-GMP (cGMP) kinase levels; c-GMP 
is a protein involved in the regulation of vascular smooth muscle tone(Ecker et al., 
1989). In humans, autopsy studies of patients with LVH due to aortic stenosis have 
shown a decrease in coronary capillary density in comparison to controls(Rakusan et 
al., 1992). 
1.4.2  INCREASED PERIVASCULAR COMPRESSION DUE TO CHANGES IN MYOCARDIAL 
STRUCTURE AND A GREATER COMPRESSIVE EFFECT OF SYSTOLE 
 In humans, there is a linear correlation between coronary resistance and left 
ventricular end diastolic pressure (LVEDP) suggesting the importance of these external 
compressive forces(Gould and Carabello, 2003); however, the reduction in coronary 
reserve is proportionally greater than the increase in LVEDP reinforcing the multi-
factorial nature of this problem. In the guinea pig model, the effect of perivascular 
compression, as well as the increase in the compressive effect of systole has been 
demonstrated to impact negatively on coronary flow reserve with LVH(O'Gorman et al., 
1992). 
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 Studies with PET scanning in adults pre- and post-aortic valve replacement for 
aortic stenosis have shown a strong correlation between CFR and the haemodynamic 
load on the left ventricle and haemodynamic severity of the valve stenosis. They did not 
find a relationship with left ventricular mass and go on to suggest microvascular 
dysfunction results predominantly from extravascular compressive mechanisms as well 
as changes in diastolic perfusion time (see 6)(Vinten-Johansen and Weiss, 1980, 
Rajappan et al., 2003). 
1.4.3  INCREASED MUSCLE MASS 
 Obviously, the more muscle mass present, the higher the oxygen demands of the 
heart will be. On a relatively macroscopic level, the size of the large coronary arteries 
increases with LVH and after aortic valve replacement the arteries return to 
normal(Villari et al., 1992). Studies in animals and humans have suggested that the 
increase in size is not proportional to the increase in cross-sectional muscle mass 
creating a relative imbalance in oxygen supply and demand(Breisch et al., 1986, 
Schwartzkopff et al., 1992).  
However, it is important to acknowledge that the increased oxygen demand from 
LVH and relative mismatch in supply play less of a role than once thought. This is 
illustrated by the fact that after an aortic valve replacement the left ventricle 
progressively remodels over a period of years(Monrad et al., 1988) but it is well 
recognised the angina and the risk of sudden death decrease instantly(Gould and 
Carabello, 2003). Additionally, the degree of LVH does not seem to bear relation to the 
development of anginal symptoms(Julius et al., 1997).  
Furthermore, in animal models an 8% reduction in LV mass produced a 
significantly larger improvement in coronary flow reserve(Gould and Carabello, 2003). 
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Similar results have been obtained from PET scans of humans before and after aortic 
valve replacement(Carpeggiani et al., 2008b). This data may seem to conflict with the 
above correlation between LV mass and the presence of systolic dysfunction(Kupari et 
al., 2005); this likely reflects the multi-factorial nature of both CFR and heart failure in 
AS. 
1.4.4  INCREASED DIFFUSION DISTANCE FROM CAPILLARY TO CENTRE OF HYPERTROPHIED 
MYOCARDIAL CELLS 
It has also been suggested that as the myocytes increase in size, there is an 
increased diffusion distance from the capillary to the centre of the cell(Zhu et al., 1996, 
Just et al., 1996). Additionally, the pressure within the myocardial cells is 
increased(Carpeggiani et al., 2008b) and these factors will impair oxygen transfer. 
However, these findings are not supported in all studies(Anversa et al., 1986). 
1.4.5  RELATIVELY LOW AORTIC PRESSURES 
Classical teaching states that aortic stenosis is associated with a relatively low 
aortic pressure and a narrow pulse pressure(Purcell and Kalra, 2011). As the disease 
progresses and the ejection fraction falls, the pressure within the coronary sinus falls 
even further, exacerbating the ischaemic effects of AS(Skalidis and Vardas, 2008).  
1.4.6  PROLONGATION OF SYSTOLE WITH SHORTENING OF DIASTOLE 
 PET scans of patients with LVH pre- and post-aortic valve replacement for AS 
have demonstrated interesting results. These studies have shown that the changes seen 
in the coronary microcirculation are not directly dependent on the regression of left 
ventricular mass but suggest an increase in diastolic perfusion time to be one of the 
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main mechanisms contributing to this(Rajappan et al., 2003, Rajappan et al., 2002). This 
is likely exacerbated further by abnormal relaxation during diastole(Paulus et al., 1988). 
1.4.7  ENDOTHELIAL DYSFUNCTION  
 Structural changes in coronary vasculature may not fully account for the 
reduction in coronary reserve and there may in fact be a change at the endothelial level 
as well. For example, coronary reserve has been shown to be reduced in hypertensive 
patients(Antony et al., 1993, Brush et al., 1988) and animal models(Rodriguez-Porcel et 
al., 2006) prior to the development of LVH. Rats with LVH have been shown to have a 
reduced production of coronary nitric oxide synthase, another reflection of endothelial 
dysfunction(Crabos et al., 1997). Using explanted coronary arteries from a guinea-pig 
model of LVH, Mcgoldrick et al. confirmed that coronary vessels from hypertrophied 
hearts have impaired relaxation to endothelial-dependent and independent 
agents(McGoldrick et al., 2007). 
Additionally, LVH also results in a greater propensity to anaerobic metabolism 
due to an attenuated microvascular response to hyperaemia(Kingsbury et al., 2000, 
McAinsh et al., 1995). They are therefore more vulnerable to the effects of myocardial 
ischaemia as they are unable to recover as well from such insults. For example, in dogs 
with LVH, occlusion of the circumflex artery resulted in a much larger area of infarction 
than controls(Koyanagi et al., 1982). 
1.4.8  INCREASE IN WALL THICKNESS TO LUMEN RATIO 
 Structural changes in the vascular bed as a result of left ventricular hypertrophy 
will also affect oxygen handling and transfer. A number of studies have demonstrated an 
increase in the thickness of the coronary vessel wall in relation to the lumen size in left 
ventricular hypertrophy in both guinea pigs(Kingsbury et al., 2000, Crabos et al., 1997, 
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Mihaljevic et al., 2003) and rats(Brilla et al., 1991b, Kalkman et al., 1996, Tomanek et al., 
1985). However, this finding has not been reproduced in ventricular biopsies taken 
from humans with LVH(Opherk et al., 1984) or in pig models(Breisch et al., 1986). More 
specifically, autopsy specimens from patients with LVH secondary to aortic stenosis do 
not show intra-myocardial arteriole wall thickening but do in patients with LVH 
secondary to hypertension. 
 
1.5 SUMMARY: POTENTIAL CAUSES OF MYOCARDIAL ISCHAEMIA IN AORTIC STENOSIS 
 Myocardial ischaemia is evident in patients with aortic stenosis as demonstrated 
by a wide variety of investigative tools. This is the cause of angina in aortic stenosis with 
normal coronary arteries and given the poor prognosis related to this symptom it is 
almost certainly connected with arrhythmias, heart failure and risk of sudden death.  
 Aortic stenosis leads to the development of LVH which increases the oxygen 
requirements of the myocardium out of proportion to that of coronary vessel expansion. 
However, it has become apparent that this only plays a small part on the aetiology of 
myocardial ischaemia particularly given the lack of a relationship between LV mass and 
CFR in some studies. 
 Possibly the more important factors in the development of myocardial ischaemia 
have been demonstrated through PET scanning and include the extravascular pressure 
effects as well as a reduction in diastolic perfusion time. Other factors such as reduced 
capillary density, increased oxygen diffusion distance and low coronary sinus pressure 
are all likely to play a role.  
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 Coronary endothelial dysfunction is obvious in hypertension-induced LVH but it 
is not completely clear if this can be applied to AS-driven LVH given the pressure of 
hypertension originates after the coronary sinuses. Likewise, there is evidence to show 
that thickening occurs within the walls of coronary vessels in LVH secondary to 
hypertension but this has not been reproduced consistently nor has it been 
demonstrated in aortic stenotic patients and therefore may not be involved in 
myocardial ischaemia in AS.  
 
1.6 APPLICATION OF CORONARY WAVE INTENSITY ANALYSIS IN AORTIC STENOSIS 
 Despite these interesting findings there are some limitations with these 
investigative methods, particularly when measuring coronary flow rate and coronary 
flow reserve alone in patients with aortic stenosis. Whilst changes in flow patterns can 
both demonstrate and quantify the burden aortic stenosis places on the myocardium, it 
is unable to qualify the origin of this burden. The technique of wave intensity analysis is 
a solution to this issue. Using simultaneously acquired measures of pressure and flow it 
is able to ascertain both the magnitude of force acting on coronary flow blood as well as 
separate and sub-qualify the force’s originating location. In disease states where 
coronary anatomy is not the primary issue and the problem is one at the myocardial 
level, this obviously has a profound advantage in terms of acknowledging the burden 
and effect of myocardial disease. The primary focus for this thesis therefore is the 
application of wave-intensity analysis to patients at varying stages in the management 
of their aortic stenosis. 
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1.7 APPROACH 
There were several arms to this research and they are divided by chapter accordingly: 
1. CONSTRUCTION OF NON-INVASIVE WAVE-INTENSITY ANALYSIS 
Aortic stenosis is a continually evolving condition. Over time the burden placed on the 
myocardium increases. After aortic-valve intervention there is a rapid and sudden 
decline in outflow-tract obstruction. Further changes occur at the myocardial level after 
valve intervention with a gradual regression of left ventricular hypertrophy. In patients 
in whom heart failure ensues before aortic valve intervention the force generated by the 
myocardium declines despite a persistent high outflow tract obstruction. 
Given the dynamism of aortic stenosis I felt it would be very useful to construct and 
validate a measure of wave-intensity that could be obtained non-invasively without the 
need for invasive coronary pressure and flow-tipped wires. This would allow several 
measurements to be obtained from the same individual following intervention or the 
passage of time.  
2. INVASIVE WAVE INTENSITY ANALYSIS IN AORTIC STENOSIS AND WITH 
TRANSCATHETER VALVE THERAPY 
Transcatheter aortic valve implantation (TAVI) allows peri-operative invasive measures 
of coronary physiology both before and after valve implantation. It also does not involve 
dissection through the pericardium or cardiopulmonary bypass and so the natural 
cardiac physiology is more accurately preserved than with conventional surgery. 
Therefore it is possible to obtain accurate invasive wave intensity in patients with 
severe aortic stenosis before and after valve implantation. Additionally, the TAVI 
procedure requires the presence of a temporary pacing wire and this could be used to 
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manipulate heart rate and therefore mimic exercise.  I therefore set out to perform 
invasive wave-intensity analysis peri-procedurally in severe aortic stenotic patients 
undergoing TAVI. 
3. NON-INVASIVE WAVE INTENSITY ANALYSIS IN PATIENTS AFTER VALVE IMPLANTATION  
After valve replacement there is a continual regression of left ventricular hypertrophy 
with time, most evident in the first 6 months but also at 1 year. Previous work has 
demonstrated that the wave-intensity profile in patients with myocardial hypertrophy 
but structurally normal hearts to be unfavourably altered. Therefore I was interested to 
learn if the profound regression of left ventricular hypertrophy following aortic valve 
replacement would result in a change in the wave-intensity profile in patients 
undergoing either TAVI or conventional valve replacement. To this end, using non-
invasive wave-intensity assessments I aimed to follow up these patients for one year 
after valve intervention.  
4. NON-INVASIVE WAVE INTENSITY ANALYSIS IN PATIENTS WITH MILD AND MODERATE 
AORTIC STENOSIS 
I also wished to use non-invasive wave intensity to measure the effect of lesser outflow 
tract obstructions on its profile. I therefore recruited a number of patients with milder 
versions of the disease and preserved left ventricular function in order to make this 
calculation. I was thus able to calculate the relationship between outflow tract 
obstruction and the resultant coronary wave-intensity profile.  
1.8 OVERALL GOAL 
My overall goal was therefore to construct an accurate picture of the progression of 
aortic stenosis and the effect of treatment on the wave-intensity profile and to ascertain 
whether this tool could be applied to the clinical population at large.  
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2 CONSTRUCTION OF NON-INVASIVE WAVE INTENSITY 
ANALYSIS 
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2.1 INTRODUCTION 
2.1.1 BACKGROUND: WAVE INTENSITY ANALYSIS 
A wave is a disturbance propagated through a medium with an exchange between 
kinetic and potential energy. Inherent to its definition is the fact that it travels at speeds 
faster than the underlying medium’s own velocity(Sun et al., 2000). In the 
cardiovascular system, the medium in question is blood and energy is exchanged 
between the kinetic force generating blood flow and the potential energy in the walls of 
the expanding elastic vessels.  
2.1.2 WAVE INTENSITY ANALYSIS IN NON-CORONARY VASCULAR SYSTEMS 
Wave intensity analysis is a mathematical approach to quantify and qualify this energy 
transfer. At its most fundamental level, it is produced from the first derivatives of 
pressure and flow across the time (as opposed to frequency) domain; it is therefore 
more readily applicable to the vascular beds of much of the cardiovascular system than 
Fourier-based models. Accordingly, it has been used to investigate ventricular-vascular 
physiology in sheep(Penny et al., 2008), coronary(Sun et al., 2000), aortic(Khir and 
Parker, 2005), pulmonary(Hollander et al., 2001), venous(Smiseth et al., 1999) and 
intra-cardiac energy transfer(Flewitt et al., 2007) in dogs, and the effects of intra-aortic 
balloon pump-drive couterpulsations in pigs(Lu et al., 2012). In humans it has been 
applied invasively to the aorta and carotid arteries in healthy and disease 
states(Manisty et al., 2009). 
Whilst wave-intensity is a therefore useful tool in all vascular circuits, it is particularly 
useful in the coronary circulation where the force generating blood flow could originate 
from either end of the arterial tree. Initial work in dogs by Sun et al. identified a 
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backward-travelling compression wave during isovolumetric contraction that increased 
coronary pressure and decreased coronary flow as well as a forward-travelling 
compression wave that occurred after aortic valve opening (Sun et al., 2000, Sun et al., 
2004). In the human coronary circulation, seminal work by Davies et al. further 
subdivided the cardiac cycle wave-intensity profile into six waves (Davies et al., 2006a). 
The magnitudanally-dominant waves were the forward-travelling compression wave 
(FCW) which is generated by the systolic ejection of blood and the corresponding rise in 
aortic pressure, and the backward-travelling expansion wave (BEW) which is formed 
from myocardial relaxation and a resultant ‘suction’ effect being applied to the coronary 
circulation retrogradely from its distal origin. Of these two, the latter is responsible for 
generating myocardial blood and accordingly coincides with the acceleration of 
coronary blood flow in early diastole.  Further work also demonstrated differences in 
the wave-intensity pattern of the right versus left coronary system accounting for the 
different flow patterns and values of these arteries but again with ascription of coronary 
flow to the backward-expansion wave (Hadjiloizou et al., 2008). 
Invasive coronary wave-intensity analysis has now been applied to various disease 
states. In patients with left-ventricular hypertrophy but no valvular pathology, the 
backward-travelling expansion wave is attenuated implying a reduction in the efficiency 
of energy transfer(Davies et al., 2006a) which may explain why myocardial hypertrophy 
is associated with reduced coronary vasodilator capacity(Hamasaki et al., 2000). 
Coronary wave-intensity has also been used to demonstrate the likelihood of functional 
myocardial recovery following myocardial infarction using late-gadolinium MRI before 
and after revascularisation(Silva et al., 2012). Additionally, using wave-intensity 
analysis Sen et al. have demonstrated a portion of the cardiac cycle with minimal 
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coronary resistance that has aided in the construction of an adenosine-free pressure-
based assessment of coronary stenosis (Sen et al., 2012).  
2.1.3 NON-INVASIVE WAVE INTENSITY ANALYSIS IN NON-CORONARY BEDS 
Traditionally, the simultaneously acquired measurements of coronary pressure and 
flow necessary for wave-intensity analysis have been recorded invasively. However, 
recent work has demonstrated that it is possible to construct wave-intensity in the 
peripheral arterial system using non-invasive methods. Although it is often difficult to 
measure intra-vascular pressure changes non-invasively, the change in area of the 
vascular wall can be successfully used as a surrogate. For example, in healthy human 
participants wave-intensity has been measured from the radial, carotid and brachial 
arteries using applanation tonometry and pulse-wave Doppler (Zambanini et al., 2005). 
In the carotid artery non-invasive wave-intensity can be useful in distinguishing non-
obstructive hypertrophic cardiomyopathy from hypertension-driven left ventricular 
changes (Li and Guo, 2013) and in patients with heart failure a delay and reduction in 
the magnitude of the systolic compression wave, combined with an increase in the 
reflective wave is seen compared to controls (Wen et al., 2010) 
In patients randomised to receive amlodipine rather than atenolol based blood pressure 
therapy, carotid pressure is lower in the amlodipine treatment arm and wave-intensity 
demonstrated this reduction to be due to a reduction in wave reflection(Manisty et al., 
2009). In the cerebral circulation, non-invasive wave intensity, constructed from carotid 
artery diameter and velocity has been useful in delineating cerebrovascular 
tone(Bleasdale et al., 2003).  
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Other imaging modalities such as MRI have also been used to calculate wave intensity 
by assessing area and velocity changes in the aorta(Biglino et al., 2012b) and applied to 
patients with congenital cardiac abnormalities to demonstrate unfavourable wave 
profiles(Biglino et al., 2012a). 
2.1.4 VARIABLES REQUIRED FOR NON-INVASIVE CALCULATION OF CORONARY WAVE 
INTENSITY 
The previously described invasive techniques of measuring coronary wave-intensity 
analysis have relied on simultaneously acquired measures of coronary flow (variable 1) 
and pressure (variable 2). First derivatives of these values are used in the single-point 
equation for the calculation of wavespeed (variable 3) as well as the construction of 
separated wave-intensity. The other variable required in this latter calculation is an 
estimate of the density of blood which is taken as 1050 kg m-3 (variable 4). Therefore, in 
order to replicate this calculation non-invasively on the coronary system, non-invasive 
measures of coronary pressure and flow are required. An alternative to pressure would 
be an estimation of coronary artery vessel size changes in a similar fashion to 
tonometrically-obtained wave-intensity; however, given the relatively small size of the 
coronary arteries, this was unlikely to be achievable.  
I hypothesized therefore that it would be possible to obtain non-invasive coronary 
wave-intensity using transthoracic echocardiography to assess coronary flow and 
suprasystolic brachial pressure waveforms to estimate coronary pressure.  
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2.2 VARIABLE 1: ACCURATELY OBTAINING CORONARY FLOW NON-INVASIVELY 
2.2.1 INTRODUCTION - ECHOCARDIOGRAPHIC ASSESSMENTS OF CORONARY FLOW 
2.2.1.1 Historic First Assessments 
Direct visualisation of the left main stem has been recognised as a feasible technique for 
over 20 years and initial studies used trans-oesophageal echo (TOE) were able to 
demonstrate stenoses through simple visual recognition(Taams et al., 1988). 
Echocardiography was then applied to assess coronary flow reserve. The earliest work 
used TOE to assess proximal coronary artery flow before and after dipyridamole 
injection. In 9 patients with angiographically normal coronary anatomy the CFR  
increased with dipyridamole whereas in 6 patients with significant coronary disease, 
this did not occur (Iliceto et al., 1991) .  
A further study comparing 16 patients with significant LAD disease to patients with 
minor (<30%) or no significant LAD disease demonstrated a CFR of <2.3 to be highly 
sensitive (88%) for the detection of underlying significant disease and in fact was more 
sensitive than wall motion analysis (75%). A combination of both CFR and wall motion 
assessment produced sensitivities of detecting underlying coronary disease of 
94%(Hutchison et al., 1996). 
Similar results were also achieved using adenosine-driven stress. A CFR of >2.1 had an 
86% sensitivity and 79% specificity of predicting the absence of LAD disease in 49 
patients(Redberg et al., 1995). Using dobutamine and a CFR cut-off of 1.81, a further 
study suggested that its sensitivity was equal to regional wall motion assessment in 
predicting LAD disease in 39 patients with no disease compared to 18 patients with 
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significant disease; it was also more sensitive in detecting minor (0-70% by 
angiography) disease in a subset of 21 patients(Stoddard et al., 1995). 
2.2.1.2 Transthoracic assessment and atherosclerotic application 
Early work suggested measuring coronary flow using transthoracic echocardiography 
was only possible in a minority of patients(Fusejima, 1987). However, its applicability 
increased following improvements in echocardiography(Ross et al., 1990, Rigo, 2005) 
particularly the introduction of second harmonic imaging (allowing better definition of 
smaller structures), high frequency transducers (up to 8 MHz in second harmonic) and 
contrast(Caiati et al., 1999). It was then possible to measure coronary flow reserve in 
the distal LAD; a failure of peak and mean coronary velocity to rise during hyperaemia 
was seen in patients with significant disease of this artery (Hozumi et al., 1998b).  
Additionally, CFR as assessed by TTE Doppler normalised in 45 patients following LAD 
stenting of significant coronary lesions(Pizzuto et al., 2001)  and was able to predict the 
development of LAD-restenosis in 53 PCI patients followed up for a period of 6 
months(Ruscazio et al., 2002). Similar to TOE results, a combination of CFR assessment 
with wall motion analysis allows a higher sensitivity for ischaemia compared to wall 
motion analysis alone in stress echocardiography using a transthoracic probe(Rigo, 
2005). After acute anterior myocardial infarction, a low CFR has been shown to predict 
poor LV recovery and a higher likelihood of adverse in-hospital events(Meimoun et al., 
2009).  
More large scale studies have now been published reflecting the rapidly increasing 
applicability of this technique. In 4313 patients, a CFR ≤ 2 was shown to be a strong 
independent predictor of mortality and interestingly conferred additional prognostic 
value over wall motion analysis(Cortigiani et al., 2012). 
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2.2.1.3 Non-atherosclerotic application 
2.2.1.3.1 Non-ischaemic dilated cardiomyopathy 
In 129 patients with a dilated cardiomyopathy of unknown aetiology and normal 
coronary arteries, a poor CFR (<2.0) as assessed by dipyridamole-stress transthoracic 
echocardiography is seen in up to 64% of patients and is a predictor of adverse events 
(defined as worsening of heart failure symptoms or death)(Rigo et al., 2006).  
2.2.1.3.2 Hypertrophic Cardiomyopathy 
Likewise, an abnormal CFR assessed by Doppler echocardiography is also a marker of 
poor outcome in hypertrophic cardiomyopathy (defined as LA dilatation, development 
of AF, hospitalization for unstable angina, ICD insertion, PPM insertion) (Rigo et al., 
2007).  
2.2.1.3.3 Coronary Syndrome X 
An abnormal CFR (mean 1.21) from transoesophageal and transthoracic imaging has 
been demonstrated in patient with coronary syndrome X compared to asymptomatic 
controls (Zehetgruber et al., 1995, Galiuto et al., 2007, Rigo, 2005).  
2.2.1.3.4 Metabolic Syndrome 
33 patients with multiple cardiovascular risk factors (hypertension, diabetes, obesity, 
impaired glucose tolerance) without coronary artery disease were compared to controls 
and shown to have an abnormally reduced CFR (mean 2.2 vs. 2.5)(Pirat et al., 2008). 
 
2.2.2 ACCURATELY OBTAINING NON-INVASIVE CORONARY FLOW: METHODS 
A good comparison between CFR from coronary Doppler and CFR measures from 
coronary flow wires (25 patients with a mix of LAD disease)(Caiati et al., 1999) and PET 
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scanning (36 patients)(Daimon et al., 2001) has previously been demonstrated in 
experienced hands. To train myself to a level where coronary flow can be accurately 
measured to such a standard I sought to obtain first hand teaching from real-world 
experts in this skill who perform non-invasive CFR on a regular basis(Rigo, 2005, Rigo 
et al., 2007, Rigo et al., 2006, Rigo et al., 2008, Rigo et al., 2010, Cortigiani et al., 2012). It 
is estimated that it takes between 80 and 100 scans before an operator can reliably 
obtain flow signals from the left anterior descending artery but ultimately with 
persistence it can be achieved in up to 95-98% of patients(Rigo, 2005). With further 
experience, imaging of other sections of the LAD or the distal right coronary artery is 
even possible(Rigo, 2005, Lethen et al., 2003b). 
However, one practical difficulty is that the majority of operators perform LAD 
assessments for the purposes of CFR calculations during stress echocardiography. They 
are therefore primarily focused on obtaining peak values but are less concerned in 
obtaining a ‘clean’ flow signal envelope for the entire cardiac cycle. To focus on 
obtaining such a clear coronary flow envelope, particularly in the region of early 
diastole that is required for the calculation of the backward-expansion wave is therefore 
a skill unpractised worldwide. It therefore required an adaption and modification of the 
existing technique for imaging the left anterior descending artery. 
2.2.2.1 Echocardiographic Machine Choice 
Initial measurements were attempted with a Phillips ie33 echocardiography machine. 
Whilst this machine is capable of producing excellent transthoracic and 
transoesophageal images it was not designed to obtain coronary flow. Therefore, 
appropriate modifications were made to its parameters for both visualising and 
performing pulse-waved analysis of the artery (Table 2-1). Despite these changes, it 
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often remained challenging to assess the period of coronary acceleration cleanly due to 
a high level of background noise in some patients. 
However, I was able to take the opportunity to use a machine more geared towards 
coronary flow imaging - the Esaote MyLabTwice. This machine has been developed in 
collaboration with experts in the field of coronary artery imaging and consequently has 
inbuilt parameters designed to optimise coronary flow analysis. The images obtained on 
this machine were of a more interpretable quality for non-invasive wave intensity 
analysis (Figure 2-1). 
 
Probe delivery 
frequency 
Colour Doppler 
PRF 
Wall 
filters 
Pulse Doppler 
Filters 
Focus 
4-8Mhz as 2nd 
harmonic 
15-25cm/s High Low On 
TABLE 2-1. Echocardiographic settings to optimise lad interrogation(RIGO ET AL., 
2008) 
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Figure 2-1. Pulse-wave Doppler of the left anterior descending artery in two patients 
using different machines. 
The Phillips ie33 demonstrated in the left hand panels versus the Esaote Mylabtwice on 
the right. The noise is much less with the esaote machine allowing easier analysis. 
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2.2.2.2 Views required for coronary flow analysis 
Echocardiographic coronary flow assessment is not usually possible in any of the 
standard echo views. The most appropriate view for visualising the LAD is described as 
a modified 2- or 3-chamber view. By moving the probe away from the apex and towards 
the parasternal long axis view and maintaining the position of the interventricular 
septum in the centre of the screen the mid-LAD is brought into view(Rigo et al., 2008). 
Other views that were found occasionally helpful were the three chamber view where 
the proximal LAD can sometimes be seen above the aortic valve (Figure 2-2) or a 
modified 4 chamber view to visualise the distal LAD (Figure 2-3). Alternatively, a 
slightly modified parasternal short axis view may also be helpful at times for imaging 
the proximal LAD or Left Main Stem (LMS) (Figure 2-4). 
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FIGURE 2-2. Mid-LAD visualised using a modified 3 chamber view. 
Initial view (upper left panel), view with reduced gain (upper right panel) and zoomed 
view with reduced gain (lower panel). 
 
FIGURE 2-3. Distal LAD visualised through a modified 4-chamber view 
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FIGURE 2-4.   Proximal LAD visualised through a modified parasternal short axis view 
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2.2.2.3 Echocardiographic Settings required for Coronary Flow Analysis  
2.2.2.3.1 Visualising the Left Anterior Descending Artery 
Conventional colour flow will not demonstrate the coronary artery due to the lower 
velocity at which blood moves through the coronary tree compared to the cardiac 
chambers. It is important to lower the colour pulse repetition frequency (PRF) to allow 
this visualisation. Unfortunately, this obviously increases the colour flow generated by 
myocardial tissue, intercostal vessels and blood moving through the cardiac chambers 
and it takes considerable practice to recognise coronary flow amongst these other 
colours.  
It is sometimes easy to mistake an intercostal vessel for a coronary artery. However, it is 
easy to distinguish the two due to the characteristic flow profile from pulsed-wave 
Doppler of an intercostal artery. Likewise, when the PRF settings are reduced, the 
myocardium can appear awash with colour, particularly in dynamic healthy ventricles. 
With experience it becomes possible to visualise the coronary artery amongst this 
movement; chances of achieving this are increased by reducing the gain settings. 
Additionally, the majority of coronary flow is seen during diastole compared with the 
majority of the systolic motion of the myocardium (Figure 2-5). Identification of 
coronary flow according to the cardiac cycle also a difficult skill to master particularly 
when the patient’s heart rate is raised but with time it is possible.  Myocardial velocity is 
usually higher than coronary therefore the colour patterns are different, again which 
can be recognised with experience.  
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FIGURE 2-5. Coronary flow during the cardiac cycle. 
Flow is most prominently seen during diastole (lower panel) as opposed to systole 
(upper panel), helpful for identification of coronary artery flow. 
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Finally, when assessing coronary flow in the views described above it is possible to 
confuse coronary flow with flow within the tip of the right ventricle. Again, a 
characteristic flow profile is produced to aid in this distinction. The usual solution to 
this issue is to tilt the probe to point more cranially where the LAD should then appear.  
Further problems arise in some patients who have relatively low LAD velocities. It may 
only be possible to recognise this when one or two pixels are seen in diastole of an 
appropriate intensity. In these cases, the colour PRF and gain need to be further 
reduced in conjunction with depth alterations to bring out the shape and direction of 
the coronary artery. This obviously makes the background myocardial colour-noise 
even more intense but is often a necessary sacrifice (Figure 2-6). 
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FIGURE 2-6.  Optimisation of LAD flow demonstrated by manipulation of depth, gain 
and PRF. 
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2.2.2.4 Active optimisation of coronary flow profile 
Once the LAD is visualised the coronary flow profile can be assessed using pulsed-wave 
Doppler. The first step in achieving a good flow envelope is to position the probe in as 
appropriate a plane of scanning as possible. This can usually be achieved by maintaining 
the coronary artery in the centre of the screen and bring the probe across the chest akin 
to the rotational technique required to switch from parasternal long- to short-axis 
whilst maintaining the location of the aortic valve.  
One problem inherent to coronary artery analysis, particularly in dynamic young 
ventricles is the excursional distance the coronary artery travels during one cardiac 
cycle. In patients with heart failure or aortic stenosis, their ventricles become stiffer and 
less mobile making assessment their flow profiles more attractive. To combat the 
problem of the left anterior descending artery moving in and out of the pulse-wave 
envelope, a large sampling area is required. The pre-set Esaote size is 10mm and this 
can be reduced (in more static hearts) or (although rarely necessary) increased if 
required.   
If there is a lot of horizontal (rather than lateral movement) of the coronary artery 
through the pulse-wave envelope, various chronological-sections of the coronary 
envelope can be visualised individually and amalgamated. Alternatively, to focus on the 
backward expansion wave, it may be most appropriate to position the sampling area at 
the point in which the coronary artery is highlighted in the change from systole to 
diastole (Figure 2-7 and Figure 2-8). 
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FIGURE 2-7.  Example of a coronary artery with a significant amount of lateral 
excursion.  
The pulse wave Doppler is here position to capture the end of diastole / start of systole 
and moving it to the left would capture early diastole to build a coherent picture. 
 
 
     
FIGURE 2-8. Example of different parts of coronary cycle imaged through pulse-wave 
Doppler positioning.  
Left hand panel demonstrates end-diastole and early systole, right hand panel late-
systole and early diastole. For construction of the backward expansion wave the right-
hand panel is essential. 
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To minimise the noise of the pulse-wave signal recorded, the velocity range needs to be 
altered. In patients with low velocity profiles this may create a challenge in achieving an 
acceptably-interpretable trace. However, a balance needs to be struck between 
background noise and signal (Figure 2-9). 
 
 
 
 
    
 
FIGURE 2-9.  By decreasing the velocity scale in the same patient, the signal becomes 
cleaner. 
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2.2.2.5 Post-Processing: Coronary flow digitalisation 
Processing coronary flow required an offline, custom-built Matlab programme which 
operated through the following steps. 
2.2.2.5.1 Manual selection 
Images were saved in either jpg or bitmap format. Initially they were processed using a 
manual selection system. This involved multiple mouse-clicks to delineate the scale, rate 
of recording and coronary flow signal. Additionally, to gate to the ECG , the Q and T 
waves had to be manually selected. Example of the imported flow trace is shown in 
(Figure 2-10). 
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FIGURE 2-10. Post-processing of transthoracic echo-obtained coronary flow. 
 (from top left to bottom right): a) selection of 1 second, b) zoom and selection of ECG, c) 
selecting the start of coronary flow and zero on the x axis, d) scaling to the y axis, e) 
tracing of the flow signal through a series of clicks, f) the digital result. 
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2.2.2.5.2 Automated selection 
Whilst a manual approach to selection was a useful way to begin the analysis, with the 
high number of patients recruited and interrogated, a more automated system was 
desirable. With assistance from the some of the software engineers affiliated with our 
group I was able to semi-automate this process.  
The resultant Matlab programme was based around pixel recognition and manipulation. 
The initial step was to select the jpg or bmp file using the command uigetfile and remove 
the top half of the picture using the code: 
corflow_image(1:top_of_fig,:,:) = 0; 
where the variable top_of_fig was required as an input so that the top pixel line to be 
read could be altered according to the position of the flow signal within the image. 
Following this, ‘corflow_image’ was then converted to black and white (Figure 2-11): 
   
FIGURE 2-11. Removal of top half of figure and conversion to black-and-white. 
Two functions were then used to organise these pixels into recognisable and readable 
areas. Bwmorph ‘thicken’ was used to add pixels to the exterior of an area. Then, using 
imfeature to recognise ‘area’ of greater than 500 grouped pixels.  The end result of the 
code is as follows: 
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tempL = bwmorph(new_im,'thicken'); 
L = bwlabel(tempL, 8); 
all_regions = imfeature(L,'PixelList','Area'); 
for reg_no = 1:length(all_regions) 
if all_regions(reg_no).Area<500 
pixels = (all_regions(reg_no).PixelList); 
for each_pix = 1:size(pixels,1) 
L(pixels(each_pix,2),pixels(each_pix,1))=0; 
end 
end 
end 
new_im = L>0; 
 
To read the top of the coronary envelope, the image was divided up into columns of 
pixels (now in binary format). Each column was read from top to bottom and the first 
value of “1” located was stored as the height of the pixel from the base of the image. By 
allowing an additional step of manual baseline selection, the height from the baseline 
was then established. Each pixel value thus located was transformed into a vector 
(Figure 2-12). 
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FIGURE 2-12. End result of Matlab pixel manipulation and tracing of envelope. 
The image is manipulated as above then ‘traced’ in the above manner by recognition of 
the first white (i.e. binary value of 1) value when each column is read from top to 
bottom. This vector is plotted in red over the pixel-manipulated black-and-white image. 
 
 
The end result is then displayed to the user (Figure 2-13). 
 
FIGURE 2-13.  Coronary flow with automated edge recognition. 
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2.2.2.5.3 Additional Steps 
2.2.2.5.3.1 Threshold: 
Additionally, a threshold value for recognising pixels at was added in to allow greater 
sensitivity in selecting the appropriate pixels (Figure 2-14): 
 
 
FIGURE 2-14.  Threshold manipulation to allow accurate tracking. 
A low sensing threshold on the upper panel causing inappropriate tracking of the 
coronary flow trace. By increasing this threshold, the tracking is more accurate. 
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2.2.2.5.3.2 Sweep speed 
The majority of images were recorded at the same sweep speed which equated to 240 
pixels per second. An option to manually enter this number was created in case a 
different sweep speed or image size was used or a manual selection of one second from 
the image could be used to calculate the sweep speed in a more bespoke fashion. 
2.2.2.5.3.3 Selection of scale 
Manual selection of the baseline and velocity scale was required to allow appropriate 
scaling. 
2.2.2.5.3.4 Cut and retrace manually 
Finally, by adding in code from the original “click-and-trace” programme, it was possible 
to manually select areas of the image that had not been traced correctly. 
2.2.2.5.4 Final Result 
The steps required in the final programme are displayed in the following figure (Figure 
2-15). 
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FIGURE 2-15. Semi-automated coronary flow digitalization. 
 
Step 1. Image is called and traced as above. Manual input is then required to select the 
baseline. 
 
Step 2. The maximum y value seen is then selected. 
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Step 3. That y value is the manually inputted 
 
Step 4. If required, a section for the tracing can be selected for manual re-selection 
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Step 5. The start and end points of the area for reselection are marked. 
 
Step 6. Manual click-and-trace is performed to reselect this area. The old vector from 
this region is discarded. 
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Step 7. Finally, the image and its first derivative can be viewed in vector format.
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2.2.2.5.5 Post processing: ECG selection 
Again, the R wave could be manually selected. However, for accuracy and speed, I again 
wrote an automated programme to allow this to occur in an automated fashion. The 
Matlab software was able to read the unique pixel colour information of the ECG trace 
and thus export it as a vector from the bmp or jpg. This vector was then converted into 
its first and second differential and values either above or below a certain value were 
identified. The default value for this identification was the mean of the vector or it could 
be inputted manually. 
To avoid selection of several values in near proximity to each other it also required an 
input representing a length to be ignored after the first recognised value. By allowing 
the programme to then call itself again if required, these values could all be actively 
manipulated and adopted to allow successful R wave tracking for each cardiac cycle 
even with heavy interference, small complexes or a wandering trace. An example of this 
software in use is displayed below (Figure 2-16): 
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FIGURE 2-16. Automated r wave recognition software. 
 
Step 1. The ECG is displayed in the top panel and the first and second differential in the 
lower panels. For ECG tracking, I found the first differential the most helpful but 
depending on lead placement there was an option to use the second if required. The 
vector is smoothed using a Savitzky-Golay filter to avoid amplification of noise. In this 
case, the cut-off value above which values are recognised, and the length of vector to 
ignore after this are too low. 
    
Step 2. Alternation of cut-off value above which values are recognised (left panel) and 
the space ignored after this value (right value).
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Step 3. End result – the peaks are now selected and the area after them ignored allowing good r wave recognition.
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2.2.2.5.6 Post processing: Selection of cardiac cycle 
After ECG recognition, the best coronary flow examples can be selected and the poorer 
traces ignored (Figure 2-17) and the output viewed and saved (Figure 2-18). 
 
   
 
FIGURE 2-17. Manual selection of coronary flow. 
By clicking in front of the R wave of the required coronary flow trace, each appropriate 
flow trace can be selected. Therefore, if there is a flow trace of poor quality this can be 
ignored and the traces either side selected instead.  
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FIGURE 2-18.  Coronary flow and its first differential displayed for each selected cardiac 
cycle. 
The heart rate is displayed according the automatically recognised r wave for the upper 
panel. The peak first differential is shown on the differential panel. 
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2.2.2.5.7 Post processing: Smoothing 
After digitalization of both flow and ECG, an option of smoothing was automated into 
the programme. Because ensemble-averaging introduces an element of smoothing, a 
variable Savitzky-Golay filter was used(Savitzky and Golay, 1964) depending on the 
number of flow traces and if more than 15 traces were ensemble, no filter was 
employed (Figure 2-19).  
 
 
FIGURE 2-19. Smoothing of the digitalized image using a Savitzky-Golay filter. 
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2.2.2.5.8 Post processing: Ensemble-averaging 
After each individual trace was digitalized and processed they were averaged to 
produce an ensembled coronary flow image. This was performed offline using another 
custom-built Matlab package. Two methods were proposed for ensemble averaging: 
alignment from the start of diastolic coronary flow acceleration or alignment according 
to the R wave from the imported gated ECG. It is possible to perform the former 
alignment in a semi-automated fashion by recognising the peak of the 2nd differential of 
coronary flow (Figure 2-20): 
  
FIGURE 2-20.  Coronary flow and the second differential of flow. 
 The onset of coronary flow is then located automatically by identifying the maximum 
value of the second differential and in this figure is marked with a dashed line. 
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2.2.3 STUDY PROTOCOL 
2.2.3.1 Assessing coronary flow non-invasively 
To assess my ability to accurately obtain non-invasive coronary flow profiles seventeen 
patients with unobstructed coronary arteries underwent both coronary flow 
assessment invasively and non-invasively. Demographic, echocardiographic and 
pharmacological details of these patients are described in chapter 2.5.3.1. Invasive 
coronary flow was performed at the time of angiography, as described in chapter 
2.5.2.2. Coronary flow assessment, processing and analysis was performed after 
angiography when the patient was recovering on the cardiac day ward, within 60 
minutes of the invasive assessment.  
2.2.3.2 Coronary flow - choice of machine 
Of the two machines available for coronary flow analysis, the Esaote MyLabTwice 
machine appeared to demonstrate better quality over the Phillips ie33. To objectively 
quantify this, a correlation was obtained between all patients who had 
echocardiographic coronary flow assessment as well as invasive coronary flow 
assessment. 
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2.2.4 RESULTS 
2.2.4.1 Optimisation of Flow Measurements 
2.2.4.1.1 ECG alignment and assessment of peak dudt 
In order to assess the correct method for ensemble-averaging of the coronary flow trace 
the two methods of ensembling were applied to each coronary flow trace: alignment at 
the start of coronary flow or R-wave alignment through ECG-gating. Correlation 
coefficients were calculated for each trace and Bland-Altman plots produced (Figure 
2-21 and Figure 2-22).  
Using coronary flow alignment resulted in overall higher mean peak dudt 
measurements compared with invasive measurements (0.0057 cm.s-2 versus 0.0040 
cm.s-2, p=0.007) whereas ECG-aligned flow resulted in a similar approximation of mean 
(0.0036 cm.s-2 versus 0.0040 cm.s-2, p=0.41). There was also a better correlation for 
coronary flow aligned according to the ECG (r = 0.58, p=0.01 vs r=0.29, p=0.26) and so 
this method was subsequently employed for coronary flow. 
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FIGURE 2-21. Scatter and Bland-Altman plot of invasive and non-invasive coronary flow 
dudt with non-invasive flow aligned by the start of diastolic coronary acceleration.  
With this method of alignment there was a significant difference between mean peak 
dudt and the correlation value was not significant (p=0.26). 
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FIGURE 2-22.  Scatter and bland-atman plots of invasive and non-invasive coronary flow 
dudt with non-invasive flow aligned according to ECG R wave.  
This produced a much more accurate mean peak dudt value (p=0.41) with a more 
impressive correlation (r=0.58, p=0.01).  
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2.2.4.1.2 Estimation of absolute values 
2.2.4.1.2.1 Peak coronary flow 
Average peak coronary flow velocity was similar in the invasive versus non-invasive 
groups (0.30 versus 0.28 cm/s, p=0.54) with a good correlation (r=0.65, p=0.004) when 
aligned by the R wave (Figure 2-23). 
 
 
FIGURE 2-23. Scatter plot and Bland-Altman plot of invasive versus non-invasive peak 
coronary flow.  
There was a good estimation of absolute values with a good correlation between 
invasive and non-invasive measures (r=0.65, p=0.004) 
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2.2.4.1.2.2 Minimum coronary flow 
The average minimum velocity was also similar between the two assessment modalities 
(0.09 invasive versus 0.11 non-invasive, p=0.10) with a correlation r value of 0.62 
(p=0.007) (Figure 2-24). 
 
 
FIGURE 2-24. Scatter plot and Bland-Altman plot of invasive versus non-invasive 
minimum coronary flow.  
There was a good estimation of absolute values with a good correlation between 
invasive and non-invasive measures (r=0.62, p = 0.007). 
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2.2.4.2 Demonstration of optimal echocardiographic machine 
In total 44 patients with a varying spectrum of aortic valve stenosis but normal 
coronary arteries underwent combined assessment (31 Phillips, 13 Esaote). Peak dudt, 
peak velocity and mean velocity were assessed. A stronger correlation was noted in all 
categories with the Esaote MyLabTwice over the Phillips ie33 (Table 2-2). 
 
 
 
 
 
  Peak Velocity Mean Velocity Peak dudt 
Machine No of 
patients 
R Value P Value R Value P 
Value 
R 
Value 
P 
Value 
Esaote 
MyLabTwice 
13 0.886 0.00006 0.8207 0.0006 0.5359 0.06 
Phillips  
ie33 
31 0.3873 0.03 0.2997 0.1 0.1083 0.56 
TABLE 2-2. Comparison of Esaote Mylabtwice and Phillips ie33 with peak and mean 
velocity and peak dudt.  
A better correlation is seen between non-invasive calculations using the Esaote 
Mylabtwice and invasive Combowire measurements rather than the Phillips ie33. 
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2.2.5 CONCLUSIONS 
Whilst most operators around the world focus on peak values of coronary flow, for the 
purposes of wave-intensity analysis, a clean coronary flow envelope is required, 
particularly around the change from systole to diastole when coronary acceleration 
occurs. Additionally, a smooth complete outline is also essential for an accurate 
calculation of wavespeed using the single point equation.  
I have demonstrated that it is possible to achieve this accurately with values obtained 
non-invasively by assessing peak and minimum velocity and dudt. I have also shown 
that the use of a dedicated machine with inbuilt probe and software settings for the 
assessment of coronary flow is much more useful than standard echocardiographic 
machines. 
In terms of post-processing, ensemble averaging is most accurately obtained through 
alignment by r wave recognition and this can be done accurately in a semi-automated 
fashion by recognising the peaks and troughs of the first differential of the ECG trace. 
Alignment by the onset of coronary flow is possible but results in overestimation of 
coronary acceleration which translates to a higher dudt.  
Therefore, it is apparent that coronary flow can be estimated and processed 
appropriately for the construction of non-invasive wave intensity analysis and that to 
provide the most accurate values, the Esaote MyLabTwice machine should be used 
where possible with alignment by the ECG’s r wave.  
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2.3 VARIABLE 2: ACCURATELY OBTAINING CORONARY PRESSURE NON-INVASIVELY 
2.3.1 INTRODUCTION 
The most basic definition of wave intensity is as the product of dP and dU (WI = dPdU). 
As demonstrated above, dU is possible to calculate directly non-invasively using 
transthoracic echocardiography. However, a direct non-invasive assessment of 
coronary pressure is impossible. An approximation could be obtained in a fashion 
similar to tonometry by measuring coronary artery wall expansion using perhaps MRI – 
however, this value would be so small errors would almost be inevitable.  
Pressure curves in normal unobstructed coronary arteries are thought to be identical 
throughout the epicardial coronary tree and also match that of central aortic pressure 
and this is the concept on which coronary pressure surrogates of flow-limiting stenoses 
are based(Pijls et al., 1995, Sen et al., 2012). Therefore, a non-invasive assessment of 
central aortic pressure could prove useful in estimating coronary dP, if this value is 
essential for coronary wave intensity analysis. 
2.3.1.1 Central aortic pressure measurement through suprasystolic brachial 
waveform interpretation 
Reliable non-invasive measurements of central aortic pressure have been desirable for 
cardiovascular risk stratification and as such a number of techniques exist. One option 
involves the application of a generalised transfer function to radial artery waveforms 
achieved from applanation tonometry. This is produced through averaging the 
individual functions calibrated to brachial cuff sphygmomanometer-measured 
BP(Weber et al., 2011, Wassertheurer et al., 2010); the transfer function is necessary to 
correct for pressure wave amplification in the upper limb. This method is slightly 
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limited as it assumes the properties of the upper limb arteries are identical among 
individuals which is not always the case(Payne and Webb, 2008). Other groups have 
attempted to individualise the transfer function by patient according to characteristics 
such as age and blood pressure but with limited success(Westerhof et al., 2008). 
An alternate option is  through use of suprasystolic brachial pressure waveform 
interpretation (Pulsecor Ltd, Auckland, New Zealand). This system estimates central 
pressures from brachial cuff pressure fluctuations by inflating to suprasystolic levels 
(approximately 30mmHg above systolic pressure) and occluding the brachial artery. 
Intra-arterial pressure waves impinging on the occluded artery transfer part of their 
energy to the surrounding upper arm tissue and then to the cuff and can be directly 
related to the intra-arterial pressure oscillations. This also means there are no 
confounding waves reflected distal to the point of measurement. A time-domain 
representation of pressure wave reflection within a uniform closed tube has been 
established and applied to the cuff-sensed pressure to produce central aortic pressure. 
Measuring central pressure in this method has been demonstrated to be comparable to 
‘gold-standard’ invasive data when systolic and diastolic values were compared (Lin et 
al., 2012, Lowe et al., 2009). 
However, in order to construct wave intensity, again the pressure waveform is required, 
not just the individual values. Therefore, to assess the Pulsecor machines accuracy in 
performing this I set out to validate its measures against simultaneously acquired 
values of invasive central aortic, left main stem and left anterior descending artery 
pressures. I also wanted to demonstrate the importance of dP in the wave-intensity 
formula.  
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2.3.2 METHODS, RESULTS AND FURTHER PROCESSING TO IMPROVE ACCURACY 
2.3.2.1 The Importance of Including Pressure in Wave Intensity 
Because of the inherent difficulties in directly measuring coronary pressure non-
invasively I initially wanted to demonstrate the relative importances of flow and 
pressure in the construction of wave-intensity to see if an approximation of the 
backward expansion wave could be constructed from flow alone. 
I therefore constructed a ‘weighting’ algorithm to display the individual effects of 
pressure and flow on the resultant wave-intensity profile where: 
 
WI (flow influence) = ± dudt * 1050 * wavespeed 
WI (pressure influence) = ± dPdt 
EQUATION 2-1. SEPARATING THE INFLUENCE OF PRESSURE AND FLOW IN WAVE-INTENSITY 
 
This was applied to several data sets and as can be seen from the example in Figure 
2-25 the influence of pressure is essential and simply differentiating flow would not be 
discriminatory. 
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FIGURE 2-25. Separation of wave-intensity components weighted according to wave-
intensity principles.  
Top panel demonstrates simultaneously acquired pressure and flow. Middle panel 
demonstrates weighted differentials of flow (dudt * 1050 * wavespeed) and pressure 
(dpdt). Lower panel demonstrates separated wave-intensity for forward (positive 
values) and backward (negative values) in red with the respective contributions from 
pressure (blue) and flow (green).  
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2.3.3 INVASIVE EXPERIMENTS: USING CENTRAL AORTIC PRESSURE TO ESTIMATE CORONARY 
PRESSURE 
There is no easily applicable technology available to non-invasively estimate coronary 
pressure directly. Therefore I made the assumption that central aortic pressure is 
equivalent to left main stem and left anterior descending artery pressure, particularly in 
terms of differential values and set out to confirm this. 
2.3.3.1 Methods 
To test this, I divided the first differential of pressure into 3 areas for comparison: peak 
of the systolic dpdt (1), minimum diastolic dpdt (2) and peak of the diastolic dpdt(3) 
(Figure 2-26). 
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FIGURE 2-26. Central aortic pressure and its first differential.  
Peak of systolic dpdt (1), peak of diastolic dpdt (3) and minimum diastolic dpdt (2) are highlighted.
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In 27 patients with unobstructed coronary arteries, invasive measurements were made 
in the left main stem and / or left anterior descending artery using either a Combowire 
((Combowire, Volcano Corp – Figure 2-60) or a dedicated pressure-tipped sensing wire 
(Primewire Prestige, Volcano Corp - Figure 2-27). The left coronary system was 
intubated from a femoral or radial approach using a Judkins guide catheter and intra-
coronary nitrates were used to stabilise the pressure signal. After normalisation with 
the pressure sensor just outside the catheter tip, the wire was passed into the left main 
stem or left anterior descending artery. Central aortic pressure data was recorded from 
the catheter tip.  
2.3.3.1.1 Processing 
Proximal and distal pressure was recorded live onto a Combomap. The data was then 
exported as an sdf file and converted to a text file using Study Manager. This was 
imported into Matlab and processed. Two options for separating the cardiac cycles were 
employed using either the first differential of the ECG or the second differential of the 
pressure trace. The latter ultimately gave a more appropriate amalgamation of pressure 
signals as it was more accurate at recognising the onset of systole (Figure 2-28).
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FIGURE 2-27. Schematic depiction of the Volcano Primewire Prestige Plus.
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FIGURE 2-28. ECG and its first differential and pressure tracing with is first and second differential.  
From top to bottom: ECG, first differential of ECG, pressure trace (red lines – division using first differential of ECG, green lines using 
second differential of pressure), first differential of pressure, second differential of pressure.
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2.3.3.2 Results 
In total 55 measurements were made in the left main stem and left anterior descending 
artery (Figure 2-29). The correlation was good in both systolic dpdt peak (Figure 2-26  
#1) (1.8039 vs 1.7268, r=0.966, p<0.001) and diastolic dpdt minimum ((Figure 2-26 # 
3) (-1.058 vs -1.073, r=0.9644, p<0.001) values (Figure 2-30 and Figure 2-31). The peak 
diastolic dpdt ((Figure 2-26 #2) was less strongly correlated but remained statistically 
significant (0.0455 vs -0.045, r=0.263, p=0.05) (Figure 2-32). Cross correlation was also 
employed to compare waveforms a strong correlation value of 0.9994 was found. 
 
FIGURE 2-29. Example of simultaneously acquired measurement of aortic and mid-lad 
pressure waveforms with first differential. 
Proximal pressure is displayed in blue and distal pressure in black. 
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FIGURE 2-30. Scatter and Bland-Altman plot for maximum systolic dpdt measured 
simultaneously proximally and distally. 
A good correlation is seen with the peak dpdt (r=0.966, p<0.001). 
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FIGURE 2-31. Scatter and Bland-Altman plot for minimum diastolic dpdt measured 
simultaneously proximally and distally. 
Again, a good correlation is seen in this section of differentiation (r=0.9644, p<0.001). 
R² = 0.93 
0
0.5
1
1.5
2
2.5
0 0.5 1 1.5 2 2.5
M
in
im
u
m
 d
ia
st
o
li
c 
d
p
d
t 
(c
o
ro
n
ar
y)
 x
1
0
-1
 
Minimum diastolic dpdt (aortic) x10-1 
101 
 
 
 
FIGURE 2-32. Scatter and Bland-Altman plot for maximum diastolic dpdt measured 
simultaneously proximally and distally. 
A reasonable correlation is seen (r=0.263, p=0.05). 
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2.3.3.3 Conclusion 
These sets of experiments demonstrate that the central aortic pressure waveform is 
highly similar to that of the left main stem and left anterior descending arteries in the 
absence of angiographically demonstrable coronary disease. Therefore, if central aortic 
pressure can be estimated non-invasively, this is a perfectly acceptable waveform from 
which to construct non-invasive coronary wave-intensity. 
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2.3.4 PULSECOR-DERIVED CENTRAL AORTIC PRESSURE – IMPROVING ITS ACCURACY FOR 
ASSESSING THE BACKWARD EXPANSION WAVE. 
2.3.4.1 Introduction 
Previous work has demonstrated that the absolute values of central aortic pressure are 
accurately estimated from suprasystolic blood pressure readings(Lowe et al., 2009, Lin 
et al., 2012). However, for wave-intensity analysis, it is the waveform that is important. 
Initial measurements exporting the Pulsecor’s inbuilt amalgamated pressure waveform 
demonstrated that whilst the central aortic pressure was relatively similar to the 
systolic phase of aortic pressure, the area in diastole appeared to be less well 
demarcated (Figure 2-33). Given that the backward expansion wave is generated from 
this section of the pressure waveform, it was important to optimise this areas accuracy.
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FIGURE 2-33. Examples of simultaneously acquired measures of central pressure and first differential from invasive and non-invasive 
sources. 
Invasive data is displayed as red and non-invasive as black. Invasive data was gathered using a Pressure- or combined pressure- and 
flow-tipped sensor. Non-invasive data was acquired simultaneously using a suprasystolic blood pressure cuff (Pulsecor). The non-
invasive pressure tracings appear more ‘smoothed’ than the invasive data and this is demonstrated by its differentiation.
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2.3.4.2 Methods 
To further document and elaborate these discrepancies, the differentials of each 
pressure recordings were broken down into several sections (Figure 2-34). 
 
FIGURE 2-34. Central aortic pressure obtained invasively and divided into 5 areas for 
analysis.  
1) max systolic dpdt, 2) minimum diastolic dpdt, 3) maximum diastolic dpdt, 4) area 
under the systolic dpdt pressure curve, 5) area under the diastolic dpdt pressure curve. 
Using the principles described in chapters 2.5.2.2 and 2.5.2.3, data was simultaneously 
obtained in 18 patients undergoing coronary angiography with normal coronary 
arteries across 38 separate simultaneous recordings from the central aorta, left main 
stem and left anterior descending arteries.  
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2.3.4.3 Results 
A good correlation was seen between the maximum systolic dpdt (Figure 2-34 - 1) and 
minimum diastolic dpdt (Figure 2-34 -2) as well as the areas under the systolic (Figure 
2-34 -4) and diastolic (Figure 2-34 -5) dpdt curves (Table 2-3). A good correlation was 
also seen between invasively obtained maximum and minimum BP readings obtained 
invasively and noninvasively (Table 2-4). The only poor correlation was with the 
maximum diastolic dpdt readings (Figure 2-34 -3).  
In terms of absolute values, the non-invasively obtained pressure recordings were 
underestimated by 0.53.
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Pressure section - Figure 2-34 1 1 2 2 3 3 4 4 5 5 
Mean (Pa/ms) 78.0 53.2 72.6 27.4 15.3 0.7 7780 5601 5831 3709 
R value 0.4  0.6  -0.1  0.8  0.9  
P value 0.009  <0.001  0.4  <0.001  <0.001  
TABLE 2-3. Maximum values of differential according to above figure with r and p values. 
 
 Maximum invasive BP Maximum non-invasive BP Minimum invasive BP Minimum non-invasive BP 
Mean (Pa) 18206 16483 10175 10691 
R value 0.906317  0.829049  
P value <0.001  <0.001  
TABLE 2-4. Maximum and minimum invasive and non-invasive BP measurements with r  and p values.
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2.3.4.4 Conclusions 
Whilst the systolic and diastolic values obtained non-invasively using suprasystolic 
brachial measurements are similar to that obtained invasively, there does appear to be a 
‘smoothing effect’ which is particularly evident when the pressure waveform is 
differentiated, as is necessary for wave-intensity analysis. This may be because of an 
insensitivity in the pressure-measuring hardware in the suprasystolic cuff or perhaps 
because the tracings are amalgamated from the foot of the aortic pressure waveform, 
thus overly smoothing the diastolic section. Accordingly, further manipulation, either 
mathematically or through access to the ‘raw’ (i.e. unamalgamated) Pulsecor data is 
necessary to improve this accuracy.  
 
2.3.5 IMPROVING THE ACCURACY OF THE DIASTOLIC PORTION OF THE PULSECOR DEVICE 
2.3.5.1 Mathematical manipulation of Pulsecor-ensembled waveform 
Firstly I endeavoured to improve the diastolic portion of the pressure waveform 
through mathematical manipulation. One possibility was to multiply the entire vector 
by a scaling factor of 0.53 (which is the value I had recognised it to be deficient by as 
above). This would produce a good equivalent peak value but would inappropriately 
exaggerate the area under the curve. A more appropriate approximation would be 
achieved by transforming the negative values by a root of 1.2 and positive values by a 
root of 1.095 (values again obtained from the above experiments) (Figure 2-35). 
Using this method of root-scaling, a good correlation was preserved with a better 
approximation of absolute values (Table 2-5 and Table 2-6).
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FIGURE 2-35. Pressure manipulation using either vector multiplication or root scaling. 
Left panel demonstrating pressure scaling using vector multiplication. Right hand panel demonstrating pressure scaling using a 1.2 root. 
The data is displayed as black (non-invasive), red (invasive) and blue (manipulated non-invasive). The invasive waveform is more 
accurately reflected in the root-scaling rather than by multiplication.
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Invasive (I) vs Non-invasive(N) I N I N I N I N I N 
Pressure section (Figure 2-34) 1 1 2 2 3 3 4 4 5 5 
Mean 77.1 79.7 -72.2 -69.0 19.3 0.48 6872 7184 5355 7539 
R value 0.41  0.62  0.23  0.85  0.77  
P value 0.007  <0.001  0.15  <0.001  <0.001  
TABLE 2-5. Invasive (I) and non-invasive (N) maximum values of pressure differential according to FIGURE 2-34 with r and p values 
with adjustment according to root 1.2.  
 Maximum invasive BP Maximum non-invasive BP Minimum invasive BP Minimum non-invasive BP 
Mean (Pa) 18234 16435 10126 10602 
R value 0.901522  0.790786  
p value <0.0001  <0.00001  
TABLE 2-6. Maximum and minimum invasive and non-invasive BP measurements, r  and p values after adjustment by a root of 1.2.
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2.3.5.2 Using ‘raw’ Pulsecor cuff Data 
Although this produced a reasonable approximation of invasive pressure, I felt that 
manipulating the raw data rather than the data automatically processed by the Pulsecor 
machine may allow for more accuracy. Particularly, the area around the dicrotic notch 
was overly smoothed by the machine’s inbuilt amalgamation and it is from this area that 
the backward expansion wave is produced.  
In the Pulsecor Matlab array the unprocessed suprasystolic data was located as a Matlab 
file “SuprasystolicFiltered” (Figure 2-36). This was also available as an amalgamated 
file, “SuprasystolicBeatsOverlaid” (Figure 2-37). 
Encouragingly, the dicrotic notch was more evident in these traces.  The first step was to 
convert the traces to Pascals. This was done by using the given systolic and diastolic 
pressures with the amalgamated CentralPressureAverage and calculating the ratio 
between that and the systolic and diastolic mean of SuprasystolicBeatsOverlaid 
(FIGURE 2-38). When more than one Pulsecor reading was taken, they could be 
amalgamated to produce even longer stretches of data for integer processing (Figure 
2-39). 
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FIGURE 2-36. “Suprasystolicfiltered” from Pulsecor Matlab cell array. 
 
 
FIGURE 2-37. Suprasystolicbeatsoverlaid from Pulsecor Matlab cell array, 
113 
 
 
Figure 2-38. Pressure from Suprasystolicfiltered in Pascals. 
 
FIGURE 2-39. Amalgamated Pulsecor signals from two separate recordings. Data 
displayed in Pascals. 
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2.3.5.3 Ensembling of Raw Pulsecor Data 
The Pulsecor machine provided an ensemble-averaged pressure file as 
SuprasystolicBeatsOverlaid. However, at times, the ensembling was inaccurate. 
Therefore, I set out to construct an automated ensembling programme using the 
differentials of pressure. At first, I concentrated on the second differential of pressure 
but I found greater accuracy with the first. My custom-built Matlab programme’s 
parameters for differential assessment could be altered during its processing to allow 
greater accuracy as demonstrated in Figure 2-40 and Figure 2-41. 
This was a useful software addition, particularly when the Pulsecor’s own ensembling 
was less accurate (FIGURE 2-42). A further addition to the programme allowed 
individual beat selection was also enabled in case of irregular heart rhythms or 
inaccuracies mid-way through the recording. 
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FIGURE 2-40. Pressure and its first differential with poor differential recognition 
 
 
FIGURE 2-41. Pressure and its first differential with altered differential settings and 
good recognition
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Figure 2-42. Pressure from Pulsecor divided by both custom-made and inbuilt software 
at rest (top diagram) and during exercise (lower diagram) 
The upper panel demonstrates pressure divided up by cardiac cycle recognised by the 
peak of the first differential (upper panel) from the above bespoke Matlab programme. 
The lower left panel shows the resultant ensembled pressure (pre-scaling) from this 
programme and the lower right panel Pulsecor’s own attempt at alignment. As can be 
seen, in this case the Pulsecor software failed to appropriately align the pressure 
waveforms resulting in an inaccurate ensemble-average. This is particularly 
exacerbated with a tachycardic patient. 
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2.3.5.4 Comparison of Invasive and Non-invasive Pressure Data 
A similar process as above was applied to compare simultaneously acquired non-
invasive and invasively pressure signals using this ‘raw’ Pulsecor data. The data was 
processed in a total of 48 simultaneous measurements in 30 patients undergoing 
coronary angiography with invasive data obtained either via the catheter tip or from a 
pressure wire.  
Initial work demonstrated the pressure traces to be more comparable when using the 
raw Pulsecor data. There remained a slight underestimation and a conversion factor 
was again applied in an attempt to modify the pressure traces appropriately. As a 
reflection of the improved signal with the raw Pulsecor data, the conversion factor was 
much lower than required with the amalgamated signals (1.03163 for systole and 
1.02976 for diastole). An example of these traces, along with the modified traces is 
shown in Figure 2-43. 
Using this modification approach, a good correlation was seen with the absolute values 
of systolic (invasive 18526Pa,  non-invasive 19806Pa, r = 0.85, p <0.001) and diastolic 
(invasive 9837Pa, non-invasive 11161Pa). A reasonable correlation was seen with the 
other sections of pressure curve analysis as demonstrated in Table 2-7 and Figure 2-44.
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FIGURE 2-43. Invasive and non-invasive (from ‘raw’, power-modified Pulsecor data) pressure and its first differential. 
Pressure (left) and differential of pressure (right) traces. Upper panels demonstrating non-invasive traces derived from the raw 
Pulsecor data and its differential with a power modification either of the original pressure trace (blue) or after differentiation (red). 
Lower panels demonstrate invasive data and its first differential.
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1 1 2 2 3 3 4 4 5 5 
Mean 19375 9550 -82 -79 21 8 8533 8427 -5171 -5922 
Correlation  0.570 
 
0.6678 
 
0.2607 
 
0.800 
 
0.7680 
P value  <0.01 <0.01 0.07 <0.01 <0.01 
TABLE 2-7. Different sections of the pressure curves for simultaneously acquired invasive (left) and non-invasive (right) data.  
The non-invasive pressure curve is modified by a root of 1.03163 in systole and 1.02976 in diastole. 
       
FIGURE 2-44. Correlation scatter graph and Bland-Altman agreement between the minimum dpdt of invasive versus non-invasively 
derived pressure. 
The non-invasive pressure is produced from raw Pulsecor data and modified as above. Data is displayed as positive values.
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2.3.5.5 Further Pulsecor Work  
Whilst this work with Pulsecor enabled an even higher accuracy for pressure 
calculation, the data from which it was derived was ultimately a measure of more 
peripheral pressure. Additionally, the mathematical manipulation required increased 
the chance of error magnification. Therefore, in order to attempt to estimate wave-
intensity with ultimate accuracy, a measure of central pressure was required that did 
not require mathematical amplification. Also, as has been demonstrated above, using 
the Pulsecor-ensembled CentralPressureAverage resulted in inaccuracies, often due to 
its mis-selection of beats which was particularly apparent in arrhythmias, including 
atrial fibrillation or sinus arrhythmia. Therefore, manual selection and alignment of the 
raw central-estimation of pressure would hopefully negate all these issues 
The unprocessed Pulsecor file was stored in the Pulsecor array as AOChannel0. The data 
from this channel was unscaled and suffered from a trending baseline providing a 
pressure trace as demonstrated in Figure 2-45. This pressure trace was detrended using 
a fast Fourier transform (Figure 2-46) 
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FIGURE 2-45. Untrended raw pressure data extracted from Pulsecor.AOChannel0.  
The pressure is unscaled and trends upwards. 
 
FIGURE 2-46. Raw data detrended using a fast Fourier transform.  
It remains unscaled.  
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As can be seen, there is now a much better preservation of the dicrotic notch which had 
become obliterated in non-selected alignment such as that inherent to the Pulsecor 
device. Therefore, I sought to align the Pulsecor data not according to the foot-to-foot 
method but according to the minimum dpdt which would therefore preserve the 
integrity of the diastolic portion more successfully (Figure 2-47). 
Once processed in this fashion the mean unscaled trace was scaled according the 
systolic and diastolic calculated central aortic pressures provided by the Pulsecor 
machine using the following formula: 
Central ‘Bespoke’ Pressure = ( d-c ) * ( x- a ) / ( b – a) + c 
d = Systolic central aortic pressure, c = Diastolic central aortic pressure, b = Maximum 
value of unscaled raw data, a = Minimum valve of unscaled raw data, x = Vector of Raw 
unscaled data 
EQUATION 2-2. SCALING OF CENTRAL PRESSURE ACCORDING TO THE PULSECOR-PROVIDED SYSTOLIC AND DIASTOLIC 
PRESSURES 
2.3.5.5.1 Correlation with Invasive Pressure 
Once again, using this new technique, the non-invasive data was correlated with the 
invasive data.  There was a slight underestimated of systolic pressure non-invasively 
(18226 vs 16648 Pa) but with a good correlation (r = 0.84, p < 0.001); diastolic pressure 
was also estimated appropriately (9813 invasively vs 10508 Pa non-invasively, r = 0.89, 
p < 0.001) (Table 2-8, FIGURE 2-48). The cross correlation coefficient of the two 
waveforms was an average of 0.9723..
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FIGURE 2-47. Pressure alignment using custom and inherent Pulsecor software.  
The upper panel shows the raw pressure traces and each cardiac cycle is divided firstly according to a foot-to-foot method using peak 
dpdt (green dashed line). After initial ensembling they are further modified to align by minimum dpdt (red dashed line). This two-step 
process was essential to prevent ‘jumps’ at the point of minimum dpdt alignment due to the fact that alternate beats were being spliced 
together to create the individual pressure cycle. The summation is demonstrated in the lower left panel and compared to Pulsecor’s 
inbuilt alignment of the raw (unprocessed) peripheral data. 
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1 1 2 2 3 3 4 4 5 5 
mean 111 60.2 -72 -40 23.9 -4.75 8040 5879 -4348 -4622 
correlation  0.27  0.60  -0.066  0.68  0.63 
P values  <0.01  <0.01  0.7  <0.01  <0.01 
TABLE 2-8. Correlation between invasive and non-invasive pressure using 
ADCChannel0 
 
 
Figure 2-48. Bland-Altman plot of invasive versus non-invasive coronary pressure data 
with non-invasive data detrended and manipulated from raw-data using a fast Fourier 
transform and scaling. 
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2.3.6 CONCLUSIONS 
I have demonstrated that whilst it is impossible to directly measure coronary pressure 
waveforms, a good approximation can be achieved from suprasystolic pressure 
recordings using the Pulsecor device. The device itself contains an inbuilt amalgamation 
programme but this results in inaccuracies, particularly in the diastolic portion of the 
waveform. Mathematical manipulation can be used to improve this but with the 
inherent risk of amplification of any errors.  
Therefore, an alternative is to access the raw Pulsecor data which has numerous 
theoretical advantages. Using a detrending protocol involving a fast Fourier 
transformation, along with scaling according the Pulsecor’s own estimation of central 
pressure, an accurate central aortic pressure waveform can be obtained that needs no 
mathematical amplification. Alignment is key and to preserve the diastolic portion of 
this waveform I have devised a programme to recognise and align according to the 
minimum dpdt.  
Finally, I have also shown that not only is pressure a significant part of the wave 
intensity calculation, that central pressure can be accurately assumed to represent 
coronary pressure providing there are no coronary lesions. In summary, I now have an 
accurate, non-invasive estimation of the coronary pressure waveform. 
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2.4 VARIABLE 3: NON-INVASIVE CALCULATION OF WAVESPEED 
2.4.1 INTRODUCTION 
Necessary for the derivation of wave-intensity analysis is the calculation of wavespeed. 
The pulse wave velocity within vessels has been of interest for some time as it is 
thought to reflect arterial stiffness and later life cardiovascular risk(Blacher et al., 1999, 
Muiesan et al., 2010, Coutinho et al., 2011). The standard approach to measuring 
wavespeed is in a ‘foot-to-foot’ fashion, by recording pressure traces at two points in the 
vessel of interest and calculating the time taken for a rise in pressure to be transmitted 
from proximal to distal site. Wavespeed is then the distance between points of 
measurement divided by this time. This can be achieved either through simultaneous 
measurements or through individual measurements gated to the ECG. 
Attempts to calculate foot-to-foot wavespeed in coronary arteries is impossible because 
the arteries are too short to provide measurable and reliable pressure changes from 
two separate sites. Alternative techniques that use single point estimations of 
wavespeed, such as P-U loop analysis (a technique that has been validated in vitro(Khir 
and Parker, 2002), in dogs(Khir and Parker, 2005) and in humans(Khir et al., 2001) are 
also not possible in the coronary artery because influences on pressure occur from 
either end of the artery. However, an invasive single-point measurement of coronary 
wavespeed (c) has been proposed by Davies et al.(Davies et al., 2006b) that avoids these 
issues. The formula for this is: 
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c = 1/ρ √ (∑dP2 / ∑dU2) 
where ρ is the density of blood, P is pressure and U is velocity measured at the same 
point.  
EQUATION 2-3. SINGLE POINT WAVESPEED CALCULATION 
 
This method has been validated against aortic wavespeed calculated by the foot-to-foot 
method and both coronary and aortic wavespeed calculated through this method has 
been shown to increase with age(SIMONSON and NAKAGAWA, 1960, Rogers et al., 2001, 
Aguado-Sierra et al., 2006). However, this method has come under some criticism as 
adenosine (which influences the microcirculation but not epicardial vessels) causes 
effects on single-point wavespeed which are thought to be inconsistent with wavespeed 
behaviour. However, with no gold-standard for wavespeed calculation, the single-point 
measurement is thought to provide a good estimate with low variation. 
Recently, a new method has been proposed to measure wavespeed by assessing vessel 
size changes (in a method similar to tonometry of proximal vessels) and flow velocity 
and as such can produce aortic wave-intensity through the use of cMR(Biglino et al., 
2012b). This has been applied to disease states in the assessment of hypoplastic left 
heart therapy in children showing aortic reconstruction to create a more unfavourable 
ventricular-vascular coupling and reduced aortic distensibility. However, 
echocardiography is not discriminatory enough to provide this information on vessel 
size expansion. 
Whilst echocardiography can accurately estimate the rate of coronary blood flow(Rigo 
et al., 2010, Hozumi et al., 1998a, Hozumi et al., 1998b) it is not as effective at estimating 
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these minute changes in vessel size. Likewise, a foot-to-foot estimation of wave speed is 
not possible in the coronary arteries because two distinct measurably-distant points 
cannot be discerned using non-invasive measures. Therefore, the single-point equation 
is required to estimate wave speed using non-invasive measures of flow and pressure.  
 
 
 
2.4.2 METHOD 
2.4.2.1 Demographics 
In total, 26 patients (11 male) with unobstructed coronary arteries were recruited 
during diagnostic angiography. Patients were selected either because they were 
relatively low risk for coronary disease or were having a workup angiogram for aortic 
valve surgery (normal aortic valve =16). Patients were only included in the study if 
there were no coronary lesions seen at angiography as this is known to affect the single-
point wavespeed calculation(Kolyva et al., 2008). 
2.4.2.2 Invasive and non-invasive data acquisition. 
Simultaneous invasive measurements of pressure and flow were recorded as described 
in section 2.5.2.2. Wavespeed was calculated according to the single point equation as 
previously described(Davies et al., 2011, Davies et al., 2006a, Davies et al., 2006b). 
Immediately following angiography, non-invasive measures of pressure and flow were 
recorded as described in section 2.5.2.3.   
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2.4.3 RESULTS 
2.4.3.1 Methods of calculating non-invasive wavespeed 
2.4.3.1.1 Integer versus mean calculation of wavespeed 
Because of the multiplicative nature of wave-intensity analysis, coronary wavespeed is 
an important value to calculate accurately. The single-point equation when used 
invasively requires an integer number of cardiac cycles (Davies et al., 2006b).  However, 
prior to the ability to manipulate the raw Pulsecor data, the only measurement initially 
available was a mean vector and so data could only be calculated across a single mean 
cardiac cycle.  
Therefore, initially I set out to ascertain the importance of an integer-based calculation 
compared to a single averaged cardiac cycle on the same invasive measurements.  
In the 26 patients with unobstructed coronary arteries, invasive single point wavespeed 
was calculated using across both an integer number of cardiac cycles and then after the 
same cycles had been averaged to form a single cardiac-cycle. A correlation was seen in 
both left main stem measurements (n=21, average = 15.23 vs 17.00m/s, r= 0.171, 
p<0.001) and the left anterior descending artery (n=26, average = 18.31 vs 17.4, 
r=0.630, p<0.001) (Figure 2-49 and Figure 2-50). 
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FIGURE 2-49. Scatter and Bland-Altman plot of integer versus mean-calculation of 
wavespeed of left main stem.  
There are differences between the values obtained but there remains a reasonable 
correlation. 
    
FIGURE 2-50. Scatter and Bland-Altman plot of integer versus mean-calculation of 
wavespeed of left anterior descending artery.  
Again, there are differences in the values obtained with a reasonable resultant 
correlation. 
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2.4.3.2 Possible approaches to calculating wavespeed non-invasively 
It was therefore apparently possible to construct wavespeed with reasonable accuracy 
from non-invasively generated vectors of mean flow and pressure over a single cardiac 
cycle. However, the optimum technique would obviously mimic the invasive method 
most closely and as several integer values of flow were obtained, I next used this integer 
technique for flow, paired against repeated mean pressure traces.  
In order to use this method, stability of flow was essential so that pressure could be 
assumed to be equally stable and thus the mean trace could be used against each flow 
trace. Because flow traces were often not consecutively recorded, when they are spliced 
together to create a long period of flow as is necessary for integer-wavespeed 
assessment, there may be large spikes in the differentials where two parts join together. 
These areas will obviously create false weight to the denominator of the single-point 
wavespeed calculation (Figure 2-51). Options for removing this were manual splicing 
out of these sections (Figure 2-52) or smoothing of the flow traces using a Savitzky-
Golay filter (Figure 2-53)(Savitzky and Golay, 1964). Additionally, as the Pulsecor was 
already ensemble averaged, some smoothing had already occurred through this method 
meaning smoothing of the flow signal may also be appropriate. 
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FIGURE 2-51. Amalgamated flow trace and its first differential without smoothing or 
splicing 
 
FIGURE 2-52. Flow trace (top panel) and its first differential (bottom panel) with 
pressure (middle panel) after splicing out of obvious jumps created by amalgamating 
flow traces. 
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FIGURE 2-53. Flow trace (top panel) and its first differential (bottom panel) after the 
flow trace is smoothed using a Savitzky-Golay filter.  
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To test the best method of wavespeed construction, several approaches were attempted 
using Matlab with its inbuilt Savitzky-Golay filter or a custom built splicing programme: 
1) Wavespeed construction from mean flow 
2) Wavespeed construction from integer measurements with no smoothing and no 
splicing 
3) Wavespeed construction from integer measurements with smoothed flow, non-
smoothed Pulsecor and no splicing 
4) Wavespeed construction from integer measurements with unsmoothed but 
‘spliced’ flow and non-smoothed Pulsecor. 
All methods were correlated against invasive measurements obtained through single-
point Combowire assessment. 
Mean invasive LAD wavespeed was 18.2±8.4m/s. Using mean flow and mean pressure 
(#1) resulted in an underestimation of wavespeed (10.4 m/s) with poor correlation (r=-
0.29, p=0.14). Wavespeed constructed from unsmoothed un-spliced flow (#2) also 
underestimated wavespeed (13.1 m/s) albeit with a better correlation (r=0.575, 
p=0.002). Wavespeed with selective splicing (#3) also resulted in an underestimation 
(13.6 m/s) with a reasonable correlation (r=0.5271, p=0.006). The best approximation 
was with (#4) smoothed flow traces processed with integer summation (mean 
wavespeed = 18.0±5.4, r=0.62, p=0.001) (Figure 2-54). 
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FIGURE 2-54. Scatter and Bland-Altman plots between invasive single-point generated 
wavespeed and non-invasively measured integer-calculated wavespeed with flow 
smoothed using a Savitzky-Golay filter. 
R² = 0.3714 
0
5
10
15
20
25
30
35
40
45
0 5 10 15 20 25 30 35 40 45
In
va
si
ve
 s
in
gl
e
-p
o
in
t 
in
te
ge
r 
ca
lc
u
la
te
d
 w
av
e
sp
e
e
d
 
Non-invasive integer-based wavespeed with smoothed flow 
Wavespeed calculated invasively and non-
invasively using smoothed integer based flow 
136 
 
2.4.3.3 Use of Unprocessed Pulsecor  
Although these methods gave a reasonable approximation of wavespeed, it was 
ultimately felt that as an averaged approach to wavespeed calculation produced only an 
approximation of the integer-based equivalent, extraction of the unprocessed Pulsecor 
data would allow a more accurate calculation. Therefore, when this became possible 
attention was turned towards using this data, as described in section 2.3.5.5. 
2.4.3.4 Calculation of Wavespeed Using Integer Pressure and Flow Signal 
After the extraction of the Pulsecor data, the single-point wavespeed could be calculated 
using a completely integer-based approach. The maximum number of integer cardiac 
cycles used depended on the maximum number of flow or pressure files available. If 
more flow cycles were available then the optimum flow signals were manually selected 
(Figure 2-55).
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FIGURE 2-55. Pressure and flow used for integer based wavespeed analysis.  
Pressure is derived from the raw detrended processed Pulsecor data and the optimum flow signals are manually selected and spliced 
together to form the most accurate flow signal.
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2.4.3.4.1 Automated splicing of data 
Finally, a custom built Matlab routine was constructed to remove the extreme 
differential points created by the splicing together of separate flow files. This was 
designed to recognise and remove any points greater than 4 times the standard 
deviation of the first differential of flow (Figure 2-56). 
 
FIGURE 2-56. Automatic splicing of flow based on standard deviation of the first 
differential 
Flow in the top panel, raw first differential in middle panel with 4-times the standard 
differential marked in dashed red line, first differential with points outside this 4xSD 
cut-off removed using an automated algorithm. 
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2.4.4 FINAL RESULTS 
Analysis was performed in the same 26 patients. Mean invasive LAD wavespeed was 
17.55±8.05m/s and mean non-invasive LAD wavespeed 18.8±7.04m/s with an r value 
of 0.69 (p<0.001). A Bland-Altman graph is displayed in Figure 2-57. This was the final 
approach used for non-invasive wavespeed calculation.  
 
FIGURE 2-57. Bland-Altman plot of integer-based lad wavespeed derived invasively and 
non-invasively.  
The non-invasive pressure data is extracted from the raw Pulsecor data and the 
optimum flow signals are selected when there are more flow cycles than pressure 
cycles. 
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2.4.4.1 Wavespeed and age 
As arteries age, their elasticity declines. As a consequence, coronary artery wavespeed 
increases with age and this has been demonstrated invasively(Davies et al., 2006b). A 
correlation was seen using the above non-invasive method to calculate LAD wavespeed 
and age in patients with unobstructed coronary arteries (n=16, r=0.601, p=0.01 – Figure 
2-58). 
 
FIGURE 2-58. Non-invasively calculated coronary wavespeed according to age in 16 
patients with unobstructed coronary arteries. 
There is an increase in coronary wavespeed with age calculated through this method.  
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2.4.5 CONCLUSIONS 
Wavespeed is an essential variable in the calculation of wave intensity analysis. 
Previous invasive work has shown it is possible to use a single-point equation in its 
calculation thus avoiding the foot-to-foot method which would be inappropriate for the 
small coronary arteries. Using a single-point calculation I have shown that it is possible 
to successfully apply this equation to non-invasively acquired coronary pressure and 
flow and that these equate to invasively acquired measures. 
I have also delved into the most appropriate mathematical approach to performing this 
calculation. Key to the invasive data is the application of the formula across an integer 
number of cardiac cycles and I have shown that whilst it is possible to do this with an 
averaged single flow and pressure recording it is more accurate to maintain the integer 
approach. Therefore, it is essential to work with the unprocessed Pulsecor data to allow 
integer based calculations to be performed.  
Finally I have gone on to apply this calculation to confirm that wavespeed increases 
with age in the coronary tree. This fact is already known but its confirmation further 
validates this non-invasive approach to measuring coronary wavespeed.  
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2.5 NON-INVASIVE CALCULATION OF THE BACKWARD EXPANSION WAVE 
2.5.1 INTRODUCTION 
I have shown that it is possible to accurately calculate coronary flow, pressure and 
wavespeed using non-invasive methods. Therefore, it should now be possible to 
perform wave intensity analysis and in particular generate the backward expansion 
wave.  
2.5.1.1 Wave-Intensity Analysis: Mathematical Theory 
Wave intensity attempts to explain phasic flow in terms of a series of wavefronts that 
underlie the changes in pressure and flow in arteries(Parker, 2009). Unlike traditional 
approaches to wave analysis using the Fourier decomposition, wave intensity analysis 
uses the time domain to quantify these wavefronts and can determine the relative 
importance of contributing factors.  
When arteries are regarded as closed fluid-filled tubes, forces can act on them from 
either end with either a compressive or decompressive (‘expansive’) effect. 
Compressive forces acting from the proximal end have the same effect as 
decompressive forces from the distal end to accelerate fluid. Likewise, decompressive 
proximal forces or compressive distal forces act to cause deceleration (Figure 2-59). 
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FIGURE 2-59. The effect of proximal (aortic) and distal (myocardium) originating 
compressive and expansive (decompressive) forces on blood flow (Davies et al., 2006a) 
Wave intensity has the units of Watts per meters squared and is therefore the flux of 
energy per unit area carried by the wave as it propagates. The simplest wave-intensity 
measure is the product of change in velocity and change in pressure during the same 
interval (dPdU). This formula can be used to calculate net wave intensity measured at a 
single point quite easily using simultaneously measured pressure and flow.  
However, in the coronary circulation problems arise because both proximally and 
distally originating forces may arrive simultaneously. Therefore, to distinguish forward 
and backward waves (i.e. non ‘net’ waves) from a single-point measurement requires 
additional mathematical steps. 
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Firstly, the water hammer equations are recognised and demonstrate the pressure and 
velocity relationship in any wavefront: 
 
dP+ = ρcdU+ 
dP- = ρcdU- 
where dP+ is the change in pressure from the proximal end and dP- is the change in 
pressure from the distal end. 
EQUATION 2-4. WATERHAMMER EQUATIONS FOR PRESSURE AND VELOCITY IN ANY WAVEFRONT 
 
Through use of these water-hammer equations and additivity the proximal and distal 
pressure changes can be separate out further to: 
dP+ = ½ (dP + ρcdU) 
dP- = ½ (dP – ρcdU) 
or equivalently: 
dU+ = ½ (dU + dP / ρc) 
dU- = ½ (dU - dP / ρc) 
EQUATION 2-5. PRESSURE AND VELOCITY CHANGES SEPARATED INTO PROXIMAL AND DISTAL 
ORIGINS 
where a positive value in dP+ indicates an accelerating wave and a negative value a 
decelerating wave. Conversely, positive dP- values indicate a decelerating wave and 
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negative values an accelerating wave(Davies et al., 2011, Davies et al., 2006a, Parker, 
2009). 
Therefore, forward and backward wave intensity (WI) can be created from these 
respective products: 
 
WI+ = + 1 / 4 ρc (dP + ρcdU)2 
WI- = - 1 / 4 ρc (dP - ρcdU)2 
EQUATION 2-6. WAVE INTENSITY SEPARATED INTO PROXIMAL AND DISTAL ORIGINS 
 
In order to remove the potential bias of sampling frequency variation, the product of 
first time derivatives can be used(Davies et al., 2006a): 
 
WI+ = 1 / 4ρc (dP/dt + ρcdU/dt)2 
WI- = - 1 / 4ρc (dP/dt - ρcdU/dt)2 
and finally: 
WInet = WI+ + WI- = (dP/dt) * (dU/dt) 
EQUATION 2-7. WAVE INTENSITY SEPARATED INTO PROXIMAL AND DISTAL ORIGINS FROM FIRST 
DIFFERENTIALS 
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2.5.2 METHODS 
2.5.2.1 Patient recruitment 
This validatory work was performed in seventeen patients (mean age 60 ± 12, 11 male). 
They were recruited from patients scheduled for coronary angiography in whom 
coronary artery disease was considered a relatively low probability. Exclusion criteria 
included previous coronary intervention, valvular pathology and regional wall motion 
abnormalities. The study was approved by a regional Ethics committee and all subjects 
gave written informed consent.  
2.5.2.2 Invasive measurements 
Formal diagnostic angiography was performed through a trans-femoral or trans-radial 
approach. Measurements were obtained if there was no angiographic evidence of 
coronary lesions as deemed by two experienced operators. The left coronary system 
was engaged with a Judkins guide catheter and intra-arterial heparin was administered. 
A 0.014-in-diameter sensor-tipped intracoronary wire (Combowire, Volcano Corp – 
Figure 2-60) was then passed into the mid-left anterior descending artery. 
Analog output feeds were taken from the pressure-velocity console and ECG over a 
period of one minute of stable recording on a Combomap console. Data was exported 
and analysed offline with a custom software package designed with Matlab (Mathworks, 
Natick, MA) as has been previously been described by our group(Davies et al., 2011, 
Davies et al., 2006a). 
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FIGURE 2-60. Schematic depiction of a Combowire (Volcano Corp).
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2.5.2.3 Non-invasive  
To ensure reproducibility and comparability, data was acquired in the same view in all 
patients in the mid-LAD. If possible, proximal LAD / LMS and distal LAD readings were 
taken as well. Multiple coronary flow signals were recorded from the same region 
(usually >20) and exported as jpg or bitmap files and processed as described in 2.2.2.5. 
Central aortic pressure was measured using a suprasystolic brachial pressure sensor 
(Pulsecor, Auckland, New Zealand). Data was exported off-line and processed as 
described in 2.3.5. A minimum of 2 Pulsecor readings were obtained and readings were 
discarded if their fidelity was rated as anything less than ‘good’ according to the device.  
2.5.2.3.1 Baseline echocardiography 
Baseline echocardiographic readings were taken according to standard principles. LV 
mass was calculated according to the formula: 
LV mass = 0.8 * (1.04 * (LVEDD + PWDD + IVSD)3 – LVEDD3) + 0.6 
EQUATION 2-8. LV MASS CALCULATED AT ECHOCARDIOGRAPHY 
LVEDD = Left Ventricular End Diastolic Dimension, PWDD = Posterior wall thickness in 
diastole, IVSD = intraventricular septal thickness in diastole. 
 
2.5.2.4 Minimisation of Influencing Factors 
2.5.2.4.1 Physical Factors  
To minimize the effects of physical exertion, all subjects rested in bed for 1 hour before 
angiography. Subjects who smoked were not excluded from the study but asked to 
refrain from smoking for 24 hours. Similarly, subjects were required to refrain from 
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coffee and alcohol for at least 12 hours before study. Subjects were also not studied 
within 9 hours of eating.  
2.5.2.4.2 Psychological Factors  
To minimize psychological stress, all subjects had careful explanation of the procedure 
during the consent phase and ample opportunity for further clarification and 
reassurance.  
2.5.2.4.3 Pharmacological Factors  
All oral and sublingual nitrates were stopped 24 hours before the procedure. 
 
2.5.2.5 Statistics 
STATA 11 (StatCorp LP) was used for analyses. Data is expressed as mean ± standard 
deviation.  Correlation was assessed with the Pearson correlation coefficient. Student’s t 
test was used to demonstrate the presence or absence of significant differences 
between groups. A value of P<0.05 was taken as statistically significant. 
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2.5.3 RESULTS 
2.5.3.1 Patient demographics 
Baseline demographics are shown in Table 2-9. Mean age was 60 years and more men 
were recruited than woman (65 vs 35%) as would be anticipated from a routine 
angiographic service. Baseline echocardiographic data is displayed in Table 2-10. 
 
2.5.3.2 Backward expansion wave production 
2.5.3.2.1 Alignment 
One issue with the calculation of non-invasive wave intensity analysis is the absence of 
an integrated blood pressure and coronary flow measurement device. Therefore, the 
individual waveforms need to be aligned to each other accurately in order to obtain the 
wave-intensity profile. The Pulsecor machine does not have an ECG trace therefore true 
ECG-gating is not an option so alternatives were sought. 
2.5.3.2.2 Invasive differential alignment 
The first step towards achieving this was to assess the time delay between peak 
pressure and flow velocity differentials using a custom built Matlab programme (Figure 
2-61). 
Using this programme in this group of patients, the time between peak flow and peak 
pressure differentials that generate the backward expansion wave was 27±9ms. This 
value was used in the non-invasive programme where flow differential was aligned to 
27ms after the pressure differential.  
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Age 60 ± 12 
male (%) 11 (65) 
hypertensive (%) 6 (35) 
DM (%) 1 (6) 
current smoker (%) 1 (6) 
Meds beta blocker (%) 3 (18) 
 
ace/arb 4 (24) 
 
ca channel 2 (12) 
 
bendroflumethiazide 2 (12) 
 
alpha blocker 1 (6) 
 
aspirin 9 (53) 
TABLE 2-9. Baseline demographics. 
Echo LVEDd 4.4 ± 0.7 
 
LVEDs 2.9 ± 0.6 
 
IVSd 1.06 ± 0.23 
 
PWd 1.05 ± 0.22 
 
IVSs 1.6 ± 0.43 
 
PWs 1.7 ± 0.43 
Mitral inflow E 65.5 ± 16 
 A 68.5 ± 17 
Septal e' 8.2 ± 2.3 
 a' 9.6 ± 2.3 
 s' 8.4 ± 2.7 
Lateral e' 10.6 ± 4.3 
 a' 8.1 ± 4.4 
 s' 9.0 ± 3.6 
LV mass  165 ± 49 
TABLE 2-10. Routine echocardiographic data 
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FIGURE 2-61. Wave intensity and the respective weighting from pressure and flow. 
Matlab software was constructed to assess the relationship of weighted (according to 
the principles of wave-intensity analysis) pressure and flow and the resultant wave-
intensity. Top panel showed pressure and flow, middle panel weighted differentials of 
pressure and flow (all as positive values) and bottom panel their timing in relation to 
the backwards expansion wave. 
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2.5.3.2.3 Alignment with coronary flow 
With the option to process raw Pulsecor data, location of the dicrotic notch could be 
more accurately established. Therefore in an attempt to improve accuracy alignment of 
the onset of coronary flow with the dicrotic notch was performed. Additionally, through 
analysis of the invasive data, the location of coronary flow in relation to the dicrotic 
notch was noted to actually occur 20ms before closure of the aortic valve and the onset 
of the dicrotic notch (Figure 2-62). Therefore alignment at 20ms before the dicrotic 
notch was also attempted in the latter stages of analysis. However, the majority of the 
work performed was through differential alignment due to the higher discovered 
accuracy. 
 
2.5.3.3 Non-invasive Backward Expansion Wave Construction 
Over the course of this work, three approaches to non-invasive wave-intensity 
construction were applied. They are of increasing complexity largely reflecting the 
increasing ability to work with the Pulsecor data. Initially, the processed Pulsecor-
assembled, mathematically-amplified pressure data was applied (2.3.5.1). Then the 
‘SupraSystolicFiltered’ data was used (i.e. the raw tracings from the suprasystolic 
pressure sensor) with operator-ensembled pressure waveforms (2.3.5.2). Finally, it 
became possible to work with the raw manually-processed manually-aligned 
‘AOChannel0’ data (2.3.5.5) 
 
 
154 
 
 
FIGURE 2-62. The onset of coronary flow in relation to the dicrotic notch 
By assessing the timing of the onset of coronary flow in 29 invasive cases, the onset was 
noted to be 20.34ms before the dicrotic notch. 
 
 
 
 
 
 
155 
 
2.5.3.3.1 Processed Pulsecor Data 
Pre-ensembled pressure measurements were obtained from the Pulsecor machine and 
modified according to the above mathematical factors (see 2.3.5.1). Peak backward 
expansion wave intensity was similar for both invasive and non-invasive groups (mean 
invasive 146632 ± 840709 Wm-2s-2 vs 149446 ± 93184 Wm-2s-2). There was a good 
correlation between the values (r=0.72, p < 0.001) (Figure 2-63) 
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FIGURE 2-63. Scatter graph and Bland-Altman plot of non-invasive versus invasive peak 
backward wave-intensity using the technique described in 2.3.5.1. 
Wave intensity is calculated using ensemble-averaged coronary flow and 
mathematically-processed Pulsecor. Data displayed as positive values 
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2.5.3.3.2  Further Work: Use of Raw Pulsecor Data 
Once it became possible to work with the raw Pulsecor data, this was used in an effort 
to further improve the accuracy of the backward expansion wave. Through the process 
of data extraction, scaling and ensembling, a more accurate pressure measurement was 
processable (section 2.3.5.2). 
Using this approach, the most accurate reconstruction of the backward expansion wave 
was possible. In the same 17 patients with normal coronary arteries, the mean peak 
backward expansion wave was -146632 ± 840709 Wm-2s-2 invasively and noninvasively -
123872 ± 76153 Wm-2s-2 without pressure modification and 139122 ± 86586 Wm-2s-2 with 
pressure modification. Without pressure modification the correlation was good with an r 
value of 0.819 (p<0.001) and 0.820 (p<0.001) with pressure modification (Figure 2-64). 
Cumulative backward expansion wave was also calculated using the trapezoidal function on 
Matlab. Mean cumulative backward wave intensity was -5914262 ± 4990053 Wm-2s-1 
invasively compared to -5460544 ± 4037460 Wm-2s-1 non-invasively (with pressure 
modification) (r = 0.70, p = 0.01) and 4863810 ± 3569202 Wm-2s-1 (without pressure 
modification (r=0.70, p = 0.01) (Figure 2-64). 
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FIGURE 2-64. Scatter plot and Bland-Altman plot of invasive versus non-invasive peak 
backward wave intensity calculated according to 2.3.5.2.. 
Non-invasive wave intensity is calculated from manually ensemble Suprasystolicfiltered 
Pulsecor data and ensemble-averaged coronary flow. Data displayed as positive values.   
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FIGURE 2-65. Scatter plot and Bland-Altman plot of invasive versus non-invasive cumulative 
backward wave intensity as described in 2.3.5.2.  
Non-invasive wave intensity is calculated from ensembled Suprasystolicfiltered Pulsecor 
data and ensemble-averaged coronary flow. Data displayed as positive values.   
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2.5.3.3.3 Use of Raw Processed Pulsecor Data from ADCChannel0 
Finally, once all the Pulsecor manipulations had been established (section 2.3.5.5), 
backward expansion wave was recalculated in the same 17 patients as demonstrated in 
Figure 2-66 . Mean peak backward expansion wave were very similar (-147551 ± 86739 
Wm-2s-2 invasively vs. -144318.9 ± 82477 Wm-2s-2 non-invasively) with a good correlation 
(r = 0.833, p < 0.001) (Figure 2-67).  
Using this technique, cumulative wave intensity was also very accurate with a mean 
value of – 6710497 ± 3882876 Wm-2s-1 invasively compared to -6704235 ± 4417512 Wm-
2s-1 non-invasively and a correlation r value of 0.66 (p = 0.005) (Figure 2-68).
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FIGURE 2-66. Non-invasively constructed coronary wave intensity.  
Top panel showing pressure and flow measurements aligned by the peak of pressure and flow. Wave-intensity analysis (red) shown in 
the panel below with weighted pressure (blue) and flow (green) displayed. 
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FIGURE 2-67. Correlation and Bland-Altman plot of invasive versus non-invasive peak 
backward expansion wave calculated according to section 2.3.5.5.  
Non-invasive wave intensity is calculated using modified raw-Pulsecor data. 
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FIGURE 2-68. Correlation and Bland-Altman plot of invasive versus non-invasive 
cumulative backward expansion wave calculated according to section 2.3.5.5.   
Non-invasive wave intensity is calculated using modified raw-Pulsecor data. 
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2.5.3.4 Alignment with coronary flow  
After these initial modifications with alignment by differentials I used coronary flow 
alignment to the dicrotic notch as described in 2.5.3.2.3 to see if the accuracy could be 
enhanced. However, this alignment resulted in a wave-intensity pattern dominated by 
the flow signal with much less influence from the pressure signal (Figure 2-69). With 
coronary flow ensembled by r-wave guidance and mean coronary flow then aligned to 
the dicrotic notch, the peak backward expansion wave was underestimated (invasive -
147551 vs non-invasive -59830 Wm-2s-2) with a correlation r value of 0.52 (p = 0.03). 
When flow was ensemble according to the onset of diastolic coronary acceleration the 
mean values were more appropriated (non-invasive -122782 Wm-2s-2) but the accuracy 
was not as high as alignment by differentials (r = 0.58, p = 0.02). Therefore, alignment 
by flow to the dicrotic notch was felt to be less helpful than differential alignment and 
this latter method was continued. 
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FIGURE 2-69.  Wave intensity calculated according to alignment of flow with the dicrotic notch. 
Alignment according to the dicrotic notch (with notch (left) and 20ms before(right)). Note the minimal effect exerted by pressure and 
the dominant effect of flow. 
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2.5.3.5 Addition of aortic valve disease patients 
A further seven patients with a spectrum of aortic valve disease and unobstructed 
coronary arteries had same-day non-invasive and invasive wave-intensity analysis as 
described above. Again, a good correlation was seen between mean peak (invasive 
154026 ± 68289 Wm-2s-2, non-invasive 139748 ± 108422 Wm-2s-2, r=0.77, p=0.04) and 
cumulative (invasive 8521726 ± 3896524, non-invasive 6449777 ± 3561035 Wm-2s-1) 
backward expansion wave according to 2.5.3.3.3 in these 7 patients. 
When included with those patients with normal aortic valves, the correlation was 
strengthened with peak (invasive 150866 ± 78390 Wm-2s-2, non-invasive 140770 ± 
87287 Wm-2s-2, r = 0.790, p<0.001)) (Figure 2-70) and cumulative (invasive 7181748 ± 
3826425 Wm-2s-1, non-invasive 6481505 ± 4068804 Wm-2s-1, r=0.70, p < 0.001) (Figure 
2-71). 
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FIGURE 2-70. Scatter-graph and Bland-Altman analysis of peak backward wave-
intensity measured invasively and non-invasively in patients with a spectrum of aortic 
valve disease. 
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FIGURE 2-71. Scatter-graph and Bland-Altman analysis of cumulative backward wave-
intensity invasively and non-invasively in patients with a spectrum of aortic valve 
disease.  
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2.6 EXERCISE INDUCED CHANGES IN NON-INVASIVELY MEASURED BACKWARD 
EXPANSION WAVE 
2.6.1 INTRODUCTION 
Previous work in subjects with normal structural hearts has shown a progressive 
increase in the backward expansion wave with increasing heart rate. This has been 
demonstrated in animal models using pacing (Sun et al., 2004) and in patients 
exercising during angiography(Lockie et al., 2012). This makes sense physiologically: at 
rest the haemoglobin concentration and oxygen extraction of coronary flow are already 
at 70-80% maximum capacity and therefore the resultant 5-fold increase in oxygen 
requirements of the myocardium during heavy exercise is largely served by an increase 
in coronary blood flow. Peak values of coronary blood flow in dynamic exercise are 3-5 
times the resting level(Duncker and Bache, 2008) and this increase in flow must be 
driven by a larger energy wave. 
In order to further validate my measures of non-invasive wave intensity I endeavoured 
to calculate the effect of exercise in patients with structural normal hearts with no 
evidence of coronary disease.  
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2.6.2 METHOD 
2.6.2.1 Patients 
9 patients (6 male) with no evidence of structural or coronary heart disease 
(demonstrated with transthoracic echocardiography and angiography) were invited to 
attend for assessment.  Patients were also selected on the basis of good coronary flow 
windows. They were asked to withhold any rate-limiting pharmacological agents in the 
48 hours prior to attendance and avoid alcohol, nicotine or nitrates in the preceding 24 
hours.  
2.6.2.2 Protocol 
This employed the use of a dedicated exercise bike designed for exercise-
echocardiography (Figure 2-72). The Pulsecor machine was applied to the left arm and 
operated by an assistant, ensuring there was no movement artefact during 
measurements. Coronary flow was interrogated continuously with increasing workload 
and heart rate aiming for a heart rate of 120bpm. A minimum of 3 recordings of the 
Pulsecor were taken: at rest, between 80-90 bpm and between 100-110bpm. 
Post-data acquisition, the coronary flow images were digitalized as described. The heart 
rate was calculated using Matlab by an automated recognition of the Q waves on the 
ECG. Coronary flow was then grouped into discrete groups of 10bpm spreads of heart 
rate (from 50-60bpm to 100-110 bpm). They were then processed with the appropriate 
Pulsecor.  
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FIGURE 2-72. Ergoline exercise bike with simultaneously recorded Pulsecor.  
The machine can be adjusted by work-rate independent of revolution speed allowing 
steady incremental increases in heart rate.  
2.6.2.3 Statistics 
Data was analysed using STATA version 11. ANOVA was performed with Sidak for 
correlation.  A p value of <0.05 was deemed significant. 
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2.6.3 RESULTS 
Although technically very challenging it did prove possible to achieve coronary flow 
data at graded-heart rates (Figure 2-73) with simultaneous Pulsecor measurements in 
these 9 patients. 
2.6.3.1 Haemodynamic parameters 
Baseline, mid-exercise and peak exercise haemodynamic parameters are demonstrated 
in Table 2-11. Coronary flow rose appropriately during exercise from 28.8 cm/s to 42.1 
cm/s (p 0.06) (example - Figure 2-73) as did systolic pressure (124 to 141 mmHg, 
p=0.018). Diastolic pressure only modestly rose from 85 to 88mmHg (p=0.66). 
Backward expansion wave was calculated as both a peak and cumulative value and a 
progressive increase was seen in both. Peak BEW was -100036 ± 65038.15 Wm-2s-2 at 
baseline and increased to -151531 ± 10275 Wm-2s-2 at moderate exercise and -204778.5 ± 
68259 Wm-2s-2 at peak (p=0.02 vs rest). Cumulative BEW was 5393160 ± 3823324 Wm-2s-1 
at rest and rose to 6779162 ± 2259721 Wm-2s-1 at moderate exercise and 14518790 ± 
8939111 Wm-2s-2 at peak (p=0.03 vs rest) (Table 2-11, Figure 2-74). 
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FIGURE 2-73. Coronary flow as measured by echocardiography with increasing heart 
rate with patient exercising on dedicated echo-exercise bike.  
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 Baseline Mid-exercise Peak-exercise 
Heart Rate (bpm) 72.3 ± 9.8 85.8 ± 11.3 102.4 ± 9.7 
Central systolic pressure (mmHg) 123.6 ± 16.5 130.2 ± 19.8 141.8 ± 25.3 
Diastolic BP(mmHg) 85.12 ± 7.7 85.6 88.4 
Peak velocity (cm/s) 28.8 ± 12.9 33.9 ± 14.3 42.1 ± 17.3 
Mean velocity (cm/s) 18.5 ± 7.1 21.3 ± 8.0 25.5 ± 9.3 
Peak backward expansion wave (Wm-2s-2) 10.0 ± 6.5 x104 15.1 ± 10.2 x 104 30.2 ± 20.4 x 104 
Cumulative backward expansion wave (Wm-2s-1) 53.9 ± 38 x 105 
 
83.4 ± 67.8 x 105 145.2 ± 89.4 x 105 
 
 
TABLE 2-11. Baseline, mid-exercise and peak-exercise haemodynamic data for 9 patients with normal coronary arteries and structural 
normal hearts undergoing a graded exercise regimen.  
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FIGURE 2-74. Coronary flow assessment and non-invasive wave-intensity analysis at increasing heart rates.  
With exercise and a resultant increasing heart rate a progressive increase is seen in the in size of the cumulative and peak backward 
expansion wave. In turn this transmits a greater ‘suction’ from the myocardium to the proximal blood flow resulting in higher coronary 
flow rates per cardiac cycle. Although technically challenging, with a moderate level of experience, non-invasive coronary flow and the 
backward expansion wave can be measured at heart rates of 120bpm (far right panel).
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FIGURE 2-75. Peak and cumulative backward expansion wave during exercise. 
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There is a significant increase in both peak and cumulative backward expansion wave 
per heart beat accounting for the increase in flow generated during exercise. Data is 
displayed as mean with SEM bars. 
 
2.6.4 CONCLUSIONS 
In both human and animal models, the backward expansion wave has been shown to 
increase with increasing heart rate. By using an echo-exercise bike I have demonstrated 
that it is possible to perform exercise wave-intensity analysis and that the backward 
expansion wave responds as expected. This confirms experimental findings that have 
been performed invasively as well as further validates this method of wave-intensity 
assessment. 
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2.7 BACKWARD EXPANSION WAVE WITH LEFT VENTRICULAR MASS 
Previous data has demonstrated a correlation between the percentage of backward 
expansion wave and LV thickness reflecting the inefficiency of increasing left ventricular 
hypertrophy. In 24 patients with normal coronary arteries and structurally normal 
hearts, left ventricular mass was calculated according to standard principles(Lang et al., 
2005) and correlated with peak backward expansion wave. Whilst it did not reach 
significance (p=0.17), there was a similar trend between peak backward expansion 
wave with left ventricular mass (Figure 2-76).  
 
FIGURE 2-76. Peak backward expansion wave with left ventricular mass. There is a 
trend towards a smaller backward expansion wave with increasing lv mass.  
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2.8 REPRODUCIBILITY 
Finally, to test reproducibility, 15 patients with unobstructed coronary arteries and 
structurally normal hearts, in whom non-invasive wave-intensity was measured were 
assessed twice. The protocol for the reassessment was: 
1. Non-invasive assessment of coronary wave-intensity using inbuilt coronary flow 
pre-sets 
2. Return to normal ‘cardiology’ pre-sets and full routine cardiac echocardiography 
3. Return to coronary flow pre-sets and further non-invasive assessment of flow 
with repeat Pulsecor measurements 
Coronary flow was not accurately obtained in 1 patient therefore they were excluded. In 
the remaining 14 a good reproducibility was obtained for both peak (r=0.90, p<0.001) 
and cumulative (r=0.90, p<0.001) backward expansion wave intensity (Figure 2-77).
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FIGURE 2-77.  Peak and cumulative backward expansion wave reproducibility displayed as a Bland-Altman plot. 
There is a good reproducibility with peak and cumulative non-invasively constructed backward expansion wave.
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2.9 CONSTRUCTION OF NON-INVASIVE WAVE INTENSITY: CONCLUSIONS 
Coronary wave-intensity analysis is a useful tool in the assessment of myocardial and 
coronary disease. It enables the quantification and qualification of the energy 
influencing the velocity of blood and as such provides information on the proximal 
(aortic) and distal (myocardial) influences of flow. The most usefully recognised wave 
within the cardiac cycle is the backward-travelling expansion wave which is responsible 
for generating coronary flow during diastole. Using non-invasive techniques, I have 
demonstrated that it is possible to construct a valid measure of this wave. I have also 
shown that it is reproducible and that it responds appropriately during aerobic exercise. 
Direct visual assessment and pulse-wave measures of coronary flow have been possible 
with echocardiography for the last 2 decades. With improvements in probe- and 
processing-technology, the coronary flow signals obtained have been steadily 
improving. However, as alluded to above, by measuring flow alone, it is impossible to 
make an assumption regarding the direction the force generating flow originates from. 
Therefore, in order to make flow measures more useful clinically, a further variable is 
required. Previously, this has been the addition of a stressor agent to increase the 
inotropic and/or chronotropic cardiac state and thus allowing derivation of coronary 
flow reserve. However, by using coronary flow along with central pressure, coronary 
wave-intensity is able to give meaningful information regarding the myocardium 
without the need for stress.  
The technique of coronary flow analysis is not without difficulties. It is important to use 
a machine which is geared towards coronary flow imaging. This is essential in order to 
visualise the acceleration of blood in early diastole and not just its peak. Additionally, 
unorthodox views are required to bring the LAD into the appropriate plane. Finally, 
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learning to adjust the settings of the machine beyond its pre-sets is also important. With 
a moderate level of experience coronary flow can be reliable obtained in approximately 
80-90% of patients and validates well with simultaneous invasive measures.  
Unlike coronary flow, less skill is required in the live acquisition of central pressure 
using the Pulsecor device. This is not always true during exercise where the presence of 
an assistant is vital to maintain arm stability during suprasystolic measurements. 
However, post-processing of this data to obtain a clean, reliable and useful sample is 
essential. This may mean removing inaccurate beats before re-ensembling as well as 
ensembling around a fixed point such as the peak negative dpdt in order to ensure that 
the diastolic portion is best preserved. I have demonstrated that the assumption that 
coronary pressure waveforms in non-obstructed arteries are the same as central aortic 
ones and that the pressure waveforms that can be obtained non-invasively, with 
appropriate post-processing after acquisition, are valid estimations of coronary 
pressure. 
Calculation of wavespeed is necessary for wave-intensity analysis and this is performed 
using a single-point technique and I have shown the values obtained non-invasively in 
this fashion to correlate well with invasive measurements. I have demonstrated 
different ways of producing this value mathematically and have shown that integer 
based calculations, involving raw Pulsecor data is the most accurate.  
Using these measurements I have gone on to calculate peak and cumulative measures of 
backward expansion wave in a group of patients with unobstructed coronary arteries 
with no significant cardiac structural abnormalities. A good correlation was found with 
similar invasive measurements. Additionally, previous invasive work has demonstrated 
that the backward expansion wave increases in animal models and humans with pacing 
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or exercise and a similar effect was seen in a group of 9 patients who underwent non-
invasive wave-intensity assessment during static-bike exercise.  This reinforces the 
validity of the measurements I obtained. Finally, I have gone on to show that non-
invasive backward expansion wave construction is a reproducible technique. 
Therefore, in summary, I have shown that it is possible to construct a coronary wave-
intensity profile non-invasively. This technique obviously has applications in a variety 
of research and clinical settings, particularly in patients not scheduled for invasive 
assessments but in whom repeated measures of wave-intensity would be useful for 
guiding the need for, or effect of, therapy. This technique therefore forms a fundamental 
tool used throughout the rest of this thesis 
 
 
 
 
 
 
 
 
 
 
184 
 
3 CHAPTER 3: INVASIVE WAVE INTENSITY ANALYSIS IN SEVERE 
AORTIC STENOSIS AND THE ACUTE EFFECT OF AFTERLOAD 
REDUCTION 
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3.1 INTRODUCTION 
3.1.1 INVASIVE WAVE INTENSITY ANALYSIS IN AORTIC STENOSIS 
The initial step in the construction of the wave-intensity profile across the spectrum of 
aortic valve disease was the application of invasive wave-intensity analysis in patients 
with severe aortic stenosis. Invasive analysis can be employed here because these 
patients can conveniently undergo catheter based interrogation either as part of their 
work-up for aortic valve replacement or during their therapy with transcatheter aortic 
valve therapy. Therefore it was possible to follow conventional invasive assessment of 
their coronary wave-intensity profile as has previously been applied to normal 
subjects(Davies et al., 2006a).  
3.1.2 TRANSCATHETER AORTIC VALVE IMPLANTATION (TAVI) AS AN EXPERIMENTAL 
MODEL 
The introduction of the TAVI procedure allowed great versatility in the peri-procedural 
assessment of aortic stenosis before and after outflow tract obstruction relief. It has 
several advantages in this area, notably: 
1. Absence of pericardotomy or the need for cardiopulmonary bypass thus 
preserving the underlying physiological status  
2. The presence of invasive monitoring and the ability to easily interrogate the 
coronary arteries  
3. The presence of a temporary pacing wire to provide a stressor of the 
myocardium 
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Therefore, intracoronary assessments during the TAVI procedure are not only possible 
but theoretically more physiologically appropriate than those that could be achieved 
during aortic valve replacement.  
3.1.3 PACING AS A STRESSOR OF MYOCARDIUM IN AORTIC STENOSIS 
Prior to the introduction of the TAVI procedure, the use of pacing to stress the 
myocardium has had a fairly limited application in the assessment of aortic stenosis. 
Previous work in dogs with LVH induced through aortic banding or coronary cusp 
plication has demonstrated abnormalities in subendocardial blood flow with right 
ventricular pacing compared to controls. There was a failure of the subendocardial 
blood flow to increase compared to the subepicardial layer in the same animal as well as 
both layers in control animals measured through radioactive microsphere 
assessment(Bache et al., 1981a, Alyono et al., 1986). This also corresponded to a 
deterioration in subendocardial fractional shortening(Nakano et al., 1989) and has also 
been shown to occur with dogs during exercise(Bache et al., 1981b).  
Older studies have also employed pacing as a means to stress the heart in humans with 
aortic stenosis. Using an temporary pacing wire in the right atrium and incremental 
pacing rates angina has been demonstrated at higher heart rates, typically around 120-
150 bpm(Fifer et al., 1986). Anecdotal reports in patients with more moderate aortic 
stenosis have documented the potential detrimental effects of ventricular pacing both 
clinically(Patel et al., 1977) and in terms of coronary flow reserve(Kawamoto et al., 
2001) . However, largely the investigation of aortic stenosis has employed other 
investigative or experimental modalities and this is where the TAVI procedure allows 
for an expansion. 
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3.1.4 LEFT VENTRICULAR HYPERTROPHY IN AORTIC STENOSIS  
Left ventricular hypertrophy involves the deposition of extracellular matrix and 
perivascular fibrosis(Schwartzkopff et al., 1992). This is a necessary step to preserve 
forward flow across an increasing outflow tract obstruction but is also detrimental to 
ventricular filling and ultimately coronary blood flow(Levy et al., 1990, Gaasch, 1979). It 
also means the work load and myocardial oxygen demand increases leading to a 
reduced coronary vascular reserve the details of which are outlined in chapter 1. This 
abnormal ventricular pathophysiology is the reason left ventricular hypertrophy is 
associated with a worse prognosis in patients without valvular heart disease but is 
essential in aortic stenosis to maintain an appropriate ejection fraction in the face of 
increase outflow tract obstruction. 
Therefore, by assessing coronary physiology using wave intensity analysis during TAVI, 
it should be possible to ascertain the effect of aortic stenosis and the resultant left 
ventricular hypertrophy on the coronary circulation and the effect of aortic valve 
implantation (without an alteration in left ventricular hypertrophy) on this profile.   
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3.2 METHODS 
Eleven patients (age, 80±9 years) scheduled for TAVI with fluoroscopically 
unobstructed coronary arteries participated in the study (Table 3-1). Transthoracic 
echocardiography was performed in all subjects (Table 3-2), and was repeated 5 to 7 
days after TAVI (Table 3-3). In addition to Doppler parameters, 2 dimensional 
measurements were calculated offline on a McKeeson workstation. Exclusion criteria 
included any previous coronary intervention, significant regional wall motion 
abnormalities, cardiac dysrhythmias, or the use of nitrates in the preceding 24 hours. All 
subjects gave written informed consent in accordance with the protocol approved by 
the local ethics committee. 
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Female, n (%) 9 (82) 
Age, y 80±9 
Weight, kg 63±15 
BMI, kg/m
2
 24±3 
Hypertension, n (%) 7 (64) 
Diabetic, n 0 
Medications, n (%)  
    Statin 9 (82) 
    Antiplatelet 10 (90) 
    ACEI or A2 4 (36) 
    β-blocker 1 (9) 
    α-blocker 1 (9) 
    Calcium antagonist 3 (27) 
    Diuretic 7 (63) 
Angina, n (%)  
    Chest pain 2 (18) 
    Breathlessness 11 (100) 
    Presyncope/syncope 1 (9) 
TABLE 3-1.  Baseline demographics 
 
 
 
LV mass, g 164±53 
BSA LV mass, g 100±30 
Peak gradient, mm Hg 81±24 
Mean gradient, mm Hg 48±15 
Area, cm
2
 0.6±0.1 
Echocardiographic parameters, 
mm 
 
    LV EDD 40±10 
    LV ESD 30±13 
    LV PWD (d) 11±3 
    LV SD (d) 13±3 
    LV PWD (s) 15±3 
    LV SD (s) 16.5±3 
TABLE 3-2. Baseline echo
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TABLE 3-3. Echocardiographic parameters before and after TAVI. 
 
3.2.1 STUDY PROTOCOL 
Patients were intubated and ventilated, and a right ventricular pacing wire was 
positioned in the right ventricle via the right femoral vein. The left coronary artery was 
intubated with a Judkins left guide catheter; then, a sensor-tipped wire was passed into 
the proximal segment of the left main stem. Pressure and velocity recordings from aorta 
and coronary arteries were made with 0.014-in-diameter sensor-tipped wire 
(Combowire, Volcano Corp). Pressure and velocity were recorded for 1 minute at the 
intrinsic heart rate and then during pacing at 90 and 120 bpm. Afterward, TAVI was 
performed, an identical set of pressure- and flow-velocity measurements were made in 
 Before TAVI After TAVI P 
Peak gradient, mm Hg 81±24 18±10 <0.001 
Aortic valve    
    Velocity time integral, cm 110±20 44±12 <0.001 
    Peak velocity, m/s 4.4±0.7 2.5±0.6 <0.001 
Left ventricular outflow tract    
    VTI 28±13 22±7 0.29 
    Peak velocity, m/s 0.8±0.3 1±0.2 0.2 
Aortic regurgitation    
    None 3 3 … 
    Mild 7 7 … 
    Moderate 1 1 … 
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the coronary arteries again at the intrinsic rate and during pacing. Fluoroscopic images 
were used to ensure that the 2 measurement sets were made at identical locations. 
 
3.2.2 ANALYSIS OF HEMODYNAMIC DATA 
Analog output feeds were taken from the pressure-velocity console and ECG, fed into a 
National Instruments DAQ-Card AI-16E-4, and acquired at 1 kHz with Labview. Data 
were analysed offline with a custom software package designed with Matlab 
(Mathworks, Natick, MA). The blood pressure and Doppler velocity recordings were 
filtered with a Savitzky-Golay filter(Savitzky and Golay, 1964) and ensemble averaged 
with the ECG R wave for timing. Pressure and velocity-time integrals (VTIs) were 
calculated and VTI.min product calculated by multiplying VTI by heart rate. Values of 
VTI are corrected for body surface area and LV mass. All microcirculatory wave 
intensity values are reported as magnitudes (i.e., positive). The coronary physiological 
reserve was calculated as the difference (δ) in the peak intensity of the backward 
decompression (or suction) wave between resting and increased heart rate (90 and 120 
bpm). 
 
3.2.3 PERCUTANEOUS AORTIC VALVE IMPLANTATION 
A 7F venous sheath was positioned in the femoral vein, and an 8F arterial sheath was 
positioned in the femoral artery. A temporary pacing wire was advanced via the femoral 
vein into the right ventricular apex to achieve a minimum pacing threshold of <1 V. With 
the use of an AL1 diagnostic catheter, an 0.035-in guidewire was used to cross the aortic 
valve via the femoral artery, and the stenotic valve was prepared using aortic 
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valvuloplasty with appropriate upsizing of the femoral arterial sheath. After 
valvuloplasty, the percutaneous valve was advanced through the stenotic aortic valve 
and deployed during a phase of rapid right ventricular pacing. In 10 cases, Edwards 
Sapien valves (Edwards Lifesciences) were used; in a single case, a Corevalve 
(Medtronic) was used. The mean valve diameter was 24.75 mm (range, 23–29 mm). 
Interprocedural aortography and transoesophageal echocardiography were performed 
to check the position of the valve immediately before, during, and after valve 
deployment. 
 
3.2.4 STATISTICAL ANALYSIS 
STATA 11 (StatCorp LP) was used for analyses. The sample size was chosen (following 
our pilot study) to detect a 1.0×105-W · m−2 · s−2 reduction in microcirculatory 
diastolic suction wave, assuming an SD of 0.4×105 W · m−2 · s−2 with an α of 0.05 at 
90% power. Correlation was assessed with the Pearson correlation coefficient. Mixed 
linear models were used to account for the repeated measures in comparisons of 
changes in hemodynamic variables at differing heart rates (intrinsic and 90 and 120 
bpm). A value of P<0.05 was taken as statistically significant. 
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3.3 RESULTS 
3.3.1 EFFECTS OF AORTIC STENOSIS ON CORONARY HAEMODYNAMICS 
The baseline and pacing hemodynamic variables are summarized in Table 3-4 and Table 
3-5. The backward expansion wave increased with increasing severity of aortic stenosis 
(r=0.59, P=0.05; Figure 3-1). After TAVI, resting coronary systolic pressure (115±9 
versus 106±11 mm Hg; P=0.38), peak coronary flow velocity (54±6 versus 44±6 cm · 
s−1; P=0.2), and intrinsic heart rate remained unchanged (73±4 versus 73±3 bpm; 
P=0.96). Coronary waves were similar before and after TAVI, except for the backward 
expansion wave, which fell significantly in magnitude (1.9±0.3 versus 1.1±0.1×10−5 W · 
m−2 · s−2; P=0.02). 
 
FIGURE 3-1. Increase in the BEW with increasing peak aortic gradient. 
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 Rest 90bpm 120bpm  
 Before After Before After Before After P 
Flow Velocity        
    Minimum 2±5 7±2 2±6 5±2 4±6 5±3 0.66 
    Maximum 54±6 44±6 58±4 45±4 60±7 52±5 0.67 
    Mean 27±3 26±4 29±3 25±2 29±5 28±2 0.23 
VTI, cm        
    VTI 49±12 21±4 19±4 17±2 18±5 16±2 0.037 
    VTI.min 3587±982 1561±300 1706±332 1494±216 2120±621 1937±273 0.006 
Change from before to after TAVI  −27±11  −2.3±3  −1.5±4  
Pressure, mm Hg        
    Minimum 54±5 53±6 56±4 56±7 56±4 58±7 0.15 
    Maximum 115±9 106±11 93±10 79±22 83±6 94±11 0.65 
Mean 82±6 76±8 72±5 72±8 69±5 74±9 0.99 
    dP/dtmax 0.4±0.05 0.4±0.03 0.3±0.03 0.4±0.03 0.3±0.03 0.4±0.03 0.10 
    dP/dtmin −0.4±0.05 −0.4±0.05 −0.3±0.03 −0.3±0.03 −0.2±0.03 −0.4±0.04 0.83 
    Pressure-time integral 63±6 58±7 44±3 43±5 37±3 39±4 0.026 
Heart rate, bpm 73±4 73±3 90 90 120 120  
TABLE 3-4. Flow velocity and pressure with increasing heart rate before and after TAVI. 
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 Rest 90bpm 120bpm  
 Before After Before After Before After P 
Peak wave intensity, ×10
5
 W · m
−2
 · s
−2
        
    Forward compression 1.7±0.4 2.7±0.6 1.4±0.4 1.8±0.3 1.0±0.3 1.9±0.3 0.58 
    Forward decompression 0.9±0.1 1.0±0.2 0.7±0.2 0.9±0.1 0.7±0.2 1.0±0.2 0.09 
    Early backward compression 1.8±0.6 1.2±0.3 1.5±0.5 1.1±0.1 1.4±0.4 1.5±0.2 0.15 
    Late backward compression 0.6±0.1 0.7±0.3 0.7±0.1 0.7±0.2 0.6±0.1 0.9±0.2 0.78 
    Backward expansion  1.9±0.3 1.1±0.1 1.4±0.3 1.0±0.5 1.1±0.2 1.4±0.2 0.001 
TABLE 3-5. Peak wave intensity before and after TAVI with increasing heart rate.
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3.3.2 ASSESSMENT OF PHYSIOLOGICAL CORONARY RESERVE IN SUBJECTS WITH SEVERE 
AORTIC STENOSIS BEFORE AND AFTER PERCUTANEOUS AORTIC VALVE 
REPLACEMENT 
Physiological coronary reserve was assessed by pacing at 90 and 120 bpm (Table 3-5). 
The backward expansion wave fell with increasing heart rate before TAVI (β 
coefficient=−0.16×10−4 W · m−2 · s−2; P<0.001; Figure 4). After TAVI, this pattern was 
reversed, and the backward expansion wave was found to increase significantly (β 
coefficient=0.9×10−3 W · m−2 · s−2; P=0.014; Figure 4). Overall, comparing the changes 
before and after TAVI resulted in a significant beneficial increase in delta backward 
expansion wave with increasing heart rate (β coefficient=0.23×10−3 W · m−2 · s−2; 
P<0.001). 
 Before TAVI, the VTI was also found to decrease significantly with increasing heart rate 
(intrinsic rate, 49±12 cm versus 120 bpm 18±5 cm; P<0.004). After TAVI, however, the 
VTI remained unchanged with increasing heart rate (intrinsic rate, 21±4 cm versus 120 
bpm 16±2 cm; P=0.06).
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FIGURE 3-2. Improvement in physiological reserve in subjects with aortic stenosis after TAVI.  
Physiological reserve was assessed by measuring the backward expansion wave at rest and then by pacing at 90 and 120 bpm. Before 
TAVI, the backward expansion wave decreased with increasing heart rate. After TAVI, the reverse was observed, and the backward 
expansion wave increased with increasing heart rate.
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3.4 DISCUSSION 
In aortic stenosis, the normal coronary physiological reserve is impaired. Instead of 
increasing when heart rate rises, the coronary diastolic suction wave decreases 
paradoxically. This phenomenon is reversed immediately after TAVI when this 
physiological reserve returns to a normal positive pattern. 
 
3.4.1 ACCOUNTING FOR THE DETRIMENTAL HAEMODYNAMICS IN SEVERE AORTIC 
STENOSIS 
Normal coronary perfusion is maintained by the balance (or coupling) between the 
pressure originating from the proximal (aortic) and distal (microcirculatory) ends of the 
coronary circulation. When the aortic valve is normal, these pressures are closely 
related during ejection because LV chamber pressure is a major determinant of both 
intra-myocardial stress and aortic pressure(Kassab et al., 2002). Any difference in the 
observed aortic and microcirculatory originating pressure waveforms observed early in 
systole is attributable to time delays in physiological processes for the period that the 
aortic valve remains shut (e.g., the isovolumic contraction phase at the onset of systole). 
Because pressures at either end of the coronary artery are so closely matched during 
systole, net changes in coronary flow velocity during this period are normally minimal. 
In diastole, aortic valve closure decouples pressure in the aorta, and aortic pressure 
decays from end-systolic pressure in a quasi-exponential manner, whereas LV 
pressures and myocardial stress fall rapidly. As a result, the pressure gradient for 
coronary perfusion increases, resulting in an acceleration of coronary blood flow. 
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With increasing workload, this mechanism is exaggerated. The increased extremes of LV 
luminal pressure and intra-myocardial pressure create a larger coronary perfusion 
pressure gradient, resulting in increased coronary blood flow in early diastole. 
The importance of ventricular pressure in the determination of coronary perfusion 
pressures by this coupled mechanism has previously been reported during 
pharmacological stress in dogs and, more recently, in humans by comparing the 
difference in coronary backward expansion wave subtended by either the LV or right 
ventricle(Sun et al., 2004). 
 
3.4.2 TESTING PHYSIOLOGICAL RESERVE 
Previous studies in animal models in the absence of aortic stenosis have demonstrated a 
marked increase in backward-originating waves with physiological stressors(Sun et al., 
2000).  In our human subjects, we expected to observe similar changes with pacing 
before TAVI at 90 and 120 bpm. Unexpectedly, rather than seeing an increase in 
backward expansion wave with physiological stress, we observed a marked fall, the 
opposite of what had been reported by Sun et al(Sun et al., 2000) when performing 
similar experiments in dogs in the absence of aortic stenosis. 
We hypothesize that the fall in backward expansion wave with pacing was due to 
decoupling of the normal mechanisms essential for maintenance of normal coronary 
perfusion. To test this theory, we repeated identical pacing studies after TAVI. In these 
studies, we found that the microcirculatory originating suction wave no longer 
decreased but was found to increase by ≈50%, suggesting the restoration of 
mechanisms contributing to physiological reserve. This is likely to be a result of a 
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marked reduction in afterload (and consequent left shift on the Frank-Starling curve), a 
reduction in myocardial stress, and a recoupling of normal regulatory mechanisms for 
control of coronary perfusion (Figure 3-3). 
 
FIGURE 3-3. Decoupling of mechanisms of coronary perfusion in subjects with severe 
aortic stenosis. 
 In the coupled mechanism, rising left ventricular luminal pressure is transmitted across 
throughout the myocardium, compressing small perforating microcirculatory vessels. 
When the lv pressure exceeds the aortic pressure, the aortic valve opens, raising 
pressure at the proximal end of the coronary artery. During diastole, this process is 
reversed; left ventricular relaxation leads to closure of the aortic valve and 
decompression of the small microcirculatory vessels. This decompression generates a 
suction wave accelerating coronary blood flow, which is aided by maintenance of high 
perfusion pressures from the aorta, which falls more slowly. In the decoupled 
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mechanism in aortic stenosis, the delicate balance between lv pressure and aortic 
pressure is lost, and pressures originating at the microcirculatory end far exceed those 
from the aortic end. 
 
3.4.3 EXPLAINING MECHANISMS OF ANGINA 
The decoupling of normal regulatory mechanisms of coronary blood flow in aortic 
stenosis that we observed may help explain why aortic stenosis patients with 
unobstructed arteries develop symptoms of angina. In such subjects, even the most 
modest increases in workload are unlikely to be met by an appropriate increase in 
coronary perfusion pressure, making them vulnerable to ischemia. This can be observed 
by considering the change in VTI before and after TAVI. The VTI, a measure of the 
quantity of blood being delivered to the myocardium over the course of the cardiac 
cycle, decreases with increasing heart rate before TAVI but remains unchanged after 
TAVI. We hypothesize that this reduction in VTI with increased heart rate before TAVI is 
due to an attenuation of coronary physiological reserve such that coronary blood flow 
velocity cannot be sufficiently increased to compensate for the increased heart rate (and 
most important, the reduction in length of the diastolic perfusion phase). This is most 
striking in the VTI.min product, in which a marked reduction can be seen between 
resting and increased heart rates. These findings are similar to the reduction in 
coronary vasodilator reserve observed by Rajappan et al(Rajappan et al., 2002) during 
pharmacological non-invasive PET assessment, although phasic changes in coronary 
blood flow were not measured. After TAVI, the physiological reserve is improved so that 
an increase in heart rate is accompanied by a relative increase in VTI (despite the 
shortening of the diastolic perfusion phase). 
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We know that in humans coronary flow reserve is reduced in aortic stenosis. Although 
this factor must in some way contribute to the potential for ischemia to develop, it is not 
clear that differences in the flow reserve account for angina symptoms(Gould and 
Carabello, 2003). Assessment of differential changes in waves occurring at different 
phases in the cardiac cycle in relation to symptoms may provide a better understanding 
of the relationship of coronary flow anginal symptoms. Although further studies are 
clearly required, it is interesting that a previous study reported that people with aortic 
stenosis and exertional symptoms showed smaller increases in coronary flow velocity 
in response to atrial pacing and dobutamine than those free of anginal 
symptoms(Petropoulakis et al., 1995). 
 
3.4.4 ACUTE REDUCTION IN MICROCIRCULATORY SUCTION WAVE AFTER PERCUTANEOUS 
AORTIC VALVE REPLACEMENT 
After TAVI, the backward expansion wave was found to decrease at an intrinsic rate and 
the forward compression wave to increase. This decrease in the backward expansion 
wave is compatible, and indeed predictable, by the intra-myocardial muscle-pump 
model first described by Spaan et al(Spaan et al., 1981). In the intra-myocardial muscle-
pump model, forward coronary blood flow is explained by the expansion in volume of 
the microcirculation (generating the suction wave) after release of compression during 
systole. Compression and recoil are interrelated in that larger compression leads to 
larger recoil. Under circumstances of high LV pressure and intramural stress, as 
observed in severe aortic stenosis, intramural vessels are highly compressed in systole, 
and recoil is commensurately increased to generate a large suction wave in early 
diastole. 
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3.5 STUDY LIMITATIONS 
Each subject undergoing TAVI was sedated and ventilated during the entire course of 
the procedure. Because TAVI procedures last >90 minutes and can cause considerable 
variations in haemodynamics, it is routine for the anaesthetist to administer 
intravenous fluids and, in extreme circumstances, vasoactive drugs to maintain a stable 
blood pressure and to offset any fluid losses that occur during the procedure. This could 
affect hemodynamic measurements; however, any change would be small compared 
with the marked reduction in ventricular afterload after TAVI (pre-TAVI mean pressure 
gradient, 80±34 mm Hg). No significant difference in administration of vasoactive drugs 
was found between the 2 measurement phases. In addition, no change in 
pharmacological therapies was made during assessment of coronary physiological 
reserve, which took place over a period lasting only 3 minutes in each subject. 
Because of the nature of the typical population selected for TAVI, we studied mainly 
symptomatic elderly women with severe aortic stenosis. Caution is therefore warranted 
in extrapolating these observations to other groups, such as men or younger patients 
undergoing conventional valve surgery, particularly because the latter group may have 
lesser degrees of myocardial fibrosis and lower levels of ventricular wall stress. 
Nevertheless, we believe that TAVI provides a more appropriate model to assess the 
immediate effects of relief of aortic stenosis on coronary physiology because it is less 
complicated by the effects associated with traditional open-chest valve surgery. 
A high proportion of our subjects were labelled hypertensive on the basis of office 
measurements over the preceding years and had begun appropriate antihypertensive 
therapy. Consequently, high blood pressure contributed to additional afterload. 
However, high blood pressure is common in aortic stenosis, and given the prevalence of 
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hypertension in individuals >55 years of age, hypertension could be regarded as the 
norm rather than the exception. It is reasonable to assume that given the good blood 
pressure control achieved (systolic, 123±9 mm Hg; diastolic, 56±12 mm Hg), the vast 
majority of LV hypertrophy was due to the aortic stenosis as opposed to increased 
afterload from high blood pressure. 
Blood pressure was found to be lower after TAVI. Although this finding seems 
surprising in view of the reduced ventricular load and could indicate an adverse effect 
of TAVI, a similar blood pressure response has been reported after open-chest aortic 
valve replacement(Bonow et al., 1988, Morita et al., 2003, Estafanous et al., 1978) which 
is thought to be due to modulation of baroreflexes rather than modulation of ventricular 
afterload per se. 
We chose to use pacing rather than a pharmacological agent to increase heart rate. 
Although drug therapies may have more profound vasodilatory effects, these effects are 
not limited to the coronary circulation but have differential effects at different vascular 
beds and can cause large drops in blood pressure in patients with critical aortic 
stenosis. On the other hand, pacing is highly reproducible, is safe in patients with critical 
aortic stenosis, is an intrinsic part of the TAVI procedure, and is rapidly reversible on 
termination. 
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3.6 CONCLUSIONS 
Severe aortic stenosis is detrimental to coronary haemodynamics. These effects are due 
to severe LV pressure loading and excessive ventricular wall stress. In subjects with 
severe aortic stenosis, coronary physiological reserve is severely impaired but improves 
immediately after TAVI. Quantifying these severe limitations in coronary physiological 
reserve may explain the angina symptoms and provide a tool for functional assessment 
of significance of aortic stenosis and the timing of valvular surgery. 
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4 RESTING NON-INVASIVE CORONARY WAVE INTENSITY IN 
SEVERE AORTIC STENOSIS, AFTER AORTIC VALVE 
INTERVENTION AND WITH THE REGRESSION OF LEFT 
VENTRICULAR HYPERTROPHY 
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4.1 INTRODUCTION 
4.1.1 LEFT VENTRICULAR HYPERTROPHY 
Previous large scale retrospective and prospective studies have demonstrated the 
unfavourable independent effect of left ventricular hypertrophy on prognosis. The 
Framington study showed that left ventricular mass measured by echocardiography 
was associated with cardiovascular events, cardiovascular deaths and death from all-
cause independent of other cardiovascular risk factors(Levy et al., 1990, Haider et al., 
1998, Levy et al., 1989). For every increment of 50g/meter height in LV mass the 
relative risk of cardiovascular disease was increased approximately 1.5-fold. Similarly, 
in 280 patients prospectively followed over 10 years, an echocardiographically-
determined left ventricular mass of greater than 125g/m2 was associated with an 
increased risk of cardiovascular death, events and all-cause mortality and this risk was 
stronger than that from blood pressure(Koren et al., 1991).  
In the MAVI study, again echocardiographically-determined LV mass was a strong, 
continuous and independent predictor of cardiovascular morbidity in 1033 patients 
followed over 4 years(Verdecchia et al., 2001a). The same group demonstrated an 
independent link between LVH diagnosed through ECG or echocardiography and stroke 
or TIA in 2363 patients (Verdecchia et al., 2001b). The presence of left ventricular 
hypertrophy may also lead to the development of heart failure independent of other 
potential confounders(Drazner et al., 2004, Gardin et al., 2001). In patients who suffer 
an acute myocardial infarction, the presence of LVH conveys a poorer prognosis 
compared to those with normal LV geometry(Carluccio et al., 2000) and is an important 
contributor to the risk of sudden cardiac death in patients with coronary artery 
disease(Burke et al., 1996). 
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4.1.2 LEFT VENTRICULAR HYPERTROPHY AND REMODELLING IN AORTIC STENOSIS 
Whilst left ventricular hypertrophy is a progressive adaption to pressure overload in 
severe aortic stenosis, the degree of hypertrophy appears variable(Dweck et al., 2012a) 
but its presence predicts the development of heart failure(Kupari et al., 2005). In a 
slightly converse but interesting animal experiments, chemical (Hill et al., 2000) or 
genetic(Esposito et al., 2002) abolition of a hypertrophic response in the face of 
pressure overload did not result in cardiac failure, at least in the short-term. Therefore 
it would appear that cardiac hypertrophy may not be necessary to maintain cardiac 
output in all patients and if it does appear, it carries a detrimental prognosis. 
The presence of and degree of myocardial fibrosis in severe aortic stenosis as assessed 
by biopsy at the time of surgery is inversely correlated with the degree of left 
ventricular improvement after surgery(Azevedo et al., 2010) as well as functional status 
increase and mortality(Weidemann et al., 2009). Additionally, a good correlation is seen 
between the degree of myocardial fibrosis and left ventricular mass as assessed by 
MRI(Debl et al., 2006, Rudolph et al., 2009). Furthermore, the degree of hypertrophy 
seems to predict outcome following aortic valve replacement(Mehta et al., 2001, 
Orsinell et al., 1993) although it doesn’t seem to influence outcome in the mid-term 
(28±9 months)(Gaudino et al., 2005).  
Whilst the mortality benefit of an aortic valve replacement is relatively instantaneous in 
severe aortic stenosis there is some evidence that the risk of sudden death persists 
post-operatively albeit at a lower rate(McGiffin et al., 1993) implying that the negative 
effect of the residual left ventricular hypertrophy is not insubstantial and behaves 
similarly to non-valvular-driven LVH. 
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Following AVR, left ventricular hypertrophy regression occurs over a fairly long time 
course although the majority of the response occurs in the first year. Early work with 
echocardiography demonstrated a reduction in muscle mass by 20% over the first 6 
months(Hildick-Smith and Shapiro, 2000) after aortic valve replacement, 31% over the 
first year(Waszyrowski et al., 1996) with a further 13% reduction 7 years later(Monrad 
et al., 1988). Similarly, using cine-angiography and endometrial biopsies the greatest 
reduction in muscle mass was seen in the first year but with further reductions over the 
following 5 years(Krayenbuehl et al., 1989). Using MRI, again there is a relative 
exponential decrease in LV mass following aortic valve replacement with a 15% 
reduction at 6 months(Biederman et al., 2011), a 30% reduction in LV mass at 1 year 
(Steadman et al., 2012, Rajappan et al., 2003) and further, albeit lesser reduction at four 
years(Biederman et al., 2011). 
Transcatheter valve implantation also results in a similar pattern of left ventricular 
remodelling with an 18% reduction in LV mass as assessed by MRI at 6 months 
following TAVI(La Manna et al., 2013, Fairbairn et al., 2013). Additionally, in surgical 
patients with a patient-prosthesis mismatch at 10 years there is a reduction in the 
degree of LVH regression compared to patient’s with well-matched prostheses(Kato et 
al., 2007). 
The importance of left ventricular remodelling is thought to be favourable, at least in 
those non-aortic stenotic patients with hypertrophied ventricles as shown in several 
retrospective and epidemiological studies such as by ECG in the Framington (Levy et al., 
1994) and HOPE cohort (Mathew et al., 2001), or by echocardiography in a prospective 
cohort of 304 patients(Yurenev et al., 1992) or the LIFE cohort(Devereux et al., 2004). 
However, this has not been supported in all studies(MacMahon et al., 1989, 1985). The 
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risk of atrial fibrillation is also reduced in patients who have a reduction in the left 
ventricular mass, independent of blood pressure lowering reduction or treatment 
modality(Okin et al., 2006). In vivo and vitro studies of rabbits treated with ACE-
inhibition demonstrated the normalization of the electrophysiological abnormalities of 
ventricular hypertrophy with pharmacological regression of LVH(Rials et al., 1997). 
 
4.1.3 CORONARY HAEMODYNAMICS AFTER AORTIC VALVE REPLACEMENT 
Using a combination of echocardiography, MRI and PET scanning it has been possible to 
show an improvement in coronary microcirculatory function in conjunction with a 
regression in myocardial muscle mass following aortic valve replacement in 22 patients 
undergoing AVR (Rajappan et al., 2003). This study is in slight conflict with earlier work 
which demonstrated a failure of resting or hyperaemic myocardial blood flow to 
improve following aortic valve replacement as well as no correlation between 
myocardial blood flow reserve and myocardial hypertrophy or aortic valve 
gradient(Carpeggiani et al., 2008a). This latter study however performed its follow-up 
study 12 months after aortic valve replacement after a significant amount of LV 
regression had occurred and this may have impacted on the results.   
Invasive coronary Doppler measurements of LAD flow velocity has been performed by 
another group pre-AVR and then repeated 1-1.5 years afterwards. There was a 
reduction in baseline diastolic mean velocity from 62 to 40cm/s but with an increase in 
CFR from 1.96 to 2.37. However, again, this study was not performed immediately after 
AVR and therefore there was some effect from left ventricular hypertrophy regression 
with a reduction in muscle mass from 354 to 223g(Nemes et al., 2002). 
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Similarly, non-invasive studies of CFR by transthoracic echocardiography showed an 
improvement in coronary flow reserve 6 months after aortic valve replacement (peak 
hyperaemic velocity 0.71 vs. 1.08cm/s) without a change in peak velocity of the distal 
LAD. Again, this study was performed at 6 months post AVR after a significant amount 
of left ventricular remodelling had occurred(Hildick-Smith and Shapiro, 2000). 
Interestingly this contradicts work using transoesophageal echo-generated coronary 
flow rates where resting mean systolic and diastolic flow was found to increase post-
TAVI(Ben Dor et al., 2009). Obviously, the effect of anaesthesia and possibly inotropic 
support in this latter study plays a role which may account for some of this discrepancy. 
Other work by Kenny et al. has shown difference in the coronary flow profile of patients 
– that of reversal of early systolic flow, a feature which returns to normal 1 week after 
replacement of the aortic valve(Kenny et al., 1994). This study also found a significant 
difference in the time taken from the onset of diastolic coronary acceleration to peak 
diastolic flow in severe aortic stenosis. However, no comment was made about the 
systolic function in these patients and poorer function may also have contributed to this 
latter finding. 
Using intra-coronary assessments of blood flow, the beneficial effect of valvuloplasty 
has also been demonstrated on isoproterenol-induced hyperaemia with an additional 
reduction in myocardial lactate production noted in humans with severe aortic stenosis 
(Smucker et al., 1988). 
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4.1.4 LEFT VENTRICULAR HYPERTROPHY REGRESSION AND CORONARY FLOW 
Previous animal work has examined the relationship between coronary flow and left 
ventricular hypertrophy. In studies of renal-clipped rats, LV hypertrophy was 
associated with a tendency towards a reduced coronary flow reserve with a reversal 
after treatment of their hypertension(Wicker et al., 1983). Similar results have been 
found by a second group using aortic-banding and release to drive and reverse 
hypertrophy where flow reserve decreased with hypertrophy and normalised with its 
regression in rats(Sato et al., 1990) and guinea pigs(Kingsbury et al., 2002). Likewise, in 
spontaneously hypertensive rats coronary flow reserve generated by dipyridamole 
improved with losartan(Nunez et al., 1997) and lisinopril(Brilla et al., 1991a) induced 
LVH regression. 
In dogs with aortic banding-induced LVH and aortoplasty-induced regression, coronary 
flow was measured with both adenosine and atrial-pacing as stressors. No significant 
difference was seen in the resting blood flow between controls, dogs with LVH and dogs 
with regressed LVH with an abnormal response to adenosine seen only in dogs with 
existing LVH. However, with atrial pacing, abnormalities persisted in coronary flow 
following aortoplasty which may reflect incomplete regression(Ishihara et al., 1992). 
Taking this further, Ito et al. examined both short- and long-term aortic-banded rats 
exploring both their cardiac morphology as well as coronary reserve. In short-term 
banded animals, cardiac hypertrophy, medial hypertrophy and vascular fibrosis 
completely regressed and this was accompanied by a normalisation of coronary flow 
reserve. After long-term banding, medial hypertrophy regressed but the vascular 
fibrosis failed to improve and this was accompanied by a failure of coronary flow 
reserve to normalise. Therefore, it may be the fibrotic changes rather than the medial 
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hypertrophy that affect coronary flow reserve in hypertrophied hearts(Ito et al., 1993). 
Interesting in pre-operative severe aortic stenotic patients investigated by PET 
scanning there is a proportional relationship between total left ventricular myocardial 
blood flow and left ventricular mass; however, this relationship is lost during 
hyperaemia implying that the degree of coronary microcirculatory dysfunction is 
independent of the degree of myocyte hypertrophy(Rajappan et al., 2002), a 
phenomenon that has also been recognised in hypertrophic cardiomyopathy 
patients(Camici et al., 1991). It may be therefore that there are different morphological 
responses to aortic stenosis at a cellular level, perhaps related to the length of time for 
which the obstruction is present, which may determine the degree of myocardial 
dysfunction and recovery after intervention. 
There has been some work in this field performed in humans. In 96 hypertensive 
patients, CFR measured non-invasively by transthoracic echocardiography improved 
with 6-months of treatment with losartan or ramipril in conjunction with an 
improvement in left ventricular mass(Xu et al., 2003) although an improvement in CFR 
is also seen following treatment with irbesartan independent of LV hypertrophy(Lethen 
et al., 2003a). A study of 122 patients with hypertension demonstrated the importance 
of optimal blood pressure control with patients not achieving adequate blood pressure 
control failing to achieve an improvement in CFR or LV mass reduction(Mizuno et al., 
2012). In 15 hypertensive patients treated with enalapril, an 8% reduction in LV mass 
was associated with a 43% increase in coronary flow reserve(Motz and Strauer, 1996). 
It is possible that the pharmacological agents directly affect coronary haemodynamics 
and previous work has demonstrated candesartan to effect coronary flow reserve 
independent of LV mass regression(Tomas et al., 2006). However, comparisons 
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between verapamil and enalapril using PET scanning have demonstrated a direct effect 
of verapamil on CFR whereas enalapril had no effect(Parodi et al., 1997). 
Work with PET scanning has not shown similar results. In 22 patients measured with 
PET pre-AVR and 1 year post-AVR an improvement in myocardial perfusion was 
demonstrated with a correlation between left ventricular mass regression and resting 
but not hyperaemic myocardial blood flow. Reduced extravascular compression and 
increased diastolic perfusion time were felt to be more important contributors to this 
favourable change and again suggest a degree of heterogeneity in the way myocardial 
hypertrophy impacts on coronary haemodynamics particularly in the hyperaemic 
state(Rajappan et al., 2003). A second smaller PET study demonstrated myocardial 
blood flow reserve to be depressed independently of myocardial hypertrophy and 
trans-valvular pressure gradient without any improvement at 12 months post-AVR -  
again this may reflect this heterogeneity, particularly as only 8 patients were included 
in the 12-month follow up (Carpeggiani et al., 2008a). 
 
4.1.5 LEFT VENTRICULAR HYPERTROPHY AND WAVE INTENSITY ANALYSIS 
Wave intensity analysis has been applied to patients with left ventricular hypertrophy 
in several situations. Firstly, in patients with normal valves and hypertension-driven 
LVH, and secondly in those with LVH and severe aortic stenosis. 
4.1.5.1 Left Ventricular Hypertrophy with Normal Aortic Valves 
Previous work by Davies et al. validating the principles of wave-intensity analysis in 
humans with normal coronary arteries has demonstrated the adverse effect of left 
ventricular hypertrophy on the backward expansion wave(Davies et al., 2006a). Whilst 
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the other 5 waves of the cardiac cycle were unconnected with the ventricular septal wall 
thickness, the backward expansion wave decreased with increasing thickness (r= -0.52, 
p<0.02). There was also a disruption in the ratio of the forward-travelling pushing wave 
to the backward-travelling expansion wave with a poorer transfer of energy between 
the two with LVH. This poor energy transfer may explain why patients with left 
ventricular hypertrophy have an impaired coronary flow reserve(Hamasaki et al., 2000) 
and in turn higher mortality(Levy et al., 1990, Schillaci et al., 2000). 
4.1.5.2 Left Ventricular Hypertrophy in Aortic Stenosis 
As described in detail in chapter 1, patients with aortic stenosis develop left ventricular 
hypertrophy in response to the gradient against which it pumps. However, in contrast 
to patients with hypertension-driven LVH the backward expansion wave is higher than 
normal individuals due to the increased force of diastolic myocardial-relaxation. 
 
4.1.6 HYPOTHESIZED CHANGES IN WAVE-INTENSITY AFTER AORTIC VALVE INTERVENTION 
After aortic valve intervention with regression of left ventricular hypertrophy further 
changes in the backward expansion wave may occur. Regression of LVH may improve 
energy transfer efficiency returning to a near-normal value (Figure 4-1). Therefore, to 
investigate this further, I set out to follow up a group of patients after aortic valve 
intervention using non-invasive measures of coronary wave-intensity.  
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FIGURE 4-1. Anticipated changes in the backward expansion wave and left ventricular 
hypertrophy with time following aortic valve replacement.  
As the left ventricle favourably remodels following valve replacement there is an 
increase in the backward expansion wave reflecting a more favourable energy transfer. 
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4.2 METHODS 
Patients scheduled to undergo either aortic valve replacement or a transcatheter aortic 
valve implantation were recruited over a period of 18 months. Consent was obtained 
and local ethics approval was granted.  
4.2.1 WAVE INTENSITY 
Patients underwent non-invasive coronary wave-intensity analysis as described above. 
Briefly, patients were scanned in the left lateral position with a Pulsecor pressure cuff 
on the right arm. The left anterior descending artery was imaged from a modified 
parasternal long axis view and pulse-wave Doppler was applied. Simultaneously, 2 or 
more Pulsecor readings were sampled; readings were discarded if the fidelity was 
deemed less than ‘good’ according to the automated software. Data was processed an 
analysed offline. 
For follow up purposes, TAVI patients in whom data was obtained invasively were also 
eligible for non-invasive follow-up at 6- and 12-months. The invasive data was gathered 
as described in chapter 3.2.1(Davies et al., 2011). 
4.2.2 PROTOCOL 
Initial non-invasive data was collected in the 24 hours prior to valve intervention. 
Patients then underwent transcatheter or surgical valve implantation according to 
clinical appropriateness. Non-invasive data was recollected on the day prior to 
discharge and then repeated at 6 months and one year in a subgroup of patients. LV 
mass was calculated according to the formula: 
LV MASS = 0.8 * (1.04 * (LVEDD + PWDD + IVSD)3 – LVEDD3) + 0.6 
EQUATION 4-1. LV MASS CALCULATED FROM ECHOCARDIOGRAPHY 
218 
 
Aortic valve area, peak velocity and mean velocity was assessed using continuous and 
pulse wave assessment of the aortic valve and outflow tract and LVOT cross sectional 
measurements.  
4.2.3 EXCLUSION CRITERIA 
Patients were excluded if they had reduced left ventricular systolic function, more than 
mild co-existing valve disease and angiographically demonstrable coronary disease. For 
the follow-up, patients were further excluded if they developed a significant change in 
left ventricular function or the presence of more than mild paravalvular aortic 
regurgitation. Patients were also excluded if they had unfavourable echocardiographic 
windows at the initial assessment. 
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4.3 RESULTS 
4.3.1 PRE-OPERATIVE INFORMATION 
In total, 29 patients (14 male, mean age 76±8.9) were interrogated before and after 
aortic valve replacement / implantation. TAVI was performed in 7 patients and 
conventional aortic valve replacement in 22 patients. Baseline information is presented 
in Table 4-1. Haemodynamic information was obtained non-invasively in all aortic valve 
replacement patients and 4 TAVI patients. The remaining 3 TAVI patients had their peri-
operative haemodynamics obtained invasively as previously described in section 3.2.1.  
22 of these patients were followed up at 6 and 12 months with further non-invasive 
assessments. One patient was excluded during the follow up due to the presence of a 
moderate paravalvular leak. Of the remaining 21 patients, 20 (95%) had adequate data 
achievable at 6 months and 17 (81%) patients at 12 months.  
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Male (%) 14 (48) 
Age 74.9 ± 9.6 
Body surface area 1.86 ± 0.22 
Medication 
 
 
Calcium channel antagonist (%) 11 (38) 
 
Beta blocker (%) 12 (41) 
 
ACE-inhibitor (%) 7 (24) 
 
Angiotensin receptor blocker (%) 5 (17) 
 
Statin (%) 18 (62) 
 
Aspirin (%) 15 (51) 
 
Loop diuretic (%) 7 (24) 
 
Bendroflumethiazide (%) 3 (10) 
Symptoms 
 
 
Angina (%) 5 (17) 
 
Syncope (%) 2 (7) 
 
Dyspnoea (%) 21 (72) 
Diabetic (%) 5 (17) 
TABLE 4-1. Baseline pre-operative demographics of the 29 patients undergoing aortic 
valve intervention 
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4.3.2 PROCEDURAL DATA 
Procedural data is presented in Table 4-2. 21 patients underwent surgery; of these 19 
(90%) had a conventional tissue valve implanted, 1 (5%) a metallic valve and 1 (5%) a 
sutureless Percival valve.  Eight patients underwent transcatheter valve implantation of 
which 5 (63%) patients received an Edwards valve and 3 (33%) a CoreValve. The 
approach was transapical in 5 (66%), subclavian in 1 (11%) and transfemoral in 2 
(22%).  
 
 
 Valve Type Approach No 
TAVI Edwards Transapical 5 
 
CoreValve Transfemoral 1 
  
Subclavian 2 
Surgical Tissue Sternotomy 19 
 
Sutureless Sternotomy 1 
 
Metallic Sternotomy 1 
TABLE 4-2. Procedural data for the 29 patients undergoing aortic valve intervention.  
28% were transcatheter valves and 72% were implanted in a surgical fashion. The 
majority of valves were tissue (28/29). One valve was implanted with a ‘sutureless’ 
approach with conventional cardiopulmonary bypass.  
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4.3.3 ECHOCARDIOGRAPHIC MEASURES OF REMODELLING 
Baseline, post-procedure and follow up data is presented in Table 4-3. There was a large 
decrease in LV mass from baseline (224g) to 6 months (153g, p<0.01) but with little 
further significant decrease in mass from 6 to 12 months (150g, p=0.7). Positive 
remodelling effects were also seen in left ventricular end diastolic dimensions which 
approached then reached significance at 6 (p=0.07) and 12 (p=0.04) months. Likewise, 
there was a decrease in systolic and posterior wall dimensions. 
 Pre 6 months p value 12 months p value 
LVEDD 4.5 ± 0.7 4.2 ± 0.6 0.07 4.0 ± 0.7 0.04 
PWd 1.2 ± 0.2 1.0 ± 0.18 0.007 1.1 ± 0.2 0.005 
IVSd 1.3 ± 0.2 1.1 ± 0.27 0.09 1.1 ± 0.2 0.005 
LV mass 225 ± 58 156 ± 30 <0.001 139 ± 59 <0.001 
LVEDS 2.9 ± 0.6 2.8 ± 0.6 0.99 2.9 ± 0.5 0.82 
peak aortic velocity  4.5 ± 0.6 2.5 ± 0.4 <0.001 2.2 ± 0.6 <0.001 
TABLE 4-3. Echocardiographic parameters pre and post aortic valve intervention and a 
6 and 12 months.  
LVEDD – left ventricular end dimension at end diastole. PWd – posterior wall thickness 
at end diastole. IVSd – intra-ventricular wall thickness at end diastole. LVEDS – left 
ventricular end dimension at end systole. P values are comparison against pre-
procedure values. 
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4.3.4 EFFECT OF AORTIC VALVE INTERVENTION ON NON-INVASIVE CORONARY 
HAEMODYNAMIC PARAMETERS 
Non-invasive flow and pressure data is presented in Table 4-4. There was no significant 
change in coronary pressure pre- and post-procedure (systolic pre 15320, post 
15185Pa (p=0.75); diastolic pre 8617 to 8695Pa (p=0.81)). There was a reduction in 
coronary flow peak (0.41m/s to 0.33m/s, p=0.0008) and mean (0.25m/s to 0.21m/s, 
p=0.006) velocity pre- and post-procedure but not minimum velocity (0.13m/s to 
0.12m/s, p=0.03). Accompanying this was a dramatic reduction in the peak (-22.1 x 104 
to -10.9 x 104 Wm-2s-2, p < 0.0001) and cumulative (-11.3 x 106 to 6.34 x 106 Wm-2s-1, 
p<0.0001) backward expansion wave intensity. 
Data was also separated according to treatment strategy. There was no significant 
variation in the pre- or post-procedure measurements between the AVR and TAVI 
groups (Table 4-5). 
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pre post p value 
Peak velocity (m/s) 0.41±0.12 0.33±0.08 0.0008 
Mean velocity (m/s) 0.25±0.06 0.21±0.06 0.04 
Min velocity (m/s) 0.13±0.04 0.12±0.03 0.38 
Systolic BP (Pa) 15204±2227 14931±1896 0.50 
Mean BP (Pa) 10705±1551 10605±1456 0.76 
Diastolic BP (Pa) 8772±1508 8767±1437 0.99 
Peak backward expansion wave (Wm-2s-2 x 104) -22.1 ± 8.03 -10.9 ± 6.78 <0.0001 
Cumulative backward expansion wave (Wm-2s-1 x 106) -11.3 ± 4.7 -6.34 ± 3.74 <0.0001 
TABLE 4-4. Coronary flow and pressure pre- and post-aortic valve intervention. 
There is a fall in velocity measures following aortic valve replacement or intervention. 
However, systolic, diastolic and mean pressure measures are unchanged. Peak and 
cumulative backward expansion wave values fall post procedure. 
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Peak Backward Expansion Wave 
 
No of patients Pre p Post p 
AVR 22 -22 x 10-4 0.23 -11 x 10-4 0.73 
TAVI 7 -18 x 10-4 
 
-9.7 x 10-4 
  
Cumulative Backward Expansion Wave 
 
No of patients Pre p Post p 
AVR 22 -1.0 x 10-7 0.051 -6.1 x 10-6 0.26453 
TAVI 7 -1.1 x 10-7 
 
-6.2 x 10-6 
 TABLE 4-5. Backward expansion wave changes according to treatment modality.  
There is no significant difference in the magnitude of the backward expansion wave or 
their changes pre- and post-procedure between conventional aortic valve replacement 
or transcatheter valve therapy.  
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4.3.5 SEPARATING OUT THE EFFECT OF LVH AND OUTFLOW TRACT OBSTRUCTION 
In order to separate out the two components acting on backward expansion wave 
intensity, namely that of left ventricular hypertrophy and outflow tract obstruction, the 
post-procedure wave intensity value was subtracted from the pre-procedure value. 
Assuming that the post-procedure value is a measure of the impact of left ventricular 
hypertrophy on wave-intensity with a negligible effect from the aortic valve, this 
subtraction value should represent the isolated effect exerted by the aortic valve 
obstruction on wave intensity and should correlate more closely with aortic valve 
stenotic measures. The mean difference between pre- and post-cumulative backward 
expansion wave was -4.7x106 ± 4.3x106 Wm-2s-1 compared with -11x106 ± 5.5x106 Wm-
2s-1 pre-procedurally; mean peak aortic velocity was 4.51ms-1. By controlling for this 
post-procedure value the correlation between wave intensity and aortic stenosis 
improved from an r value of -0.29 using pre-procedure only (p=0.14) to -0.41  (p=0.04) 
using pre-procedure but accounting for the impact of left ventricular hypertrophy 
(Figure 4-2).
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FIGURE 4-2. Improvement in correlation between aortic valve gradient and non-invasively calculated cumulative backward expansion 
wave when LVH is controlled 
 By subtracting the post-procedure backward expansion wave value (i.e. the value related to the degree of left ventricular hypertrophy 
only) the correlation improves between aortic valve gradient and wave intensity. This shows the negative but variable effect of left 
ventricular hypertrophy is evident even in severe aortic stenosis. 
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4.3.6 CORONARY HAEMODYNAMICS WITH LEFT VENTRICULAR HYPERTROPHY REGRESSION 
Coronary haemodynamics are presented in Table 4-6. Immediately after aortic valve 
replacement there was a decrease in coronary flow rates but with no change in pressure 
parameters. Peak coronary flow fell from 43±14 cm/s to 33±9 cm/s (p<0.01) whereas 
systolic BP did not change significantly (15485 ± 2567 Pascals pre, 15115 ± 2988 Pascals 
post, p=0.75). At 6 months there was no change in coronary flow rate (35±10 cm/s, 
p=0.58) but with an increase in pressure (systolic post 15115 ± 2988 Pascals, 6 months 
16545 ± 2286 Pascals, p=0.02). At 12 months, pressure measures were unchanged but 
there was a further slight decrease in coronary flow rate (peak velocity fell from 35 ± 10 
to 29 ± 10 cm/s, p=0.01). 
With regression of left ventricular hypertrophy there was an increase in the peak 
backward expansion wave. Immediately post-procedure the peak BEW was -107631 ± 
65493 Wm-2s-2 and this increased to -215938 ± 126233 Wm-2s-2 at 6 months post-
procedure (p=0.003) and in fact had returned to values similar to that pre-operatively 
(p=0.91). At 12 months, the value remained elevated at -155141 ± 87116 Wm-2s-2 (p = 
0.05) (Figure 4-3). 
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 pre post p  6 months p  12 months p: 6 vs 12 months p: post vs 12 months 
peak velocity 43 ± 14 33 ± 9 <0.01 35 ± 10 0.58 29 ± 10 0.01 0.03 
mean velocity 25 ± 6 21 ± 4 0.01 22 ± 6 0.32 19 ± 6 0.01 0.01 
min velocity 13 ± 3 12 ± 3 0.68 13 ± 4 0.72 11 ± 4 0.01 0.09 
systolic BP (Pa) 15485 ± 2567 15115 ± 2988 0.75 16545 ± 2286 0.02 17255 ± 2142 0.49 0.11 
mean BP (Pa) 10809 ± 1807 10574 ± 2110 0.91 11559 ± 1761 0.07 12130 ± 1704 0.19 0.05 
diastolic BP (Pa) 8663 ± 1739 8559 ± 1844 0.81 9352 ± 1511 0.05 9955 ± 1495 0.17 0.03 
heart rate 70 ± 10 75 ± 10 0.01 69 ± 12 0.03 66 ± 12 0.39 0.005 
TABLE 4-6. Coronary haemodynamics before and after aortic valve intervention and with regression of left ventricular hypertrophy.
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FIGURE 4-3. Change in the peak backward expansion wave over the year following 
aortic valve intervention.  
There is an instant reduction in the magnitude of the BEW following aortic valve 
replacement or implantation. Over the next 6 months this value increases to a value 
equivalent to that seen pre-procedurally. At 12 months there is a slight reduction in this 
value but it remains greater than the immediate pre-intervention values. 
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4.4 DISCUSSION 
Using the technique of non-invasive wave-intensity analysis I have successfully 
demonstrated that following aortic valve replacement or implantation there is a) an 
immediate reduction in the magnitude of the backward expansion wave and b) the 
backward expansion wave then increases with the regression of left ventricular 
hypertrophy in parallel to the decline in LV mass.  
Previous work exploring the temporal effect of aortic valve replacement on coronary 
haemodynamics has been slightly hampered by the inability to perform multiple 
measurements on the same patients either because it requires administration of a 
stressor or measurements to be obtained invasively. For example, previous work has 
demonstrated an improvement in coronary flow reserve 6 months after aortic valve 
replacement compared to pre-operative measurements but interpretation is slightly 
damped by the significant amount of left ventricular remodelling that must have 
occurred in that time period (Hildick-Smith and Shapiro, 2000, Rajappan et al., 2003, 
Nemes et al., 2002). Therefore, the application of non-invasive, (stressor-free) wave-
intensity analysis is highly desirable in investigating these patients as it allows sampling 
of coronary haemodynamics at various time points following aortic valve replacement. 
Additionally, it allows a measure of myocardial efficiency in the resting state thus 
removing any potential bias exerted by hyperdynamism where there may also be an 
alteration in the systolic : diastolic time ratio. 
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4.4.1 IMMEDIATE EFFECTS OF AFTERLOAD REDUCTION 
The effects demonstrated in this study using non-invasive wave-intensity mirror that 
seen using peri-procedural invasive data acquisition in the TAVI population (Chapter 3). 
The key difference in these patients is that measurements are performed at rest in the 
absence of anaesthesia or inotropic agents and therefore more accurately reflect the 
resting physiological state. They therefore validate the information that has been 
obtained invasively. The values obtained were also of a similar magnitude (19x104 
invasive vs 22x104 Wm-2s-2 non-invasive pre-procedure, 11x104 invasive vs  10.9x104 
non-invasive post-procedure) reinforcing the integrity of this non-invasive technique.  
Pre-operatively, the peak and cumulative backward expansion wave was larger than 
that seen in individuals without valvular disease(Davies et al., 2006a) due to the 
increase force required to successfully oxygenate the harder working and increased 
volume of myocardial tissue. The backward expansion wave is a measurable 
representation of this increased force and occurs at the onset of diastole with 
myocardial relaxation. It is caused by the elastic recoil of the myocardial 
microvasculature generated from the potential energy imparted from systolic 
contraction.  
A fall in this value is seen immediately post-operatively with an almost-50% reduction 
in the magnitude of the backward expansion wave after either TAVI or AVR with no 
differences between the two treatment modalities. Whilst there is no change in the 
coronary pressure, there is an accompanying fall in coronary flow velocity reflecting the 
reduction in force being applied to accelerate blood through the coronary artery. This in 
turn also reflects the greatly reduced systolic force (and its resultant diastolic 
myocardial elastic recoil) now required to eject blood through the aortic valve orifice.  
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4.4.2 SEPARATING OUT THE CONTRIBUTORS TO WAVE-INTENSITY 
The negative effect of left ventricular hypertrophy on prognosis in patients without 
aortic stenosis is well known. This has also been seen pathophysiologically as a 
reduction in coronary flow reserve implying a disruption of normal coronary flow 
patterns and a relative ischaemia in the face of stress (Julius et al., 1997, Eberli et al., 
1991, Marcus et al., 1982). Wave-intensity analysis, as a measure of energy transfer 
efficiency is also known to be impaired in left ventricular hypertrophy(Davies et al., 
2006a).  
Aortic stenosis often involves substantial left ventricular hypertrophy which could be 
anticipated to impair coronary energy transfer in this fashion. However, there is also an 
opposite positive force exerted on the coronary circulation by the increased diastolic 
relaxation indirectly generated from the stenotic aortic valve. Therefore, a dichotomy 
exists at a wave-intensity level in aortic stenosis between the presence of an increased 
energy force being applied to blood at a less ‘efficient’ level. This is reflected in 
measurements of wave-intensity that are obtained following a successful aortic valve 
implantation or replacement where a reduction in the magnitude of the backward 
expansion wave immediately occurs, to a level much lower than that seen in normal 
individuals.  
In an attempt to separate these component features of wave intensity and to determine 
the true effect of the outflow tract obstruction on the backward expansion wave, I 
subtracted the post-procedure value from that measured pre-procedure. Theoretically, 
the post-procedure value reflects only the presence of left ventricular hypertrophy as 
the aortic valve gradient has been normalised. This isolated aortic-valve contribution to 
backward expansion wave correlated much more strongly with conventional 
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echocardiographic measures of aortic stenosis such as aortic valve peak velocity (r=-
0.29, p=0.12 compared to r=-0.41, p=0.02). 
This demonstrates the fact that even though the backward expansion wave magnitude 
is dominated in severe aortic stenosis by the outflow tract obstruction, the effect of left 
ventricular hypertrophy is both variable and significant. It may be, therefore, that aortic 
stenosis in the absence of left ventricular hypertrophy is a ‘safer’ state than with it and 
therefore, this may provide an option for further risk stratification, particularly in 
asymptomatic patients.   
 
4.4.3 LEFT VENTRICULAR HYPERTROPHY REGRESSION FOLLOWING AORTIC VALVE 
INTERVENTION AND ITS EFFECT ON WAVE INTENSITY 
The regression of left ventricular hypertrophy is a dynamic process maximal in the first 
6 months after aortic valve intervention but also continuing measurably to one year and 
beyond. Both animal and human studies of coronary flow reserve have shown the 
beneficial effect of hypertrophy regression on this measure. However, there have been 
some slightly contradictory reports (Carpeggiani et al., 2008a) in addition to evidence 
that left ventricular hypertrophy may fail to completely regress in animal models at a 
histological level(Ito et al., 1993). However, using wave-intensity analysis after aortic 
valve intervention I have been able to measure a non-pharmacologically driven 
regression of LVH and in this setting, an increase in backward expansion wave occurs 
with the reduction of left ventricular mass reflecting a progressive increase in coronary 
efficiency (Figure 4-4). 
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FIGURE 4-4. Schematic representation of the change in LVH and aortic valve gradient 
and their effect on wave intensity.  
Immediately following aortic valve intervention the aortic valve gradient rapidly falls. 
This results in a reduction in the overall energy expenditure per cardiac cycle as well as 
a reduction in the backward expansion wave driving coronary flow. However, the 
presence of the now-dominant left ventricular hypertrophy results in a relative 
inefficiency with the a low percentage backward expansion wave. Over time there is a 
progressive reduction in the degree of left ventricular hypertrophy whilst the aortic 
valve gradient remains low and static. There is therefore no change in the overall 
energy expenditure per cardiac cycle. However, cardiac function becomes more efficient 
with a greater percentage backward expansion wave. 
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This data correlates with previous coronary flow reserve data in left ventricular 
hypertrophy and its regression (Wicker et al., 1983, Sato et al., 1990, Kingsbury et al., 
2002, Kingsbury et al., 2000, Nunez et al., 1997, Brilla et al., 1991a, Ishihara et al., 1992, 
Ito et al., 1993, Xu et al., 2003, Lethen et al., 2003a, Mizuno et al., 2012, Motz and 
Strauer, 1996, Tomas et al., 2006, Parodi et al., 1997). Wave intensity can be regarded as 
a measure of the transferable energy from myocardium to blood flow and therefore 
reflects its efficiency. One can further hypothesize that a more efficient myocardium 
would be able to respond better to inotropic stimuli as in coronary flow reserve 
assessment. Therefore, as LVH improves, the myocardium becomes more energy 
efficient and this would recognisable as an improvement in coronary flow reserve. 
Interestingly, there has been some conflicting data in animal and human models 
regarding coronary flow reserve changes with LVH regression. For example, with atrial 
pacing, abnormalities persist in dog models of LVH which the authors thought may 
represent incomplete hypertrophy regression(Ishihara et al., 1992). Additionally, the 
length of time and degree of remodelling that results may play a role as demonstrated in 
rat models where long-term aortic banding induced irreversible histological and 
physiological changes compared with medium-term banding(Ito et al., 1993). PET 
scanning has also alluded to the idea that the degree of left ventricular hypertrophy is 
not necessarily directly equivalent to the degree of microvascular dysfunction(Rajappan 
et al., 2003, Rajappan et al., 2002, Carpeggiani et al., 2008a, Camici et al., 1991). These 
factors most likely reinforce the fact that the fairly simplistic measure of LV mass does 
not precisely reflect the degree myocardial and of coronary dysfunction.  
Human modelling of hypertension-driven LVH and its regression are harder to control 
independently as the addition of pharmacological agents may cause significant 
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confounding independent of LVH regression(Lethen et al., 2003a, Parodi et al., 1997) 
although there is a clear reduction in LV mass alongside an improvement in CFR in 
these studies(Xu et al., 2003, Mizuno et al., 2012, Tomas et al., 2006, Motz and Strauer, 
1996). 
 
4.4.4 ENERGY TRANSFER INEFFICIENCY WITH MYOCARDIAL HYPERTROPHY: HYPERTENSION 
VERSUS AORTIC STENOSIS 
We know from previous work that myocardial hypertrophy in the absence of valvular 
disease impacts negatively on wave intensity. However, there are distinct differences 
between the patterns of fibrosis in humans depending on aetiology – whilst both 
hypertension and aortic stenosis result in myocytic hypertrophy and perimyocytic 
fibrosis, additional changes are seen with hypertension where intra-myocardial 
arteriole wall-thickening and perivascular fibrosis are also present. This may reflect the 
fact that hypertension-driven changes involve the coronary arteries as opposed to their 
relative sparing in aortic stenosis.  
It was therefore previously unclear if the hypertrophy seen in severe aortic stenosis 
would have a similar negative impact on energy transfer as had been seen with 
hypertension-driven hypertrophy given the absence of these latter findings(Davies et 
al., 2006a). However, after aortic valve implantation or replacement when the dominant 
effect of wave intensity is that of hypertrophy, a reduced backward expansion wave is 
seen compared to that in normal individuals implying that despite subtle differences at 
a histological levels, the effect on coronary energy transfer is the same. 
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4.5 LIMITATIONS 
Due to the technical challenge of measuring non-invasive wave intensity, particularly 
with the learning curve required and adoption of correct echo machine, not all patients 
could be followed up accurately. However, the patients in whom data was not gathered 
either at 6 or 12 months did not differ from those included at these time points in any 
way and so it is unlikely that this resulted in a significant bias.  
Additionally, there was a change in echo machine used for the follow-up from a Phillips 
ie33 to an Esaote MyLabTwice. However, this would not change the absolute 
measurements obtained, simply enhance their accuracy. Patients were initially only 
included in the study if adequate echocardiographic views could be obtained. Therefore, 
if accurate images were obtained on the ie33, an even easier ascertainment of coronary 
flow was usually possible with the MyLabTwice. 
There is also the possibility of other factors influencing coronary wave-intensity 
following aortic valve intervention such as pharmacological agents. Four patients had 
an alteration in cardiac-acting drugs (addition of beta-blockade x2, increase in 
amlodipine x1 and increase in ACE-inhibitor x1). However, whilst this may have acted 
on the regression of left ventricular hypertrophy it seems unlikely that the majority of 
these drugs (perhaps with the exception of the ACE-inhibitor) would alter the 
myocardium’s suction force. Therefore, whilst these agents may improve the rate of 
LVH regression, this would only aid in appropriately demonstrating the relationship 
between LVH regression and favourable coronary wave-intensity. 
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4.6 CONCLUSION 
Non-invasive wave intensity analysis is a viable and useful tool to assess the effects of 
aortic stenosis and its treatment. The initial reduction in outflow tract gradient is seen 
immediately following either transcatheter aortic valve implantation or conventional 
aortic valve replacement as a large fall in the cumulative and peak backward expansion 
wave. This reflects the decreased force required to eject blood in the post-procedural 
state. 
After aortic valve replacement, the dominant effect modulating the backward expansion 
wave is the presence of myocardial hypertrophy. This results in a reduction in the 
magnitude of this wave compared to normal individuals. However, with regression of 
left ventricular hypertrophy, this value increases reflecting an improvement in the 
efficiency of the myocardium over time. 
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5 AORTIC STENOSIS PROGRESSION AND WAVE INTENSITY 
ANALYSIS CHANGES 
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5.1 INTRODUCTION 
5.1.1 ESTABLISHED METHODS FOR ASSESSING AORTIC STENOSIS SEVERITY 
5.1.1.1 Echocardiography 
The primary haemodynamic parameters recommended by the European Association of 
Echocardiography for the assessment of aortic stenosis are jet velocity, mean 
transaortic gradient and valve area by continuity. Jet velocity is estimated using 
continuous wave Doppler ideally with a dedicated ‘blind’ probe. It has shown a good 
correlation with outcome in aortic stenosis even when the disease is less than 
severe(Rosenhek et al., 2004) or the patient asymptomatic(Otto et al., 1997) and can be 
useful if monitored serially(Rosenhek et al., 2001). 
The transaortic pressure gradient is easily calculated using the Bernoulli equation. This 
is based on the concept that the pressure gradient across the valve is composed of the 
convective acceleration plus flow acceleration plus viscous friction. However, in severe 
aortic stenosis this can be conveniently shortened to: 
∆P = 4V2 
EQUATION 5-1. CALCULATION OF THE PRESSURE GRADIENT ACROSS THE AORTIC VALVE USING PRESSURE (P) AND VELOCITY 
(V) INTHE MODIFIED BERNOULLI EQUATION – APPROPRIATE FOR HIGH VELOCITIES. 
The peak gradient is therefore directly correlated with the measured peak velocity. If 
the peak velocity is lower than 3.5m/s however, the velocity proximal (Vp) to the 
obstruction should be incorporated as well as: 
∆P = 4(V2 – Vp2) 
EQUATION 5-2. CALCULATION OF THE PRESSURE GRADIENT USING THE BERNOULLI EQUATION AND INCORPORATING THE 
LVOT (VP) VELOCITY – APPROPRIATE FOR AORTIC VALVE LOWER VELOCITIES 
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The mean gradient is calculated by averaging the instantaneous gradients over the 
ejection period and therefore is produced conveniently through inbuilt software on all 
modern echo machines by tracing round the velocity envelope.  
Doppler velocity and pressure gradients are dependent on flow rate. Valve area is 
largely independent of flow rate however and therefore can be useful in making the 
diagnosis of aortic stenosis independent of flow. Aortic valve area is particularly useful 
in patients with poor left ventricular function where flow rates are low and can be used 
to guide the need for surgery in these patients(Connolly et al., 2000, O'Sullivan et al., 
2013, Pereira et al., 2002).  It is based on the concept that stroke volume (SV) is 
conserved on both sides of the valve and that SV can be calculated as area multiplied by 
VTI. Therefore: 
AVA = LVOT CROSS SECTIONAL AREA X LVOT VTI / AORTIC VALVE VTI 
EQUATION 5-3. CALCULATION OF THE AORTIC VALVE AREA (AVA) USING THE PRINCIPLE OF CONSERVATION OF STROKE 
VOLUME 
The LVOT cross sectional area is calculated from the assumption that the LVOT is 
circular and therefore is π x radius2.  
An alternative approach particularly in patients with a poor ejection fraction, is to 
calculate the dimensionless index, which is the ratio of LVOT to transaortic 
gradient(Hachicha et al., 2007). In order to further stratify these patients, stress 
echocardiography also has a role in ascertaining the contribution of the aortic valve to 
the failing ventricle(Blais et al., 2006).  
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In clinical practice it is unusual for many other modalities to play a role in the 
quantification of aortic stenosis. Nevertheless there are roles for other techniques as 
documented below. 
 
5.1.1.2 Cardiac Catheterisation 
Historically, measuring invasive pressure changes before and after the aortic valve was 
a useful way to quantify aortic stenosis. However, discrepancies were noted between 
echocardiographic flow-derived measures of severity when compared to pressure with 
invasive measures often underestimating the pressure changes compared to flow-
derived Bernoulli-calculated non-invasive measures. It became apparent this was 
because of ‘pressure recovery’ – a phenomenon where pressure increases the further it 
is measured from the valve due to the reconversion of turbulent-flow-generated kinetic 
energy to potential energy downstream. This has been demonstrated 
experimentally(Niederberger et al., 1996, Baumgartner et al., 1993, Levine et al., 1989) 
and clinically(Schöbel et al., 1999). Despite formulae to correct for pressure 
recovery(Baumgartner et al., 1999) or energy loss(Garcia et al., 2000) this technique is 
rarely used in the routine assessment of aortic stenosis particularly with the knowledge 
that there is a modest degree of micro-embolisation when the valve is crossed (Omran 
et al., 2003). 
5.1.1.3 Computerised Tomography 
CT can be used to quantify aortic valve area and a good correlation has been seen with 
echocardiographically derived valve area(Feuchtner et al., 2006, Feuchtner et al., 2007, 
Bouvier et al., 2006). However, CT probably has a stronger role in qualifying aortic valve 
morphology at present(Chun et al., 2008, Sebastia et al., 2003). 
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5.1.1.4 Cardiac MRI 
Cardiac MRI is useful for evaluating myocardial structure and function and may also 
have the ability to quantify aortic stenosis. Mapping of anterograde flow was first 
demonstrated to be possible using MRI scanning 20 years ago across both the mitral 
and aortic valve(Kilner et al., 1993) and by using the simplified Bernoulli equation the 
resultant mean and peak systolic gradients correlated well with cardiac catheterisation 
(and in fact was more accurate(John et al., 2003, Kupfahl et al., 2004)), 
transthoracic(Eichenberger et al., 1993) and transoesophageal Doppler(Reant et al., 
2006), and indicator dilution(Sondergaard et al., 1993). Planimetry can be used to 
calculate aortic valve area and this has been validated experimentally(Strohm et al., 
2001) and clinically(Debl et al., 2005) and improved on with more modern 
techniques(Schlosser et al., 2007). By mapping VTIs and aortic valve area, the continuity 
equation can also be employed through MRI scanning(Caruthers et al., 2003). 
MRI scanning may also play a more complimentary role in severe aortic stenosis due to 
its ability to assess function and scarring. For example, it is possible to predict aerobic 
exercise capacity in severe aortic stenosis by assessing myocardial blood flow and 
myocardial perfusion reserve(Steadman et al., 2012). Prognostically, the presence of 
late-gadolinium enhancement on MRI scanning, a correlate of the degree of myocardial 
fibrosis, was able to predict the left ventricular functional improvement (mean ejection 
fraction in this study 53%) and all-cause mortality after aortic valve replacement in 
severe aortic stenosis(Azevedo et al., 2010). 
5.1.1.5 Positron Emission Tomography 
PET scanning has largely been confined to a research tool in the assessment of aortic 
stenosis. However, in severe aortic stenosis a reduction in myocardial blood flow 
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reserve has been demonstrated, with a relative independence from myocardial 
hypertrophy(Carpeggiani et al., 2008a, Rajappan et al., 2002). It has also proven useful 
in recognising the degree of inflammation and calcification in the aortic valve of these 
patients (Dweck et al., 2012b). 
5.1.1.6 Valvuloarterial impedance (Zva) 
As has already been mentioned, it is well accepted that the occurrence of LV 
dysfunction, symptoms and adverse outcomes does not always correlate with the 
classical markers of haemodynamic severity as measured by echocardiography. Some 
investigators have suggested that this is because these measures only take into account 
the pressure placed on the left ventricle by the stenotic valve and fail to take into 
account the additional burden presented by the arterial system which increases with 
age and shows significant variability(Mattace-Raso et al., 2006). Reduced arterial 
compliance, caused by increasing arterial stiffness, contributes to increased LV afterload 
and myocardial oxygen demand and diminished coronary flow during 
diastole(O'Rourke et al., 2002). Therefore, these investigators sought to integrate this 
into the assessment of LV burden in aortic stenosis. 
Initial work in this field was with pigs where two sources of afterload were created by 
banding at both the supravalvular level and then at the distal aorta. With this distal 
afterload in place, there was a fall in peak-to-peak pressure gradients across the valve 
but an increase in the peak systolic LV wall stress as measured by 
echocardiography(Kadem et al., 2005). Elaboration of this concept required an accurate 
approximation of systemic arterial compliance (SAC) which can be achieved in a 
practical fashion using the systolic arterial pressure (SAP) to Stroke Volume index (SVi) 
ratio(Sunagawa et al., 1983, Chemla et al., 2003): 
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SAC = SAP / SVI 
EQUATION 5-4. CALCULATION OF SYSTOLIC ARTERIAL COMPLIANCE (SAC) FROM SYSTOLIC ARTERIAL 
PRESSURE (SAP) AND SYSTOLIC VOLUME INDEX (SVI) 
Stroke Volume index is calculated by relating stroke volume (SV) to the size of an 
individual using their Body Surface Area (BSA): 
SVI = SV / BSA 
EQUATION 5-5. CALCULATION OF STROKE VOLUME INDEX (SVI) FROM STROKE VOLUME (SV) AND 
BODY SURFACE AREA (BSA). 
In turn, stroke volume can be calculated from echocardiography using the LVOT area 
and the LVOT Velocity Time Integral (VTI) so that: 
SV = LVOT AREA X LVOT VTI = π (LVOT DIAMETER / 2)2 X LVOT VTI 
EQUATION 5-6. CALCULATION OF STROKE VOLUEME FROMM LVOT AREA AND VELOCITY TIME 
INTEGRAL 
Finally, this needs to have the aortic valve mean pressure load (MG) integrated into it to 
produce the valvulo-arterial impedance (Zva): 
ZVA = (SAP + MG) / SVI 
EQUATION 5-7. CONSTRUCTION OF THE VALVULO-ARTERIAL IMPEDENCE 
Initial work using this concept in 208 patients with moderate and severe aortic stenosis 
demonstrated that Zva was independently associated with LV dysfunction(Briand et al., 
2005). Retrospective analysis of the 1591 patients in the SEAS (Simvastatin Ezetimibe 
in Aortic Stenosis) study demonstrated that LV global afterload (Zva) impacts 
unfavourably on LV myocardial function in asymptomatic patients with aortic stenosis. 
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Using speckle tracking, Zva was also found to be an independent marker of myocardial 
dysfunction in asymptomatic aortic stenosis(Lancellotti et al., 2010b). However, a 
further study showed that Zva was not helpful in distinguishing true and pseudo-severe 
aortic stenosis in low-flow low-gradient cases (although this study also reinforced the 
link between Zva and low ejection fraction and reduced contractile reserve as assessed 
by dobutamine stress echocardiography)(Levy et al., 2011). 
Zva is also associated with outcome. Of 163 patients with moderate and severe aortic 
stenosis followed over a mean of 20 months, a higher Zva was associated with an 
increased risk of events (operation, symptoms or death)(Lancellotti et al., 2010a). 
Additionally, a retrospective analysis of 544 patients with at least moderate aortic 
stenosis also showed the four-year event rate to be significantly higher in those with a 
high Zva(Hachicha et al., 2009). Using ROC curves in the former study, a Zva value of 4.9 
mmHg / ml / m2 was identified as the best cut-off value associated with events. The 
latter study showed a Zva of greater than 4.5 mmHg / ml / m2 increased the mortality 
risk by 2.76-fold. 
 
5.1.2 CORONARY HAEMODYNAMICS IN LOW-FLOW LOW-GRADIENT AORTIC STENOSIS 
In order to distinguish true- from pseudo-aortic stenosis in patients with low-flow low-
gradient aortic stenosis dobutamine stress-echocardiography has been used to 
demonstrate those patients with contractile reserve from those without(Monin et al., 
2001, Schwammenthal et al., 2001). Other methods to distinguish these patients using 
projected effective orifice area at a normal transvalvular flow rate has been shown to 
correlate reasonably with patient sub classification(Blais et al., 2006). Alternatively, the 
degree of calcification is also a predictor of the severity of aortic stenosis and this can be 
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useful in this situation(Cueff et al., 2011). PET scanning is a useful tool for 
demonstrating coronary vasodilator reserve(Rajappan et al., 2002) and has been used 
to distinguish patients with low-flow low-gradient aortic stenotic patients(Burwash et 
al., 2008).  
 
5.1.3 WAVE INTENSITY ANALYSIS IN AORTIC STENOSIS 
Up until now it has not been possible to gather wave-intensity data on patients with 
more moderate degrees of aortic stenosis. This is because they are largely 
asymptomatic and therefore have no need to undergo invasive coronary assessments 
necessary for coronary pressure and flow assessment. However, certain predications 
can be made regarding mild and moderate aortic stenosis based on previous wave 
intensity work. 
Again, there is a balance between the detrimental effect of myocardial hypertrophy and 
the increased intra-myocardial force generated by driving blood against a stenotic 
aortic valve. The former results in a reduction in the backward expansion wave 
responsible for transferring energy to drive coronary flow(Davies et al., 2006a) whilst 
the latter results in a progressive increase in this force due to the transmission of 
greater systolic compression to diastolic relaxation and resultant coronary 
suction(Davies et al., 2011). 
Of these two opposing pathophysiological efforts, it is likely that the latter will dominate 
although its effect will be attenuated by the former. For example, it has already been 
shown that in patients pre-TAVI with severe aortic stenosis, the backward expansion 
wave is much greater than in control patients and that once the aortic stenosis and 
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stenotic forces are relieved, there is a large decline in these values (see chapter 4). 
Therefore, overall there is likely to be a linear or quasi-linear relationship between 
backward peak and cumulative wave intensity and conventional echocardiographic 
measures of aortic stenosis in patients with normal left ventricular function.  
To further elaborate on wave-intensity in lesser degrees of aortic stenosis it is now 
possible to apply non-invasive wave-intensity analysis to these patients using the 
methods described above. 
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5.2 METHODS 
25 patients (11 female, mean age 72 ± 13) with varying degrees of aortic stenosis and 
preserved left ventricular function were recruited for non-invasive wave intensity 
assessments. Patients were either asymptomatic or had undergone a coronary 
angiogram showing no coronary lesions. Other exclusion criteria were concomitant 
moderate or severe aortic insufficiency or mitral valve disease or left ventricular 
ejection fraction <50%. 
Patients were identified either at the time of angiography or through a manual search of 
a hospital database. They were invited to attend and asked to abstain for nicotine, 
caffeine or nitrate therapy (if applicable) for 24 hours beforehand.  
 
5.2.1 WAVE INTENSITY ANALYSIS 
Wave-intensity was measured either invasively at the time of angiography (n=3) or 
using non-invasive assessment with transthoracic echocardiography and Pulsecor 
assessment (n=21). Briefly, the invasive assessment involved intubation of the left main 
stem with a Judkins guide catheter followed by administration of intra-arterial heparin. 
The Combowire (Volcano Corp - Figure 2-60) was then advanced into the mid-LAD and 
a continuous recording of 1 minute was taken once a stable signal had been achieved. 
Data was recorded onto a Combomap console and wave-intensity analysis performed 
offline using custom built Matlab (Mathworks, Natick, MA) software.  
Non-invasive assessment was performed using an Esaote MyLabTwice (Esaote, Genoa, 
Italy) and a Pulsecor Cardioscope II (Pulsecor, Auckland, New Zealand). Coronary flow 
was imaged using a modified parasternal long axis view with inbuilt coronary flow 
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probe parameters activated. A minimum of 20 coronary flow signals were recorded and 
exported as a bmp file. A minimum of 2 Pulsecor readings (incorporating 6-10 beats per 
recording) were taken simultaneously (of fidelity ‘good’ or above) and exported as a 
Matlab file. Wave intensity was calculated using custom built Matlab (Mathworks, 
Natick, MA) software. 
5.2.2 AORTIC VALVE STENOSIS SEVERITY 
All patients also had conventional echocardiographic measures of aortic stenosis with 
the use of the modified Bernoulli equation, standard continuity equation for valve area 
and mean gradient calculated from flow VTI.  
5.2.3 LV MASS 
LV mass was calculated according to the standard echocardiographic formula: 
LV mass = 0.8 x (1.04 x (LVEDD + PWDD + IVSD)3 – LVEDD3) + 0.6 
LVEDD = Left Ventricular End Diastolic Dimension, PWDD = Posterior wall thickness in 
diastole, IVSD = intraventricular septal thickness in diastole. 
5.2.4 GLOBAL LV HEMODYNAMIC LOAD 
As a measure of global LV load, the valvuloarterial impedance was calculated according 
to previously described methods(Hachicha et al., 2009):  
Zva = (SAP + MG) / SVI 
where SAP is the systolic arterial pressure and MG is the mean transvalvular pressure 
gradient. 
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Advantageously, I used the Pulsecor-derived measure of central systolic arterial 
pressure for SAP rather than peripheral systolic pressure which seemed more 
appropriate for measuring the global LV haemodynamic load. 
5.2.5 STATISTICS 
Continuous data were expressed as mean ± SD. Correlation was ascertained using a 
Pearson’s correlation coefficient. p<0.05 is taken as significant. Student’s unpaired t test 
was used for comparisons between groups. 
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5.3 RESULTS 
5.3.1 DEMOGRAPHICS 
Baseline demographics are displayed in Table 5-1.  15 patients (60%) were treated for 
hypertension but overall the BP control was good (systolic mean 125 ± 18mmHg). All 
patients were asymptomatic. 
 
 
Age 72 ± 13 
Male (%) 15 (56) 
Diabetes 3 
Hypertension 15 
Smoker 2 
Weight, kg 79 ± 21 
Height, m 171 ± 10 
BSA , m2 1.1 ± 0.3 
Systolic central BP, 
mmHg 
125 ± 18 
TABLE 5-1. Baseline demographic data 
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5.3.2 ECHOCARDIOGRAPHIC DATA 
Echocardiographic data is displayed in Table 5-2. There was a wide spectrum of aortic 
valve disease from mild to severe. The minimum aortic gradient was 23mmHg 
(2.41m/s) and maximum 117 (5.43m/s). Mean gradient ranged from 13 to 77mmHg 
(mean 33mmHg). LV mass varied appropriately (mean 186±62.5) given the spectrum of 
aortic valve disease as did LV dimensions (LVEDd range: 3.4-5.9). 
 
 
 Mean Standard Deviation Minimum Maximum 
LVEDd 4.61 0.68 3.40 5.91 
LVEDs 3.01 0.60 2.00 4.10 
IVSd 1.13 0.22 0.70 1.60 
PWd 1.04 0.24 0.50 1.60 
LV mass (kg) 186 62.5 84.1 321 
Peak gradient 59 32 23 117 
Mean gradient 33 20 13 75 
Peak velocity 3.7 1.04 2.41 5.43 
AVA 0.97 0.37 1.60 0.40 
TABLE 5-2. Echocardiographic data 
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5.3.3 WAVE INTENSITY ANALYSIS 
Wave-intensity arranged according to AVmax is shown in Table 5-3 and by Zva in Table 
5-4. Across both spectrums of classification there is an increase in peak and cumulative 
backward expansion wave magnitude although this is most obvious when the 
cumulative backward expansion wave is classified by Zva.  
When lowest and highest magnitudes of division were compared, when classified by 
AVmax, the difference was not significant (AVmax 2-3m/s BEW = -118944 Wm-2s-2 vs 
AVmax 5-6m/s BEW = -264696 Wm-2s-2, p =0.051) whereas this reached significant 
when divided by Zva (2-4 mmHgml-1m-2 BEW = -141789 Wm-2s-2 vs 8-10 mmHgml-1m-2 
BEW = -370553 Wm-2s-2, p=0.02), (Figure 5-1). 
Correlation scatter graphs were constructed for aortic valve area, mean gradient, 
AVmax and Zva against peak and cumulative wave intensity. Data for cumulative wave 
intensity is shown in Figure 5-2. The correlation coefficient steadily increased with the 
highest r value associated with valvulo-arterial impedance (Zva): AVA r=0.41 (p=0.04), 
Mean gradient r = -0.51 (p=0.01), AVmax r=-0.5 (p=0.01), Zva r = -0.66 (p<0.001) 
(Figure 5-2). 
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AVmax n AVA Peak BEW Cumulative BEW 
2-3 8 1.3 11.9 ± 5.4 x104 64.8 ± 31.7 x 105 
3-4 7 1.1 18.4 ± 9.17 x104 88.1 ± 40.6 x 105 
4-5 4 0.9 14.7 ± 4.77 x104 65.6 ± 16.8 x105 
5-6 6 0.7 30.0 ± 23.1 x104 155.8 ± 77.0 x105 
TABLE 5-3. Wave intensity arranged according to AVmax categories.  
There is a steady appropriate increase in peak and cumulative backward expansion 
wave with progressive aortic valve gradient.  
 
Zva (mmHg  
ml-1 m-2) 
n Peak BEW 
(Wm-2s-2) 
Cumulative BEW 
(Wm-2s-1) 
AVA 
(cm2) 
AVmax 
(ms-1) 
Mean gradient 
(mmHg) 
2-4 9 -14.1 x104 -71.6 x 105 1.2 3.4 26 
4-6 7 -13.9 x104 -76.5 x 105 1.0 3.6 31 
6-8 5 -18.0 x 104 -82.8 x 105 0.95 3.6 32 
8-10 4 -37.1 x 104 -180.0 x 105 0.74 4.0 42 
TABLE 5-4. Wave intensity arranged according to Zva categories.  
Again, there is a steady appropriate increase in peak and cumulative backward 
expansion wave. The Zva categories broadly match the valve area and gradients.  
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FIGURE 5-1. Peak and cumulative backward expansion waves according to AVmax and 
Zva.  
Wave intensity values are displayed as positive with error bars reflecting SEM. Using 
both peak and cumulative measures of BEW there is an increase in BEW with AVmax 
although this is only significant with cumulative measures. When Zva was used both 
cumulative and peak BEW were significant with a more impressive p value than seen 
with AVmax. 
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FIGURE 5-2. Cumulative backward expansion wave with aortic valve area, mean aortic 
gradient, AVmax and Zva 
Again, there was an appropriate correlation with both AVmax and Zva and the 
backward expansion wave. However, the most accurate correlation was seen with the 
valvulo-arterial impedance particularly with the cumulative BEW. 
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5.4 DISCUSSION 
Using non-invasive wave-intensity I have demonstrated that it is possible to assess 
coronary energy transfer across a spectrum of aortic valve disease. Using this technique, 
I have shown that the increasing valve gradient and resultant increase in systolic 
contraction and corresponding diastolic relaxation is indeed the dominant effect on 
coronary wave intensity. As aortic valve disease progresses, the peak and cumulative 
backward expansion wave increases in response to the increased intra-ventricular 
forces. This is therefore both a new measure of the severity of aortic stenosis as well as 
a physiological validation of our concepts of wave-intensity in aortic stenosis. 
 
5.4.1 AORTIC STENOSIS VARIABILITY 
The process of aortic stenosis progression is a dynamic one and shows a great deal of 
chronological and pathological variability between patients. Additionally, as has been 
highlighted by various MRI studies, the response of the left ventricle to the increased 
pressure load in terms of myocardial hypertrophy and underlying fibrosis is also highly 
variable as the disease progresses(Debl et al., 2006, Rudolph et al., 2009, Dweck et al., 
2012a); post-operatively the amount of fibrosis is linked with LV recovery and 
outcome(Azevedo et al., 2010). Therefore, whilst conventional echocardiographic 
measures of aortic stenosis are practical and easily applicable within clinical practice, 
they remain slightly crude in providing information about the entirety of cardiac 
function within aortic stenosis.  
For example, risk stratification and outcome following aortic valve surgery in moderate 
or severe aortic stenosis can be predicted more accurately when additional assessments 
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of LV function are included with strain or exercise echocardiography (Ng et al., 2011, 
Maréchaux et al., 2010, Poulsen et al., 2007). Additionally, BNP correlates better with 
outcome over the usual echocardiographic measures of aortic stenosis(Gerber et al., 
2003, Bergler-Klein et al., 2004, Weber et al., 2006). These studies reinforce the fact that 
it is the impaction of the pressure gradient on the left ventricle (rather than the 
pressure gradient itself) and the response of the left ventricle to this burden that drives 
prognosis and outcome.  
Therefore, it is not a surprise therefore that wave-intensity analysis, a measure that 
incorporates ventricular function as well as the direct haemodynamic effects of a 
stenotic aortic valve does not have a perfectly linear relationship with simple measures 
of aortic valve stenosis. Moreover, wave-intensity should provide a more accurate 
measurement of the impact of aortic stenosis and correlates with other measures of 
aortic stenotic burden would provide a useful direction for future work. 
5.4.2 FIBROSIS VERSUS HYPERTROPHY 
One thing that is unclear is the differing effects and deposition patterns of myocardial 
fibrosis and hypertrophy in aortic stenosis. Although imaging studies using MRI have 
shown the two entities are closely linked there is obviously some inherent variability 
between the presence and absence of fibrosis in patients with LVH. Histological studies 
seem to suggest that the change from hypertrophy to fibrosis is involved in the 
transition to heart failure in aortic stenosis(Hein et al., 2003) and indeed, if mid-wall 
fibrosis as well as LVH is noted on MRI, patients with severe aortic stenosis tend to have 
a poorer outcome (Azevedo et al., 2010). Basic transthoracic echocardiography can only 
document hypertrophy and left ventricular function and can provide little information 
on the degree of fibrosis although we assume the former to be a surrogate for the latter.  
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Therefore, it is not certain whether wave-intensity is negatively impact upon by the 
presence of fibrosis in these aortic stenotic patients or whether it is a mechanical effect 
exerted by the hypertrophy although it is perhaps most likely a combination of the two. 
This may also introduce a degree of variability into the wave-intensity values if LVH 
alone is measured in aortic stenosis; ultimately however, this tool may prove useful in 
the long-term in separating these components perhaps when used in conjunction with 
MRI scanning. 
Additionally, as has been commented on in detail in previous chapters, in aortic stenosis 
the second influence on the backward expansion wave is the presence of myocardial 
hypertrophy which exerts an effect counter to that of the stenotic valve. This may 
explain why, particularly in the mild- and moderate-aortic stenotic range where the two 
opposing forces may be of similar magnitude, there is not a perfectly linear relationship 
between conventional measures of aortic stenosis and wave-intensity.  
 
5.4.3 ACCOUNTING FOR VASCULAR LOAD 
Previous work has demonstrated the importance of accounting for the pressure effect 
beyond the valve in risk stratification in aortic stenosis(Briand et al., 2005, Lancellotti et 
al., 2010a, Lancellotti et al., 2010b, Hachicha et al., 2009). Given that this impedance 
value is believed to be a more accurate measurement of the pressure effect on the left 
ventricle, assessing valvulo-arterial impedance should provide a more accurate 
correlation with wave-intensity analysis and this is indeed the case. This is therefore a 
validation of the valvulo-arterial impedance concept where a higher Zva results in 
greater energy exchange at a myocardial level through an increased systolic force 
translating to an increased diastolic relaxation.  
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5.5 CONCLUSION 
I have successfully demonstrated the application of non-invasive wave-intensity to a 
group of patients with no invasive sampling option and have gone on to show that the 
backward expansion wave increases with increasing severity of aortic stenosis. I have 
also confirmed the relative crudity of simple echocardiographic measures of severity 
which provide information about the valve but not about the effect it is having on the 
underlying myocardium. Finally I have demonstrated that the valvulo-arterial 
impedance calculation provides a more accurate measure of energy exchange at the 
myocardial level. 
The use of non-invasive wave-intensity analysis may therefore form an alternate option 
in the assessment of aortic valve disease. Future work may direct itself at correlating 
other measures of myocardial function with wave-intensity in these patients through 
use of non-invasive coronary flow reserve or speckle-tracking. It will also be interesting 
to recognise differences in the wave-intensity profile based on the variability of fibrosis 
and hypertrophy documented at MRI.  
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6 CHAPTER 6: CONCLUSIONS AND FUTURE DIRECTIONS 
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6.1 SUMMARY OF MAIN FINDINGS 
6.1.1 MYOCARDIAL ISCHAEMIA IN AORTIC STENOSIS 
Myocardial ischaemia is a detrimental problem in aortic stenosis. Its cause is largely 
linked with the two dominant pathological features in aortic stenosis: the stenotic aortic 
valve and the resultant but necessary left ventricular hypertrophy. At present, in the 
majority of cases we are reliant on relatively crude measures to assess and time 
intervention in aortic stenosis such as the presence of symptoms combined with 
echocardiographic-derived values of valve gradients and ejection fraction.  
In up to 50% of patients with chest pain and aortic stenosis, unobstructed coronary 
arteries are noted at angiography(Gould and Carabello, 2003). However, using more 
sophisticated techniques it is possible to recognise abnormalities in the coronary 
physiology of these patients through use of lactic acid sampling, thallium scans and 24-
hour Holter monitors, invasive coronary Doppler techniques, resting coronary flow 
rates, contrast and stress echocardiography and PET scanning. 
Previous animal and human works has endeavoured to recognise the 
pathophysiological features that contribute to abnormal coronary physiology in aortic 
stenosis. The most important abnormalities appear to be exerted through extravascular 
compression effects, a shortened diastolic perfusion time, reduced capillary density, 
increased oxygen diffusion distances and low coronary sinus pressures. What is 
certainly most clear from all these studies is that the effect of aortic stenosis on the left 
ventricle is only indirectly assessed by quantifying the aortic valve using echo. There is 
a large variability in the way the left ventricle responds to the increased outflow tract 
obstruction and therefore what would be more useful in the assessment of aortic 
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stenosis would be an easily applicable measurement that can be used to quantify this 
global burden. 
 
6.1.2 INVASIVE WAVE INTENSITY ANALYSIS IN SEVERE AORTIC STENOSIS 
Wave intensity analysis may be such a measurement. This concept is based on fluid 
dynamics and is a temporal-based assessment of energy transfer that provides a 
measure of both magnitude and direction of energy acting on the coronary blood flow. It 
has been applied to normal coronary arteries and shown an inverse relationship with 
left ventricular hypertrophy reflecting the inefficiency of this state(Davies et al., 2006a).  
With the expansion of the TAVI procedure to higher risk patients with severe aortic 
stenosis, it has become possible to conveniently measure wave-intensity peri-
procedurally in these patients. I have shown that severe aortic stenosis results in an 
increase in the magnitude of the backward suction wave responsible for antegradely 
driving coronary flow and that this is likely a reflection of the increased force of 
contraction which is then transmitted as an increased force of relaxation due to the 
elastic properties of the left ventricle. More interestingly, this wave profile changes 
unfavourably pre-TAVI and returns to the physiological norm(Lockie et al., 2012, Sun et 
al., 2000) post-TAVI in response to pacing. This implies a discoordination and 
worsening efficiency of energy transfer in aortic stenotic patients with increasing heart 
rate and is likely to be involved in the generation of symptoms in these patients.  
Wave-intensity analysis is a very useful tool in this setting to provide key information 
about these aortic stenotic patients. However, until now its main disadvantage is that it 
requires invasive measurements of coronary flow and pressure albeit from a single 
266 
 
sensor tipped wire. The ability to perform coronary wave-intensity non-invasively 
would therefore be highly desirable in order to perform multiple measurements in the 
same individual. 
 
6.1.3 NON-INVASIVE CORONARY WAVE INTENSITY 
It has been possible to measure coronary flow using transthoracic echocardiography for 
over 20 years. However, as hardware technology improved, the quality of the signal 
obtained is now higher than ever and allows for accurate discrimination of the period of 
diastolic acceleration necessary for the construction of non-invasive wave-intensity. 
Additionally, much work in the field of invasive coronary pressure (particularly that 
involving Fractional Flow Reserve) has demonstrated that the central aortic pressure is 
a good reflection of the pressure in the coronary arteries providing there is an absence 
of obstructions. There are now several ways to estimate central aortic, and therefore 
indirectly coronary, pressure non-invasively. 
Using these two techniques simultaneously has allowed the development of non-
invasive coronary wave-intensity analysis. In this thesis I have gone on to validate this 
technique in 17 patients with unobstructed coronary arteries. In a further 9 patients I 
have shown this technique produces an appropriate response during exercise as seen 
with invasive measurements and a trend towards the appropriate response with 
increasing left ventricular mass. Finally I have demonstrated the technique to be easily 
reproducible. 
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6.1.4 APPLICATION OF NON-INVASIVE WAVE INTENSITY IN PATIENTS WITH AORTIC 
STENOSIS 
As the gradient across the aortic valve increases, there is a progressive increase in the 
force required to eject blood across this valve. This is accompanied by an increase in the 
trans-capillary compression during systole and the potentially stored elastic energy in 
the myocardium from this compression is transferred to a kinetic force as the capillaries 
re-expand resulting in coronary acceleration. Although reports are slightly conflicting, 
the majority of data supports the notion that coronary flow rates increase with 
increasing aortic stenosis and this is certainly demonstrated here.  
Using a spectrum of aortic valve disease patients I have shown that this theory does 
indeed hold true when assessed with non-invasive wave-intensity analysis where there 
is a reasonable correlation between the aortic valve gradient and the peak and the 
cumulative backward expansion wave. Additionally, previous work by other groups has 
also highlighted the importance of incorporating the arterial stiffness burden that acts 
in tandem with the aortic valve gradient to impact on the left ventricle(Briand et al., 
2005). Therefore, we would anticipate that the Zva (the valvuloarterial impedance) 
which is a measure of the global force acting on the left ventricle would more accurately 
correlate with coronary energy transfer than simple echocardiographic measures of 
aortic stenotic severity and this is indeed found to be the case.  
Therefore it appears that the backward expansion wave responds as anticipated with 
increasing severity of aortic stenosis. Additionally, I have also shown that the backward 
expansion wave decreases in magnitude appropriately after TAVI or conventional AVR 
as has been seen invasively. This confirms this phenomenon and also shows that it is 
not just confined to patients undergoing the TAVI procedure but also to AVR patients, 
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nor is it a result of the inotropic or adrenergic influences apparent peri-procedurally 
during TAVI.  
Interestingly, the reduction in backward expansion wave is to a level much less than 
normal and this is most likely an effect of the residual myocardial hypertrophy which is 
known to add inefficiency to energy transfer. However, with the removal of the outflow 
tract obstruction, there is a regression of left ventricular hypertrophy over time and 
importantly, this translates to a progressive increase in the backward expansion wave 
to levels similar to that seen in normal individuals. 
 
6.2 FURTHER HYPOTHESES – WHAT HAPPENS IN THE FAILING VENTRICLE? 
Using these techniques, I have been able to give an idea of the ‘life cycle’ of wave-
intensity with aortic stenosis. However, there is a final clinical scenario that I have not 
explored fully and may prove an important future direction of research – that is of 
aortic stenosis with the failing left ventricle. The hypothesis is that as the LV starts to 
fail from the continual afterload burden, its force of contraction and resultant relaxation 
would also decline, perhaps in a similarly linear fashion.  
To that end, it is interesting to note some of the very early work on coronary flow in 
aortic stenosis using transoesophageal echocardiography noted that patients with 
severe aortic stenosis and angina, presyncope or syncope have higher than average 
coronary flow rates but flow rates in those with shortness of breath did not differ from 
controls. One possible implication from this study, which did not comment on LV 
systolic function in their patient group, is that when patient’s hearts are failing (causing 
dyspnoea), coronary flow rates may fall(Omran et al., 2011). 
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I have performed non-invasive wave-intensity in some of these patients with failing LV 
secondary to aortic stenosis and not coronary disease or another cause. Initial pilot 
work suggests that there appears to be two patterns of coronary flow in these patients: 
1) patients in whom peak coronary flow rate is maintained but the rate of acceleration 
is reduced and 2) patients in whom peak coronary flow is reduced (Figure 6-1). This 
former pattern has been recognised in the literature but linked crudely with severity 
rather than severity plus LV impairment in early studies(Kenny et al., 1994).
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FIGURE 6-1. Flow patterns in severe aortic stenosis with severe LV impairment. 
Note the different scales in these two examples. The left hand panel demonstrates the first example where peak coronary flow rates are 
preserved but acceleration reduced compared to the right hand panel where coronary flow rates are reduced.
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Both of these patients had greatly reduced peak backward expansion wave (-45661 and 
-31688 Wm-2s-2) but very different cumulative expansion waves (-43x105 versus -
18x105 Wm-2s-1). This can be seen graphically in Figure 6-2.  
Therefore, it would appear that despite a severely impaired LV, the patient with the 
preserved peak coronary flow rate still has the ability to generate a significant energy 
transfer compared to the low coronary flow rate patient. One could hypothesize further 
that wave-intensity may in fact be able to distinguish patients with severe aortic 
stenosis and severe LV impairment who would do well following aortic valve 
replacement by assessing the ratio of peak-to-cumulative backward expansion wave 
magnitude.  This is demonstrated pictorially in Figure 6-3. 
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FIGURE 6-2. Coronary wave intensity analysis in severe aortic stenosis with severe left 
ventricular impairment.  
The upper panels demonstrate coronary flow (blue) and pressure (green) and the lower 
panels overall wave-intensity (red), and the influence of flow (green) and pressure 
(blue). Note the backward expansion waves are similar in peak but there is a much 
larger area under the curve in the left hand panel where coronary flow rates are 
preserved with a slower acceleration rate.  
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FIGURE 6-3.  Figurative representation of the changes occurring with the peak and 
cumulative BEW as severe aortic stenosis progresses to left ventricular dysfunction.  
With the onset of LV dysfunction there is initially a decline in the peak backward 
expansion wave. The cumulative backward expansion wave is preserved. As time 
progresses further, the cumulative backward expansion wave also declines reflecting a 
loss of the ability of the left ventricle to recover following at aortic valve intervention. At 
this point aortic valve replacement or TAVI will provide no benefit and medical therapy 
is the appropriate management strategy. 
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6.3 THE BACKWARD EXPANSION WAVE IN AORTIC STENOSIS 
Through the use of non-invasive techniques, it is therefore now possible to construct 
the complete life-cycle of the backward expansion wave in aortic stenosis (Figure 6-4). 
 
FIGURE 6-4. Suggested graphical representation of the backward expansion wave 
throughout the development and treatment of aortic stenosis.  
There is a progressive increase in its value until it reaches a point when the LV is 
detrimentally ischaemic. At this point aortic valve intervention (TAVI or AVR) will result 
in a large decrease in its size followed by a steady increase with the regression of LVH. 
Alternatively, if no intervention occurs the left ventricle starts to fail and the backward 
expansion wave falls slowly and presumably irreversibly (see FIGURE 6-3) 
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6.4 MYOCARDIAL FIBROSIS VERSUS HYPERTROPHY 
One other unanswered but interesting area of potential exploration is the distinction 
between myocardial fibrosis and hypertrophy. Whilst the two pathologies are present in 
aortic stenosis there appears to be a degree of variability and it may be that they 
respond differently following aortic valve intervention. One can imagine the 
hypertrophy can regress fully but fibrosis may be irreversible. This may create some 
variability in the response of the backward expansion wave following aortic valve 
replacement and may even account for some of the differences in the two patients 
above with coexisting severe left ventricular dysfunction. It also may explain why the 
relationship between worsening aortic stenosis and wave intensity is not entirely linear.  
Therefore, a future direction of study would be in linking MRI data and outcome with 
wave-intensity analysis and discerning the effect of late-gadolinium enhancement 
changes from non-fibrotic hypertrophy and resultant wave intensity recovery following 
intervention. Additionally, discerning the differing effects of fibrosis and hypertrophy 
on wave-intensity expression would also be insightful.  
 
6.5 WAVE INTENSITY ANALYSIS – CLINICAL APPLICATION 
The potential for the use of wave-intensity analysis in the assessment of aortic stenosis 
is multi-faceted. Firstly, it obviously can provide a non-invasive assessment of left 
ventricular burden. The key theme throughout this thesis is that whilst simple 
echocardiographic measures of aortic stenosis severity are helpful in risk-quantification 
on a crude level,  the left ventricle is influenced by many other factors as well (such as 
arterial impedance) and its response to this is also variable (varying degrees of 
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hypertrophy and/or fibrosis). Therefore, an assessment of the effect of aortic stenosis 
on the left ventricle is highly desirable in these patients and that is what wave intensity 
provides. 
Additionally, I have demonstrated the use of non-invasive wave intensity analysis 
during exercise in patients with normal hearts and the effect of pacing on wave intensity 
analysis in patients with severe aortic stenosis. The next step could be to use non-
invasive exercise wave-intensity measures as an assessment of myocardial reserve to 
aid in the appropriate timing of intervention particularly in asymptomatic patients or 
patients with moderate aortic stenosis. In patients with a fall in the backward expansion 
wave with exercise a move towards intervention would be appropriate; if the backward 
expansion wave is preserved or increased a more conservative strategy could be 
adopted.  
Finally, it may also have a role in the assessment of low-flow low-gradient aortic 
stenosis where the left ventricle is failing and the flow is low. In these patients, it can be 
hard to discern whether the low flow rates through the valve are appropriate for the 
ventricular function or whether there is significant impaction from a severely stenotic 
but underestimated aortic valve. By assessing the ratio of cumulative-to-peak backward 
expansion wave intensity, it may be possible to recognise an energy reserve in the form 
of a preserved cumulative backward expansion wave and thus a high ratio. This is an 
area that obviously needs further exploration. 
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6.6 CONCLUSIONS 
Aortic stenosis is a dynamic and variable disease state. The key feature of this condition 
is not the degree of back-pressure exerted by the aortic valve but how the left ventricle 
responds and adapts to this afterload. Wave-intensity analysis provides both an 
invasive and non-invasive way to assess the left ventricular load in these patients and 
therefore has the potential to provide a more accurate risk stratification and outcome 
prediction in these patients.  
Non-invasive wave intensity has the advantage that unlike MRI it is relatively 
inexpensive and unlike stress testing it requires no inotropic action. Its disadvantage is 
in a relative high degree of technical skill to achieve accurate coronary-flow 
measurements. It is also not yet clear as to what effect coronary lesions would have on 
the wave-intensity profile and therefore it may not have a role in all patients or in those 
who have undergone previous bypass surgery. 
However, I believe this thesis has greatly advanced our understanding at a technical 
level of the behaviour of the backward expansion wave and at a clinical level it may 
have a role in the assessment of individual patient risk in a variety of settings. Further 
work is encouraged in this field to elucidate the varying effects of valvular, arterial and 
hypertrophy on wave-intensity in these complex patients coupled with other modalities 
such as MRI and exercise echocardiography. 
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